data_2rv0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rv0 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 m -136.43 135.09 38.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.445 1.098 . . . . 0.0 111.399 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -57.96 127.8 80.03 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.446 1.098 . . . . 0.0 112.104 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.62 -6.83 19.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.952 2.435 . . . . 0.0 113.587 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -115.9 -34.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.41 1.084 . . . . 0.0 113.092 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -132.71 5.57 3.97 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 61.72 12.9 4.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.93 2.092 . . . . 0.0 116.0 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -61.66 139.12 58.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.705 -1.247 . . . . 0.0 111.258 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.6 m -81.49 148.0 29.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.354 1.062 . . . . 0.0 113.236 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -141.13 147.63 38.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.96 2.104 . . . . 0.0 111.679 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 p -92.86 -17.21 24.35 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -142.67 150.04 39.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.656 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.52 -37.62 81.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.227 1.411 . . . . 0.0 112.899 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -66.33 -30.14 70.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.21 -42.72 25.35 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.601 0.761 . . . . 0.0 111.465 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -66.59 -38.24 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 118.329 0.513 . . . . 0.0 111.548 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.83 -40.85 97.58 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.902 -1.124 . . . . 0.0 112.198 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -61.6 -40.77 96.0 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.558 0.617 . . . . 0.0 111.916 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.0 -46.41 84.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.689 0.795 . . . . 0.0 112.674 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.0 -42.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.607 -0.683 . . . . 0.0 110.487 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -68.15 -32.5 72.82 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.8 p -91.97 -35.89 13.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -107.36 -26.4 11.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.48 1.112 . . . . 0.0 113.425 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 . . . . . 0 CA--C 1.556 1.203 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 -172.73 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.856 -0.053 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -131.39 136.74 48.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.932 0.893 . . . . 0.0 112.11 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.0 t -61.18 131.77 92.23 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.122 0.969 . . . . 0.0 111.967 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.01 -7.54 20.04 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.405 2.736 . . . . 0.0 113.935 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.02 -37.06 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.28 1.032 . . . . 0.0 113.492 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -129.82 14.1 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 61.53 4.69 1.05 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.351 2.661 . . . . 0.0 117.285 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.27 147.45 53.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.728 1.211 . . . . 0.0 112.794 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 m -96.39 140.71 30.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.959 1.304 . . . . 0.0 112.954 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -137.66 147.62 45.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 111.605 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 m -89.51 -13.89 36.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -142.54 151.39 41.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.649 1.18 . . . . 0.0 111.954 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -14.94 63.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -81.98 -32.99 30.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.121 0.968 . . . . 0.0 112.86 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.57 -39.45 70.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.565 0.746 . . . . 0.0 111.365 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 118.094 0.406 . . . . 0.0 111.789 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -62.89 -46.29 88.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.656 0.782 . . . . 0.0 111.407 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -59.23 -42.67 91.62 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.391 0.541 . . . . 0.0 112.248 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -64.18 -46.76 82.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.106 0.866 . . . . 0.0 112.542 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.04 -42.61 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.692 -0.63 . . . . 0.0 110.655 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.84 -34.17 73.27 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 p -85.86 -35.56 20.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -109.42 -28.19 9.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -169.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -139.62 143.21 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.6 130.64 81.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.344 1.458 . . . . 0.0 112.471 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.79 -8.42 22.35 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.119 2.546 . . . . 0.0 113.557 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -113.88 -37.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.547 1.139 . . . . 0.0 112.826 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -135.22 11.63 3.55 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.2 6.71 1.39 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.192 2.597 . . . . 0.0 117.407 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -63.56 142.64 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.895 -1.128 . . . . 0.0 111.649 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 p -95.29 146.4 24.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.513 1.125 . . . . 0.0 114.006 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.87 144.4 33.82 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.923 1.689 . . . . 0.0 111.685 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.2 m -81.9 -20.24 39.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -142.82 151.68 41.39 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.962 1.305 . . . . 0.0 112.104 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.85 -34.88 76.77 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.333 1.053 . . . . 0.0 112.896 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -67.8 -31.05 70.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.98 -43.62 57.5 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.381 0.672 . . . . 0.0 111.372 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.09 -37.58 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.671 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -60.84 -43.55 98.14 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.957 1.253 . . . . 0.0 112.227 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -63.15 -37.33 86.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.227 0.921 . . . . 0.0 112.738 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.51 -46.12 87.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.21 0.913 . . . . 0.0 112.547 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.94 -41.78 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.549 -0.719 . . . . 0.0 110.725 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.32 -34.89 78.3 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 p -88.66 -34.26 17.31 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -109.61 -27.16 9.53 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 . . . . . 0 CA--C 1.557 1.222 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -171.109 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 p -142.35 141.92 32.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.681 0.792 . . . . 0.0 112.352 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -57.34 132.4 81.27 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.758 1.223 . . . . 0.0 112.72 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.85 -10.12 27.07 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.165 2.577 . . . . 0.0 113.833 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.93 -37.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.318 1.047 . . . . 0.0 113.184 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.21 4.91 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 60.23 12.1 3.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.264 2.226 . . . . 0.0 116.14 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.79 133.2 54.06 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.824 1.249 . . . . 0.0 111.119 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.8 m -85.86 145.32 27.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.214 1.006 . . . . 0.0 112.87 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.31 152.13 46.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.986 1.714 . . . . 0.0 111.763 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.1 p -97.69 -11.74 23.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.54 151.41 43.22 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.24 1.416 . . . . 0.0 111.484 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -36.45 83.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.198 0.599 . . . . 0.0 112.456 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -65.06 -28.78 69.71 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.57 -44.66 33.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.461 0.705 . . . . 0.0 111.617 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -68.27 -37.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.562 0.619 . . . . 0.0 111.737 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -60.01 -44.81 94.32 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.594 1.088 . . . . 0.0 111.512 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 m -61.07 -41.82 97.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.03 0.532 . . . . 0.0 112.053 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.28 -46.91 84.57 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.573 -0.705 . . . . 0.0 112.691 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.63 -44.48 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.592 -0.692 . . . . 0.0 110.265 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -68.25 -30.33 69.34 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.3 p -92.35 -35.2 13.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -107.99 -26.53 10.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.073 0.949 . . . . 0.0 113.116 -172.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 110.707 -0.109 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -137.73 134.29 35.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.797 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.43 130.19 80.81 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.798 1.239 . . . . 0.0 112.413 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.12 -9.98 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.158 2.572 . . . . 0.0 113.67 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -111.97 -37.07 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.379 1.072 . . . . 0.0 113.026 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -130.91 3.03 4.4 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 58.29 22.96 9.87 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.59 1.956 . . . . 0.0 115.45 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.53 135.62 51.85 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.726 169.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 m -87.05 144.83 26.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 113.235 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.88 145.98 38.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.643 1.577 . . . . 0.0 112.251 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 -18.41 37.23 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -142.26 148.62 38.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.65 1.58 . . . . 0.0 112.091 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.28 -34.27 73.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.49 1.116 . . . . 0.0 112.843 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -67.32 -29.81 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.881 0.873 . . . . 0.0 113.274 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.68 -37.29 27.65 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.319 1.048 . . . . 0.0 111.969 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.61 -38.58 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.748 -0.595 . . . . 0.0 110.955 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -60.53 -46.86 88.61 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.885 1.22 . . . . 0.0 112.387 174.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.8 p -65.22 -36.39 84.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.097 0.862 . . . . 0.0 112.385 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.8 -50.32 73.91 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.978 0.808 . . . . 0.0 112.52 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.09 -42.13 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 10.1 mmpt? -75.14 -16.13 60.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -99.25 -34.37 10.37 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.581 1.152 . . . . 0.0 113.73 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -106.15 -28.01 10.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.644 1.178 . . . . 0.0 113.465 -173.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 125.196 1.398 . . . . 0.0 111.623 -176.431 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p -140.09 142.55 36.09 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.11 131.39 87.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.25 1.42 . . . . 0.0 112.599 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 -10.13 23.87 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.262 2.642 . . . . 0.0 113.686 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.6 t -113.18 -36.34 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.598 1.159 . . . . 0.0 112.897 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -134.96 10.61 3.6 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 60.89 9.45 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.011 2.524 . . . . 0.0 117.18 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.65 144.8 56.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.439 1.096 . . . . 0.0 112.003 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.8 m -96.64 143.74 27.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.43 1.092 . . . . 0.0 113.633 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -140.16 154.25 46.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.348 1.859 . . . . 0.0 111.54 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.3 p -97.83 -10.2 25.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -142.01 151.78 42.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.498 1.119 . . . . 0.0 112.818 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.71 -39.13 76.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.245 1.418 . . . . 0.0 112.448 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.112 0.965 . . . . 0.0 113.541 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.83 -44.24 41.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.469 0.708 . . . . 0.0 111.415 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -67.43 -38.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.717 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.29 -42.98 99.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.809 1.186 . . . . 0.0 112.072 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.7 t -57.79 -45.18 86.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.667 0.667 . . . . 0.0 111.596 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -60.69 -49.14 78.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.712 0.805 . . . . 0.0 112.947 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.12 -42.39 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -72.7 -23.86 60.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 t -104.01 -15.82 15.49 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -116.03 -28.62 6.57 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 . . . . . 0 CA--C 1.557 1.238 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.274 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -137.86 134.15 34.75 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 0.0 112.148 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.5 t -56.84 128.96 77.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.133 1.373 . . . . 0.0 112.185 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.52 -8.52 22.71 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.107 2.538 . . . . 0.0 113.481 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.25 -37.13 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.614 1.166 . . . . 0.0 112.682 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 p -136.5 7.56 3.06 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 58.55 22.26 9.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.103 2.161 . . . . 0.0 116.073 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -72.71 142.44 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.003 -1.061 . . . . 0.0 111.129 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 p -96.24 145.03 25.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.445 1.098 . . . . 0.0 113.923 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -141.26 157.61 44.99 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.2 1.8 . . . . 0.0 111.668 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -106.2 -2.77 22.11 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -146.14 150.71 36.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.469 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.64 -35.25 79.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.729 0.812 . . . . 0.0 112.626 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -68.84 -29.45 67.78 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.11 -44.59 53.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.676 0.671 . . . . 0.0 111.398 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.87 -38.94 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.805 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -60.92 -42.71 98.66 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.016 1.28 . . . . 0.0 112.095 172.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.47 -42.34 98.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.357 0.526 . . . . 0.0 111.765 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -62.5 -48.51 79.23 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.687 -0.633 . . . . 0.0 112.628 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.4 mt -57.71 -44.49 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.431 0.692 . . . . 0.0 110.441 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.98 -32.67 71.0 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 p -89.43 -37.46 14.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.62 -24.75 14.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.438 1.095 . . . . 0.0 113.168 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 125.019 1.328 . . . . 0.0 112.772 -175.554 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.3 p -115.19 141.37 48.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.186 0.994 . . . . 0.0 113.06 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.36 129.49 86.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.308 . . . . 0.0 112.198 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.83 -8.96 23.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.309 2.673 . . . . 0.0 113.424 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.4 t -113.28 -38.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.601 1.16 . . . . 0.0 112.59 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 p -137.51 20.74 2.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 58.26 -6.58 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.756 3.222 . . . . 0.0 119.221 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -62.25 146.23 51.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.055 1.298 . . . . 0.0 112.531 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.4 m -108.11 146.52 32.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.529 1.132 . . . . 0.0 113.855 -171.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -137.71 145.12 42.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.829 2.051 . . . . 0.0 110.972 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -87.39 -8.27 56.76 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -143.32 152.54 41.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.008 1.323 . . . . 0.0 111.471 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.31 -33.65 75.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.818 0.847 . . . . 0.0 112.828 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.5 -29.6 69.06 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.309 -0.869 . . . . 0.0 113.181 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.21 -42.05 47.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.613 0.765 . . . . 0.0 111.389 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -68.61 -38.71 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.493 0.588 . . . . 0.0 111.846 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -63.58 -39.99 95.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.903 1.229 . . . . 0.0 112.174 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -60.65 -44.53 96.32 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.358 0.663 . . . . 0.0 111.78 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.44 -47.99 83.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 112.532 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.2 mt -60.24 -42.49 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 110.79 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.2 -20.12 60.3 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 p -99.02 -27.6 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.812 1.245 . . . . 0.0 114.014 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -111.08 -28.74 8.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.294 1.038 . . . . 0.0 113.776 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 CA--C 1.557 1.221 0 C-N-CA 125.352 1.461 . . . . 0.0 112.77 -173.715 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.048 -0.025 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.3 p -137.83 140.8 40.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.752 0.821 . . . . 0.0 112.973 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.3 t -56.87 131.96 79.25 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.06 1.344 . . . . 0.0 112.592 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.67 -9.61 25.24 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.149 2.566 . . . . 0.0 113.774 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.15 -38.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 113.009 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.2 p -132.72 10.73 4.34 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 60.56 7.17 1.28 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.295 2.638 . . . . 0.0 117.208 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -62.21 142.78 57.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.423 1.089 . . . . 0.0 111.658 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 p -96.1 146.26 24.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.634 1.173 . . . . 0.0 113.983 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.36 144.27 33.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.996 1.719 . . . . 0.0 111.774 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 m -84.38 -19.08 34.16 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -143.63 153.78 42.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.173 1.389 . . . . 0.0 111.78 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.54 -40.39 87.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.633 0.773 . . . . 0.0 112.435 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -60.56 -30.01 69.52 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.149 -0.969 . . . . 0.0 113.565 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.58 -44.89 26.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.8 -38.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.37 0.532 . . . . 0.0 111.942 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.751 1.16 . . . . 0.0 111.474 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 t -59.03 -44.93 91.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.396 0.544 . . . . 0.0 111.792 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.82 -46.03 92.15 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.383 -0.823 . . . . 0.0 112.981 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.51 -44.02 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.726 0.811 . . . . 0.0 110.588 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -72.79 -28.63 62.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -90.15 -35.72 15.23 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -108.35 -26.4 10.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.393 1.077 . . . . 0.0 113.662 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 113.797 -173.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -136.68 134.44 37.25 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 112.468 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.59 132.75 82.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.155 1.382 . . . . 0.0 112.695 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.06 -10.72 26.43 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.161 2.574 . . . . 0.0 113.569 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.16 -41.08 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.399 1.08 . . . . 0.0 112.91 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.9 p -124.9 7.12 8.03 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 58.43 10.96 1.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.423 2.289 . . . . 0.0 115.392 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -66.49 135.7 54.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.486 2.315 . . . . 0.0 111.372 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 p -97.12 145.54 25.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -142.31 153.94 44.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.501 1.92 . . . . 0.0 111.808 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -87.22 -23.3 24.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -141.52 155.49 45.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.677 1.191 . . . . 0.0 113.085 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.56 -39.75 74.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.965 1.306 . . . . 0.0 112.652 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -64.48 -30.64 71.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.21 -44.31 26.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.937 0.895 . . . . 0.0 111.2 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.27 -41.22 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.543 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -63.38 -40.27 96.8 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.078 1.308 . . . . 0.0 111.85 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -60.57 -40.48 91.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.994 0.816 . . . . 0.0 112.01 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -63.41 -51.76 64.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.558 0.617 . . . . 0.0 112.657 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.83 -40.83 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.488 0.586 . . . . 0.0 110.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.3 -33.84 76.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -92.97 -29.8 15.67 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 113.959 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -106.86 -25.57 11.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.421 1.088 . . . . 0.0 113.766 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 . . . . . 0 CA--C 1.556 1.197 0 C-N-CA 124.755 1.222 . . . . 0.0 111.307 -172.643 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -134.75 141.0 46.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.719 0.808 . . . . 0.0 112.926 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.73 129.3 81.27 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.394 1.478 . . . . 0.0 112.608 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.02 -9.07 21.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.323 2.682 . . . . 0.0 113.387 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.4 t -112.34 -37.91 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.703 1.201 . . . . 0.0 112.693 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.4 p -137.72 19.92 2.87 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -172.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.51 -5.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 129.55 3.14 . . . . 0.0 119.05 168.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -62.18 143.66 56.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.916 1.235 . . . . 0.0 112.48 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.0 p -101.07 150.36 23.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.697 1.199 . . . . 0.0 113.891 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -140.03 147.82 40.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.009 2.124 . . . . 0.0 110.685 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 p -89.81 -10.4 45.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -150.92 158.95 44.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 111.652 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.38 -33.32 75.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -67.21 -24.91 65.89 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.057 -1.027 . . . . 0.0 112.931 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.43 -42.82 34.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 111.497 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -67.8 -38.59 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.428 0.558 . . . . 0.0 111.623 171.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.49 -39.72 94.37 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.853 1.206 . . . . 0.0 111.888 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -62.82 -42.07 99.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.571 0.623 . . . . 0.0 111.991 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.62 -46.69 88.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.635 0.774 . . . . 0.0 112.419 174.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.64 -42.49 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.038 0.935 . . . . 0.0 110.675 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -30.39 68.76 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -92.94 -25.84 17.84 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -114.18 -28.46 7.29 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 . . . . . 0 CA--C 1.554 1.124 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.916 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -137.18 139.23 40.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.862 0.865 . . . . 0.0 112.067 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.8 129.64 71.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.576 1.55 . . . . 0.0 112.294 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.51 -7.87 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 113.469 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -113.02 -37.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 112.756 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -135.78 11.49 3.4 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 61.66 10.07 3.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.871 2.468 . . . . 0.0 117.024 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.59 141.17 55.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.609 -1.307 . . . . 0.0 111.773 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -99.57 147.14 25.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -139.91 148.11 41.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.953 2.101 . . . . 0.0 111.329 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -88.11 -20.58 25.48 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -141.33 151.03 43.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.615 1.166 . . . . 0.0 112.699 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -61.72 -36.59 81.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.346 1.458 . . . . 0.0 113.769 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -68.2 -26.35 65.68 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.147 -0.971 . . . . 0.0 113.107 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.45 -43.24 33.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.679 0.792 . . . . 0.0 111.345 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.49 -39.57 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.115 0.416 . . . . 0.0 111.448 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -63.72 -38.27 90.49 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.983 -1.073 . . . . 0.0 112.373 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.2 m -62.59 -43.67 98.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.288 0.635 . . . . 0.0 111.692 171.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.92 -45.2 94.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 0.0 112.537 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.0 -42.11 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.404 0.681 . . . . 0.0 110.298 175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.68 -36.44 82.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 113.529 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -88.42 -33.9 17.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.44 -27.67 10.79 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 124.687 1.195 . . . . 0.0 113.976 -171.224 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -139.41 142.03 37.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -61.1 130.05 91.07 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.839 1.256 . . . . 0.0 112.31 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.17 -7.58 20.77 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.058 2.505 . . . . 0.0 113.525 177.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.88 -36.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.5 1.12 . . . . 0.0 113.055 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.85 3.5 4.46 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 62.16 12.91 5.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.907 2.083 . . . . 0.0 116.181 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.54 138.22 58.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.701 -1.249 . . . . 0.0 111.169 170.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -82.3 148.91 28.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.8 152.69 43.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.962 2.105 . . . . 0.0 111.458 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -96.49 -14.36 22.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -141.98 144.59 33.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.489 1.115 . . . . 0.0 112.32 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.42 -37.63 81.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.275 1.43 . . . . 0.0 113.156 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.44 -31.3 70.52 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.73 -43.59 46.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.39 0.676 . . . . 0.0 111.419 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.74 -38.83 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.135 0.425 . . . . 0.0 111.681 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -63.39 -41.22 98.76 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.674 1.125 . . . . 0.0 112.208 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -60.96 -43.66 98.41 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.615 . . . . 0.0 111.905 172.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -60.45 -48.47 81.61 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.836 0.855 . . . . 0.0 112.792 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.03 -41.99 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.997 0.919 . . . . 0.0 110.476 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -66.57 -36.77 83.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.909 1.284 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 t -95.01 -27.27 15.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -103.12 -28.62 11.84 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -169.882 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -124.0 131.73 53.6 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.868 0.867 . . . . 0.0 112.24 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.9 t -56.22 131.34 75.23 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 112.45 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.16 -9.38 23.28 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.298 2.665 . . . . 0.0 113.923 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.57 -36.85 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.324 1.05 . . . . 0.0 113.253 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 p -132.51 10.11 4.38 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 60.17 12.0 3.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.923 2.489 . . . . 0.0 116.918 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -64.78 147.26 53.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.457 1.103 . . . . 0.0 111.922 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.9 t -101.73 145.62 28.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 113.282 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -141.58 149.28 40.56 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.178 2.191 . . . . 0.0 111.119 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -90.81 -14.99 30.82 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.654 1.354 . . . . 0.0 114.654 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -141.59 151.58 43.28 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.603 1.161 . . . . 0.0 112.73 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.328 1.451 . . . . 0.0 112.896 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -67.61 -28.68 67.96 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.05 -42.72 25.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.634 0.774 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 tt -66.02 -38.7 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.243 0.474 . . . . 0.0 111.414 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.42 -39.01 93.02 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.669 1.122 . . . . 0.0 112.33 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -61.86 -41.2 97.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.729 0.695 . . . . 0.0 111.944 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -64.13 -46.28 84.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.519 0.727 . . . . 0.0 112.578 174.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.56 -43.24 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 110.788 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -29.66 67.88 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 p -91.9 -30.92 15.89 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -113.71 -27.73 7.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 CA--C 1.558 1.287 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -169.922 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -137.47 142.77 41.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.5 t -58.32 132.92 84.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.083 1.353 . . . . 0.0 112.684 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.9 -10.51 26.35 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.297 2.665 . . . . 0.0 113.973 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 -39.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.234 1.014 . . . . 0.0 113.039 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -129.69 9.9 5.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.94 10.7 2.26 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.071 2.548 . . . . 0.0 116.933 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -64.06 144.32 57.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.531 1.132 . . . . 0.0 111.771 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -98.27 143.85 28.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.464 1.106 . . . . 0.0 113.367 -172.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.26 145.98 39.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.157 1.783 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m -88.49 -15.15 36.04 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -140.82 148.72 41.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.797 1.239 . . . . 0.0 112.09 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.06 -37.64 83.39 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 112.684 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -67.52 -28.47 67.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.97 -43.91 33.2 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.438 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.79 -38.85 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.437 0.562 . . . . 0.0 111.573 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.39 -40.05 96.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.589 1.086 . . . . 0.0 112.19 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.9 m -61.67 -41.41 97.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.685 0.675 . . . . 0.0 111.882 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.51 -47.62 80.95 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.681 -0.637 . . . . 0.0 112.582 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.55 -43.6 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.406 0.683 . . . . 0.0 110.462 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -67.59 -31.5 71.59 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.9 p -91.47 -32.75 15.48 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 114.061 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -109.38 -27.47 9.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 CA--C 1.555 1.17 0 C-N-CA 124.435 1.094 . . . . 0.0 112.936 -172.737 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 m -127.36 135.3 50.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.723 0.809 . . . . 0.0 112.418 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.02 133.66 74.12 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.529 1.532 . . . . 0.0 112.959 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -10.5 27.62 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.16 2.574 . . . . 0.0 114.021 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.15 -34.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.114 0.966 . . . . 0.0 113.51 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -129.02 2.88 5.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 60.38 10.22 2.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.247 2.219 . . . . 0.0 116.347 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -62.48 143.91 56.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.048 -1.032 . . . . 0.0 111.574 171.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.0 p -102.9 148.75 25.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.86 149.31 41.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.912 2.085 . . . . 0.0 111.161 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 p -89.48 -14.52 35.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.59 146.29 39.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.19 1.396 . . . . 0.0 112.349 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.19 -36.59 80.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.198 1.399 . . . . 0.0 113.146 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -69.23 -28.65 66.54 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.29 -42.75 44.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.359 0.663 . . . . 0.0 111.552 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.6 -39.53 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 118.407 0.549 . . . . 0.0 111.573 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -63.53 -41.28 98.48 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.704 1.138 . . . . 0.0 112.203 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -59.12 -45.54 90.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.145 0.578 . . . . 0.0 111.46 171.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -60.98 -47.55 85.95 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.334 -0.854 . . . . 0.0 112.86 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.75 -45.19 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.971 0.908 . . . . 0.0 110.778 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.83 -25.2 52.92 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -91.17 -36.75 13.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 113.895 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -104.9 -27.63 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.182 0.993 . . . . 0.0 113.488 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 . . . . . 0 CA--C 1.552 1.05 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.23 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -137.09 146.61 45.33 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.01 129.51 86.3 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.523 1.129 . . . . 0.0 111.666 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 -7.32 19.0 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.122 2.548 . . . . 0.0 113.251 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 t -111.94 -38.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.691 1.196 . . . . 0.0 112.749 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 p -135.09 9.98 3.53 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.82 7.95 2.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.079 2.552 . . . . 0.0 117.04 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -66.19 147.31 53.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.43 1.092 . . . . 0.0 111.967 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.5 p -108.05 144.33 35.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.888 1.275 . . . . 0.0 113.796 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -141.73 156.59 45.6 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.686 1.995 . . . . 0.0 111.52 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.18 -18.99 34.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -172.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.57 155.99 43.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.212 1.005 . . . . 0.0 113.037 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.86 -35.72 80.9 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.5 -0.75 . . . . 0.0 112.253 173.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -66.32 -9.08 29.61 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -100.42 -44.45 5.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.624 1.17 . . . . 0.0 111.407 171.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 tp -67.72 -38.6 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.19 0.904 . . . . 0.0 112.985 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -65.52 -40.25 92.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.564 -0.71 . . . . 0.0 111.193 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 m -65.26 -40.21 93.66 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.1 -48.56 81.22 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.463 0.705 . . . . 0.0 112.019 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.08 -40.88 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 0.0 110.66 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.38 -40.36 89.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.769 1.228 . . . . 0.0 112.764 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 t -90.23 -28.02 19.12 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -101.63 -28.7 12.36 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 . . . . . 0 CA--C 1.558 1.286 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.651 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 p -144.73 143.28 30.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 0.0 112.664 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -59.84 129.11 87.6 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.55 1.14 . . . . 0.0 112.159 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -8.56 21.62 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.57 -38.07 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.159 . . . . 0.0 112.701 -176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.7 p -137.37 25.78 2.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 61.11 -20.36 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.996 3.318 . . . . 0.0 118.816 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -54.36 139.6 36.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.197 1.399 . . . . 0.0 113.629 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -92.94 148.58 21.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.769 1.228 . . . . 0.0 113.392 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.84 148.69 42.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.203 1.801 . . . . 0.0 111.688 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 m -88.95 -11.86 43.23 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -145.15 154.09 42.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.092 1.357 . . . . 0.0 111.741 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.09 -35.57 80.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.926 0.891 . . . . 0.0 112.693 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -67.95 -33.42 74.64 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.426 -0.796 . . . . 0.0 113.113 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.37 -45.53 69.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.386 0.674 . . . . 0.0 111.313 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.55 -36.82 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.183 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -63.33 -42.35 98.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.945 1.248 . . . . 0.0 112.21 174.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -61.42 -41.16 96.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.205 0.911 . . . . 0.0 112.198 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -62.4 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.01 0.823 . . . . 0.0 112.537 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.58 -42.67 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.655 0.782 . . . . 0.0 110.517 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -74.58 -21.65 59.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -94.22 -34.86 12.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.783 1.233 . . . . 0.0 113.975 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -106.74 -27.72 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.258 1.023 . . . . 0.0 113.656 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 125.489 1.516 . . . . 0.0 112.18 -172.232 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -133.71 138.48 45.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.604 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.17 133.18 87.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.363 1.465 . . . . 0.0 112.83 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.19 -11.52 25.11 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.257 2.638 . . . . 0.0 113.692 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.7 -40.64 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.332 1.053 . . . . 0.0 112.876 -176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -128.24 1.28 5.77 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 60.33 16.8 6.52 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.644 1.978 . . . . 0.0 115.618 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -64.45 137.26 57.78 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.902 -1.124 . . . . 0.0 110.648 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.2 m -102.2 147.48 26.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.207 1.003 . . . . 0.0 113.537 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -140.66 149.61 42.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.624 1.97 . . . . 0.0 111.552 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -87.96 -18.25 29.48 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -142.61 152.1 42.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.952 1.301 . . . . 0.0 111.802 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.91 -37.43 86.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -23.1 62.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.66 -45.42 37.18 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.616 0.767 . . . . 0.0 111.063 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -68.11 -40.48 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.711 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.74 -43.68 90.29 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.581 1.082 . . . . 0.0 111.75 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -62.89 -43.91 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.164 0.586 . . . . 0.0 111.95 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -59.76 -52.28 66.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.737 0.699 . . . . 0.0 112.41 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.37 -40.55 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.153 0.433 . . . . 0.0 110.202 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -71.09 -32.43 69.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.133 0.973 . . . . 0.0 113.398 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -88.86 -27.58 20.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.24 -25.03 11.69 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 124.533 1.133 . . . . 0.0 111.625 -172.167 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 111.201 0.075 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -121.04 133.29 55.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.369 1.068 . . . . 0.0 112.114 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.55 131.12 71.14 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.897 1.279 . . . . 0.0 112.164 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.38 -6.21 18.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.294 2.663 . . . . 0.0 113.784 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.86 -37.61 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.287 1.035 . . . . 0.0 113.244 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.04 8.96 4.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 59.7 16.37 5.44 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.906 2.482 . . . . 0.0 116.679 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -68.09 150.21 48.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.469 1.108 . . . . 0.0 112.078 172.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -103.28 142.06 34.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.699 1.2 . . . . 0.0 113.249 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -140.0 133.03 29.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.429 1.491 . . . . 0.0 111.633 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -82.84 -1.23 51.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -141.33 141.7 33.85 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.429 1.892 . . . . 0.0 110.544 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.19 -33.77 76.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.244 0.618 . . . . 0.0 112.453 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -66.84 -29.55 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.186 0.995 . . . . 0.0 113.471 173.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.5 mt -78.69 -40.34 34.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.959 0.8 . . . . 0.0 112.114 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.73 -40.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.268 0.94 . . . . 0.0 111.292 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.97 -40.0 94.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.801 1.182 . . . . 0.0 111.897 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.8 m -63.43 -42.41 98.69 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.786 0.721 . . . . 0.0 112.223 173.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -62.49 -45.85 91.13 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.486 -0.759 . . . . 0.0 112.227 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.09 -44.23 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.328 0.651 . . . . 0.0 109.934 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -68.67 -31.29 70.31 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.065 1.302 . . . . 0.0 113.958 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 p -91.39 -40.27 11.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.612 1.165 . . . . 0.0 113.847 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -102.8 -30.9 10.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.505 1.122 . . . . 0.0 112.536 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 . . . . . 0 C--O 1.242 0.695 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 -177.543 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -75.27 154.87 37.24 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.06 0.944 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -68.79 144.13 54.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.784 1.234 . . . . 0.0 113.142 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.01 -178.32 50.72 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.394 0.997 . . . . 0.0 113.898 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 m -63.14 148.26 48.48 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.503 1.121 . . . . 0.0 112.413 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 t -146.48 154.45 41.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.532 1.133 . . . . 0.0 112.71 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.42 141.51 5.93 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.392 1.949 . . . . 0.0 110.941 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.59 155.64 46.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.794 1.238 . . . . 0.0 113.051 -170.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -107.03 165.32 11.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.479 1.912 . . . . 0.0 110.91 169.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -133.88 157.04 46.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.808 1.243 . . . . 0.0 111.851 -169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 m -136.43 135.09 38.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.445 1.098 . . . . 0.0 111.399 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -57.96 127.8 80.03 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.446 1.098 . . . . 0.0 112.104 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.62 -6.83 19.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.952 2.435 . . . . 0.0 113.587 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -115.9 -34.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.41 1.084 . . . . 0.0 113.092 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -132.71 5.57 3.97 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 61.72 12.9 4.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.93 2.092 . . . . 0.0 116.0 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -61.66 139.12 58.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.705 -1.247 . . . . 0.0 111.258 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.6 m -81.49 148.0 29.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.354 1.062 . . . . 0.0 113.236 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -141.13 147.63 38.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.96 2.104 . . . . 0.0 111.679 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 p -92.86 -17.21 24.35 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -142.67 150.04 39.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.656 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.52 -37.62 81.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.227 1.411 . . . . 0.0 112.899 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -66.33 -30.14 70.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.21 -42.72 25.35 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.601 0.761 . . . . 0.0 111.465 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -66.59 -38.24 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 118.329 0.513 . . . . 0.0 111.548 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.83 -40.85 97.58 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.902 -1.124 . . . . 0.0 112.198 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -61.6 -40.77 96.0 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.558 0.617 . . . . 0.0 111.916 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.0 -46.41 84.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.689 0.795 . . . . 0.0 112.674 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.0 -42.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.607 -0.683 . . . . 0.0 110.487 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -68.15 -32.5 72.82 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.8 p -91.97 -35.89 13.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -107.36 -26.4 11.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.48 1.112 . . . . 0.0 113.425 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -134.28 40.82 0.59 Allowed Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.2 -36.21 70.25 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.797 2.331 . . . . 0.0 114.474 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.53 -2.91 27.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -113.56 -4.22 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.943 2.097 . . . . 0.0 112.042 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.254 1.312 0 C-N-CA 126.387 1.875 . . . . 0.0 112.62 179.193 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m -67.15 152.17 46.23 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.454 1.101 . . . . 0.0 113.152 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -70.81 -16.8 62.75 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.92 179.94 48.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.493 1.52 . . . . 0.0 112.828 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 86.4 p -149.25 167.69 25.34 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.174 1.389 . . . . 0.0 112.265 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -79.33 -6.29 56.41 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.91 168.34 53.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.011 1.291 . . . . 0.0 114.754 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -134.2 155.69 49.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.826 1.65 . . . . 0.0 112.153 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -127.3 165.43 19.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.419 1.888 . . . . 0.0 111.537 172.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -125.8 146.63 49.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 110.856 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -131.39 136.74 48.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.932 0.893 . . . . 0.0 112.11 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.0 t -61.18 131.77 92.23 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.122 0.969 . . . . 0.0 111.967 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.01 -7.54 20.04 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.405 2.736 . . . . 0.0 113.935 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.02 -37.06 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.28 1.032 . . . . 0.0 113.492 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -129.82 14.1 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 61.53 4.69 1.05 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.351 2.661 . . . . 0.0 117.285 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.27 147.45 53.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.728 1.211 . . . . 0.0 112.794 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 m -96.39 140.71 30.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.959 1.304 . . . . 0.0 112.954 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -137.66 147.62 45.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 111.605 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 m -89.51 -13.89 36.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -142.54 151.39 41.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.649 1.18 . . . . 0.0 111.954 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -14.94 63.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -81.98 -32.99 30.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.121 0.968 . . . . 0.0 112.86 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.57 -39.45 70.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.565 0.746 . . . . 0.0 111.365 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 118.094 0.406 . . . . 0.0 111.789 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -62.89 -46.29 88.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.656 0.782 . . . . 0.0 111.407 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -59.23 -42.67 91.62 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.391 0.541 . . . . 0.0 112.248 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -64.18 -46.76 82.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.106 0.866 . . . . 0.0 112.542 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.04 -42.61 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.692 -0.63 . . . . 0.0 110.655 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.84 -34.17 73.27 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 p -85.86 -35.56 20.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -109.42 -28.19 9.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -137.48 38.57 0.37 Allowed Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -169.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.76 -20.04 67.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.762 2.308 . . . . 0.0 114.338 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.19 -14.61 63.11 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.14 -19.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 119.203 0.911 . . . . 0.0 113.233 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.05 1.74 . . . . 0.0 113.357 -178.338 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.2 p -77.06 162.61 27.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.704 1.202 . . . . 0.0 113.069 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -73.18 -16.35 61.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.39 175.91 40.77 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.037 1.303 . . . . 0.0 113.538 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 m -86.13 23.72 1.47 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.405 1.482 . . . . 0.0 114.225 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 p -72.34 156.87 38.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.207 1.403 . . . . 0.0 113.66 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.96 -177.56 48.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.012 1.291 . . . . 0.0 113.184 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -86.71 -6.05 58.95 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -66.86 157.79 32.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.971 1.308 . . . . 0.0 113.188 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -107.55 154.86 20.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.334 1.854 . . . . 0.0 110.851 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -139.62 143.21 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.6 130.64 81.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.344 1.458 . . . . 0.0 112.471 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.79 -8.42 22.35 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.119 2.546 . . . . 0.0 113.557 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -113.88 -37.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.547 1.139 . . . . 0.0 112.826 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -135.22 11.63 3.55 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.2 6.71 1.39 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.192 2.597 . . . . 0.0 117.407 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -63.56 142.64 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.895 -1.128 . . . . 0.0 111.649 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 p -95.29 146.4 24.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.513 1.125 . . . . 0.0 114.006 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.87 144.4 33.82 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.923 1.689 . . . . 0.0 111.685 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.2 m -81.9 -20.24 39.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -142.82 151.68 41.39 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.962 1.305 . . . . 0.0 112.104 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.85 -34.88 76.77 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.333 1.053 . . . . 0.0 112.896 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -67.8 -31.05 70.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.98 -43.62 57.5 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.381 0.672 . . . . 0.0 111.372 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.09 -37.58 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.671 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -60.84 -43.55 98.14 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.957 1.253 . . . . 0.0 112.227 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -63.15 -37.33 86.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.227 0.921 . . . . 0.0 112.738 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.51 -46.12 87.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.21 0.913 . . . . 0.0 112.547 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.94 -41.78 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.549 -0.719 . . . . 0.0 110.725 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.32 -34.89 78.3 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 p -88.66 -34.26 17.31 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -109.61 -27.16 9.53 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -134.72 40.0 0.51 Allowed Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -171.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.67 -23.35 56.57 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.003 2.469 . . . . 0.0 114.769 -170.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -90.52 3.93 52.6 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.756 1.222 . . . . 0.0 113.804 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.25 -0.81 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.806 1.643 . . . . 0.0 112.817 -170.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.686 1.594 . . . . 0.0 114.536 179.134 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -76.0 167.28 22.15 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.944 1.298 . . . . 0.0 113.14 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -80.93 -10.31 59.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.084 1.354 . . . . 0.0 113.296 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.0 -140.55 48.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.554 1.074 . . . . 0.0 113.056 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.2 m -71.21 -12.14 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.2 m -84.15 -11.18 57.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.31 -174.9 46.15 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.156 0.889 . . . . 0.0 114.656 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.5 tpp85 -61.31 137.13 58.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.032 1.333 . . . . 0.0 111.516 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.6 m -127.13 152.7 46.98 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.849 1.66 . . . . 0.0 111.67 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -134.27 137.38 44.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.977 1.311 . . . . 0.0 109.78 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 p -142.35 141.92 32.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.681 0.792 . . . . 0.0 112.352 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -57.34 132.4 81.27 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.758 1.223 . . . . 0.0 112.72 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.85 -10.12 27.07 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.165 2.577 . . . . 0.0 113.833 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.93 -37.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.318 1.047 . . . . 0.0 113.184 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.21 4.91 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 60.23 12.1 3.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.264 2.226 . . . . 0.0 116.14 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.79 133.2 54.06 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.824 1.249 . . . . 0.0 111.119 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.8 m -85.86 145.32 27.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.214 1.006 . . . . 0.0 112.87 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.31 152.13 46.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.986 1.714 . . . . 0.0 111.763 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.1 p -97.69 -11.74 23.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.54 151.41 43.22 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.24 1.416 . . . . 0.0 111.484 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -36.45 83.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.198 0.599 . . . . 0.0 112.456 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -65.06 -28.78 69.71 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.57 -44.66 33.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.461 0.705 . . . . 0.0 111.617 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -68.27 -37.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.562 0.619 . . . . 0.0 111.737 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -60.01 -44.81 94.32 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.594 1.088 . . . . 0.0 111.512 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 m -61.07 -41.82 97.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.03 0.532 . . . . 0.0 112.053 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.28 -46.91 84.57 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.573 -0.705 . . . . 0.0 112.691 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.63 -44.48 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.592 -0.692 . . . . 0.0 110.265 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -68.25 -30.33 69.34 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.3 p -92.35 -35.2 13.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -107.99 -26.53 10.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -135.74 62.38 47.53 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.073 0.949 . . . . 0.0 113.116 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -66.23 -19.64 56.31 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.401 2.068 . . . . 0.0 115.798 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.07 -2.38 27.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.49 145.47 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.355 1.862 . . . . 0.0 111.527 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.172 1.789 . . . . 0.0 112.852 -178.453 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -148.39 161.22 42.03 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.322 1.449 . . . . 0.0 111.707 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -136.55 153.59 50.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 -173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.41 177.62 50.31 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.758 1.17 . . . . 0.0 114.549 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -85.56 -10.35 56.06 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m 54.27 30.13 11.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.834 1.654 . . . . 0.0 114.993 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.17 171.87 44.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.962 1.268 . . . . 0.0 113.385 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -120.62 12.06 11.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.429 1.892 . . . . 0.0 113.588 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 m -66.92 154.51 40.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.946 1.298 . . . . 0.0 113.612 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -102.55 155.55 18.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 110.707 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -137.73 134.29 35.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.797 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.43 130.19 80.81 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.798 1.239 . . . . 0.0 112.413 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.12 -9.98 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.158 2.572 . . . . 0.0 113.67 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -111.97 -37.07 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.379 1.072 . . . . 0.0 113.026 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -130.91 3.03 4.4 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 58.29 22.96 9.87 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.59 1.956 . . . . 0.0 115.45 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.53 135.62 51.85 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.726 169.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 m -87.05 144.83 26.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 113.235 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.88 145.98 38.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.643 1.577 . . . . 0.0 112.251 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 -18.41 37.23 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -142.26 148.62 38.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.65 1.58 . . . . 0.0 112.091 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.28 -34.27 73.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.49 1.116 . . . . 0.0 112.843 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -67.32 -29.81 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.881 0.873 . . . . 0.0 113.274 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.68 -37.29 27.65 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.319 1.048 . . . . 0.0 111.969 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.61 -38.58 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.748 -0.595 . . . . 0.0 110.955 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -60.53 -46.86 88.61 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.885 1.22 . . . . 0.0 112.387 174.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.8 p -65.22 -36.39 84.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.097 0.862 . . . . 0.0 112.385 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.8 -50.32 73.91 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.978 0.808 . . . . 0.0 112.52 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.09 -42.13 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 10.1 mmpt? -75.14 -16.13 60.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -99.25 -34.37 10.37 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.581 1.152 . . . . 0.0 113.73 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -106.15 -28.01 10.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.644 1.178 . . . . 0.0 113.465 -173.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -135.96 56.81 15.76 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.196 1.398 . . . . 0.0 111.623 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -58.33 -32.45 96.09 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.758 2.305 . . . . 0.0 116.748 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.16 -4.8 38.02 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -172.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 p -126.75 141.58 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.358 1.863 . . . . 0.0 110.387 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.906 1.682 . . . . 0.0 112.012 -176.291 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -135.74 153.64 51.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.151 1.38 . . . . 0.0 112.079 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.9 m -71.6 153.2 42.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 113.019 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.49 177.51 46.64 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.632 1.11 . . . . 0.0 114.727 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -82.84 -22.77 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.304 1.042 . . . . 0.0 113.808 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -132.31 155.68 47.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.464 1.505 . . . . 0.0 112.795 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.43 178.57 43.7 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.425 1.488 . . . . 0.0 112.688 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -135.7 157.03 47.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.166 1.386 . . . . 0.0 112.58 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.2 p -135.01 157.5 46.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.871 1.668 . . . . 0.0 111.456 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -131.62 148.5 52.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p -140.09 142.55 36.09 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.11 131.39 87.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.25 1.42 . . . . 0.0 112.599 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 -10.13 23.87 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.262 2.642 . . . . 0.0 113.686 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.6 t -113.18 -36.34 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.598 1.159 . . . . 0.0 112.897 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -134.96 10.61 3.6 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 60.89 9.45 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.011 2.524 . . . . 0.0 117.18 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.65 144.8 56.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.439 1.096 . . . . 0.0 112.003 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.8 m -96.64 143.74 27.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.43 1.092 . . . . 0.0 113.633 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -140.16 154.25 46.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.348 1.859 . . . . 0.0 111.54 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.3 p -97.83 -10.2 25.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -142.01 151.78 42.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.498 1.119 . . . . 0.0 112.818 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.71 -39.13 76.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.245 1.418 . . . . 0.0 112.448 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.112 0.965 . . . . 0.0 113.541 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.83 -44.24 41.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.469 0.708 . . . . 0.0 111.415 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -67.43 -38.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.717 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.29 -42.98 99.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.809 1.186 . . . . 0.0 112.072 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.7 t -57.79 -45.18 86.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.667 0.667 . . . . 0.0 111.596 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -60.69 -49.14 78.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.712 0.805 . . . . 0.0 112.947 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.12 -42.39 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -72.7 -23.86 60.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 t -104.01 -15.82 15.49 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -116.03 -28.62 6.57 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -132.33 26.16 0.12 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.45 -22.75 51.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.689 2.259 . . . . 0.0 114.689 -169.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.58 10.09 31.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.711 1.604 . . . . 0.0 113.222 174.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.49 -28.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.393 1.477 . . . . 0.0 112.902 -169.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.256 1.41 0 C-N-CA 125.455 1.502 . . . . 0.0 114.652 176.468 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 t -147.97 158.45 44.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.331 . . . . 0.0 111.684 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -70.27 148.21 48.81 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.91 1.284 . . . . 0.0 113.313 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.89 162.5 28.42 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.971 1.272 . . . . 0.0 113.097 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t -153.78 153.53 32.35 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.881 1.272 . . . . 0.0 111.773 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.0 t 61.38 -58.0 0.1 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.506 2.722 . . . . 0.0 116.068 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.57 162.6 53.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.97 1.272 . . . . 0.0 114.008 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -144.56 145.75 31.98 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.026 1.73 . . . . 0.0 110.844 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -91.77 137.07 32.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.128 0.971 . . . . 0.0 111.673 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -127.53 149.45 50.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.367 1.867 . . . . 0.0 109.777 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -137.86 134.15 34.75 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 0.0 112.148 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.5 t -56.84 128.96 77.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.133 1.373 . . . . 0.0 112.185 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.52 -8.52 22.71 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.107 2.538 . . . . 0.0 113.481 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.25 -37.13 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.614 1.166 . . . . 0.0 112.682 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 p -136.5 7.56 3.06 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 58.55 22.26 9.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.103 2.161 . . . . 0.0 116.073 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -72.71 142.44 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.003 -1.061 . . . . 0.0 111.129 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 p -96.24 145.03 25.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.445 1.098 . . . . 0.0 113.923 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -141.26 157.61 44.99 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.2 1.8 . . . . 0.0 111.668 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -106.2 -2.77 22.11 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -146.14 150.71 36.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.469 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.64 -35.25 79.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.729 0.812 . . . . 0.0 112.626 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -68.84 -29.45 67.78 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.11 -44.59 53.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.676 0.671 . . . . 0.0 111.398 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.87 -38.94 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.805 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -60.92 -42.71 98.66 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.016 1.28 . . . . 0.0 112.095 172.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.47 -42.34 98.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.357 0.526 . . . . 0.0 111.765 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -62.5 -48.51 79.23 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.687 -0.633 . . . . 0.0 112.628 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.4 mt -57.71 -44.49 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.431 0.692 . . . . 0.0 110.441 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.98 -32.67 71.0 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 p -89.43 -37.46 14.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.62 -24.75 14.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.438 1.095 . . . . 0.0 113.168 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -130.88 48.5 3.78 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 125.019 1.328 . . . . 0.0 112.772 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -62.44 -29.69 79.32 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.493 2.795 . . . . 0.0 115.075 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.8 0.34 31.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.289 1.036 . . . . 0.0 113.153 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.9 -3.37 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 127.462 2.305 . . . . 0.0 111.827 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.489 1.916 . . . . 0.0 113.072 -179.469 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.6 m -72.07 149.01 45.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.332 1.053 . . . . 0.0 113.019 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -137.61 147.41 44.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.404 1.481 . . . . 0.0 111.74 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.44 -5.94 33.38 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.058 1.313 . . . . 0.0 116.376 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -141.34 150.23 42.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.931 1.692 . . . . 0.0 111.737 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.1 m -137.81 154.66 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.584 1.554 . . . . 0.0 111.807 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.62 -178.41 48.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.48 1.038 . . . . 0.0 113.336 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -142.11 146.46 35.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.647 1.579 . . . . 0.0 111.656 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -124.75 157.55 35.44 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.756 1.623 . . . . 0.0 110.845 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -128.29 134.87 49.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.705 1.602 . . . . 0.0 110.126 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.3 p -115.19 141.37 48.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.186 0.994 . . . . 0.0 113.06 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.36 129.49 86.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.308 . . . . 0.0 112.198 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.83 -8.96 23.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.309 2.673 . . . . 0.0 113.424 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.4 t -113.28 -38.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.601 1.16 . . . . 0.0 112.59 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 p -137.51 20.74 2.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 58.26 -6.58 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.756 3.222 . . . . 0.0 119.221 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -62.25 146.23 51.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.055 1.298 . . . . 0.0 112.531 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.4 m -108.11 146.52 32.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.529 1.132 . . . . 0.0 113.855 -171.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -137.71 145.12 42.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.829 2.051 . . . . 0.0 110.972 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -87.39 -8.27 56.76 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -143.32 152.54 41.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.008 1.323 . . . . 0.0 111.471 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.31 -33.65 75.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.818 0.847 . . . . 0.0 112.828 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.5 -29.6 69.06 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.309 -0.869 . . . . 0.0 113.181 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.21 -42.05 47.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.613 0.765 . . . . 0.0 111.389 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -68.61 -38.71 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.493 0.588 . . . . 0.0 111.846 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -63.58 -39.99 95.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.903 1.229 . . . . 0.0 112.174 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -60.65 -44.53 96.32 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.358 0.663 . . . . 0.0 111.78 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.44 -47.99 83.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 112.532 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.2 mt -60.24 -42.49 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 110.79 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.2 -20.12 60.3 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 p -99.02 -27.6 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.812 1.245 . . . . 0.0 114.014 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -111.08 -28.74 8.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.294 1.038 . . . . 0.0 113.776 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -133.59 42.59 0.86 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 125.352 1.461 . . . . 0.0 112.77 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -60.25 -19.92 59.79 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.7 2.933 . . . . 0.0 115.46 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.15 -17.74 42.71 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 p -93.0 -9.57 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.463 1.105 . . . . 0.0 113.59 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.466 1.506 . . . . 0.0 112.539 -178.051 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 m -67.91 151.32 47.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.575 1.15 . . . . 0.0 113.174 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 p -77.29 162.16 27.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.924 1.29 . . . . 0.0 113.146 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.73 178.72 48.43 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.941 1.258 . . . . 0.0 113.203 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 t -149.96 144.27 25.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.823 1.249 . . . . 0.0 111.864 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -68.51 -23.2 64.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.402 1.081 . . . . 0.0 112.879 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.4 -9.78 86.11 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.001 1.286 . . . . 0.0 114.311 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.6 mmt-85 60.48 163.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.526 2.731 . . . . 0.0 115.525 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -127.6 160.79 30.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.413 1.885 . . . . 0.0 110.865 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.04 152.4 26.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.45 1.5 . . . . 0.0 110.975 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.3 p -137.83 140.8 40.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.752 0.821 . . . . 0.0 112.973 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.3 t -56.87 131.96 79.25 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.06 1.344 . . . . 0.0 112.592 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.67 -9.61 25.24 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.149 2.566 . . . . 0.0 113.774 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.15 -38.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 113.009 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.2 p -132.72 10.73 4.34 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 60.56 7.17 1.28 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.295 2.638 . . . . 0.0 117.208 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -62.21 142.78 57.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.423 1.089 . . . . 0.0 111.658 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 p -96.1 146.26 24.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.634 1.173 . . . . 0.0 113.983 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.36 144.27 33.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.996 1.719 . . . . 0.0 111.774 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 m -84.38 -19.08 34.16 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -143.63 153.78 42.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.173 1.389 . . . . 0.0 111.78 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.54 -40.39 87.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.633 0.773 . . . . 0.0 112.435 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -60.56 -30.01 69.52 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.149 -0.969 . . . . 0.0 113.565 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.58 -44.89 26.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.8 -38.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.37 0.532 . . . . 0.0 111.942 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.751 1.16 . . . . 0.0 111.474 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 t -59.03 -44.93 91.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.396 0.544 . . . . 0.0 111.792 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.82 -46.03 92.15 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.383 -0.823 . . . . 0.0 112.981 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.51 -44.02 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.726 0.811 . . . . 0.0 110.588 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -72.79 -28.63 62.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -90.15 -35.72 15.23 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -108.35 -26.4 10.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.393 1.077 . . . . 0.0 113.662 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -134.08 44.73 1.3 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 113.797 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.66 -23.97 41.94 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.803 1.668 . . . . 0.0 114.514 -174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -66.15 -12.16 54.04 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -117.61 -7.49 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.739 2.016 . . . . 0.0 112.821 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--O 1.255 1.366 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m 57.71 -71.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 127.896 2.479 . . . . 0.0 116.014 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.9 m -80.31 -12.71 59.57 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.153 1.381 . . . . 0.0 113.635 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.13 165.67 39.09 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.573 1.559 . . . . 0.0 112.514 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.3 p -78.57 -7.6 57.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 m -61.15 135.17 57.67 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.936 1.294 . . . . 0.0 112.879 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.13 -6.33 78.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.64 1.114 . . . . 0.0 115.345 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -138.5 118.93 13.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.138 1.775 . . . . 0.0 110.621 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -144.24 150.83 38.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.093 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -132.05 148.02 52.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.319 1.848 . . . . 0.0 109.483 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -136.68 134.44 37.25 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 112.468 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.59 132.75 82.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.155 1.382 . . . . 0.0 112.695 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.06 -10.72 26.43 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.161 2.574 . . . . 0.0 113.569 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.16 -41.08 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.399 1.08 . . . . 0.0 112.91 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.9 p -124.9 7.12 8.03 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 58.43 10.96 1.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.423 2.289 . . . . 0.0 115.392 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -66.49 135.7 54.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.486 2.315 . . . . 0.0 111.372 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 p -97.12 145.54 25.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -142.31 153.94 44.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.501 1.92 . . . . 0.0 111.808 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -87.22 -23.3 24.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -141.52 155.49 45.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.677 1.191 . . . . 0.0 113.085 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.56 -39.75 74.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.965 1.306 . . . . 0.0 112.652 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -64.48 -30.64 71.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.21 -44.31 26.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.937 0.895 . . . . 0.0 111.2 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.27 -41.22 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.543 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -63.38 -40.27 96.8 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.078 1.308 . . . . 0.0 111.85 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -60.57 -40.48 91.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.994 0.816 . . . . 0.0 112.01 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -63.41 -51.76 64.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.558 0.617 . . . . 0.0 112.657 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.83 -40.83 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.488 0.586 . . . . 0.0 110.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.3 -33.84 76.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -92.97 -29.8 15.67 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 113.959 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -106.86 -25.57 11.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.421 1.088 . . . . 0.0 113.766 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -133.88 68.15 74.82 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.755 1.222 . . . . 0.0 111.307 -172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -56.68 -28.41 75.32 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.954 3.102 . . . . 0.0 117.103 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.84 -3.58 42.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.28 -23.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.827 1.651 . . . . 0.0 112.465 -170.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.251 1.161 0 C-N-CA 126.331 1.852 . . . . 0.0 111.777 169.697 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m -72.19 -22.43 61.28 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -150.53 153.48 35.88 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.359 1.464 . . . . 0.0 112.39 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.59 158.01 48.3 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.253 0.93 . . . . 0.0 113.454 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.3 m 52.35 36.51 20.03 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.495 1.518 . . . . 0.0 114.442 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.9 t -144.6 173.84 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.493 1.517 . . . . 0.0 112.248 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.81 179.75 43.16 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.506 1.527 . . . . 0.0 114.948 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -105.55 5.28 31.26 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.555 1.942 . . . . 0.0 113.584 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.8 m -81.42 146.78 30.1 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.211 -0.931 . . . . 0.0 112.644 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.3 154.05 51.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.186 1.794 . . . . 0.0 110.418 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -134.75 141.0 46.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.719 0.808 . . . . 0.0 112.926 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.73 129.3 81.27 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.394 1.478 . . . . 0.0 112.608 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.02 -9.07 21.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.323 2.682 . . . . 0.0 113.387 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.4 t -112.34 -37.91 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.703 1.201 . . . . 0.0 112.693 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.4 p -137.72 19.92 2.87 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -172.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.51 -5.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 129.55 3.14 . . . . 0.0 119.05 168.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -62.18 143.66 56.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.916 1.235 . . . . 0.0 112.48 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.0 p -101.07 150.36 23.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.697 1.199 . . . . 0.0 113.891 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -140.03 147.82 40.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.009 2.124 . . . . 0.0 110.685 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 p -89.81 -10.4 45.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -150.92 158.95 44.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 111.652 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.38 -33.32 75.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -67.21 -24.91 65.89 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.057 -1.027 . . . . 0.0 112.931 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.43 -42.82 34.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 111.497 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -67.8 -38.59 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.428 0.558 . . . . 0.0 111.623 171.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.49 -39.72 94.37 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.853 1.206 . . . . 0.0 111.888 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -62.82 -42.07 99.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.571 0.623 . . . . 0.0 111.991 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.62 -46.69 88.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.635 0.774 . . . . 0.0 112.419 174.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.64 -42.49 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.038 0.935 . . . . 0.0 110.675 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -30.39 68.76 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -92.94 -25.84 17.84 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -114.18 -28.46 7.29 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -135.52 36.53 0.31 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.08 -21.75 72.57 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.641 2.228 . . . . 0.0 114.352 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.71 -14.25 62.3 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -13.85 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.232 1.013 . . . . 0.0 113.31 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.58 1.552 . . . . 0.0 113.088 -179.648 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -64.74 -26.52 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -93.26 -8.71 41.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.953 1.301 . . . . 0.0 114.373 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.93 162.42 15.94 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.183 0.897 . . . . 0.0 114.365 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.0 p -150.09 160.04 43.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.696 1.598 . . . . 0.0 112.286 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -94.58 -31.89 13.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.089 1.356 . . . . 0.0 113.726 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.8 160.65 47.09 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.852 1.215 . . . . 0.0 113.34 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -136.59 149.61 48.13 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 111.473 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -127.8 168.97 14.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.424 1.89 . . . . 0.0 111.764 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -130.6 150.18 51.92 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.494 1.518 . . . . 0.0 110.695 -172.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -137.18 139.23 40.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.862 0.865 . . . . 0.0 112.067 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.8 129.64 71.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.576 1.55 . . . . 0.0 112.294 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.51 -7.87 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 113.469 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -113.02 -37.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 112.756 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -135.78 11.49 3.4 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 61.66 10.07 3.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.871 2.468 . . . . 0.0 117.024 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.59 141.17 55.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.609 -1.307 . . . . 0.0 111.773 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -99.57 147.14 25.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -139.91 148.11 41.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.953 2.101 . . . . 0.0 111.329 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -88.11 -20.58 25.48 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -141.33 151.03 43.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.615 1.166 . . . . 0.0 112.699 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -61.72 -36.59 81.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.346 1.458 . . . . 0.0 113.769 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -68.2 -26.35 65.68 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.147 -0.971 . . . . 0.0 113.107 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.45 -43.24 33.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.679 0.792 . . . . 0.0 111.345 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.49 -39.57 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.115 0.416 . . . . 0.0 111.448 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -63.72 -38.27 90.49 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.983 -1.073 . . . . 0.0 112.373 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.2 m -62.59 -43.67 98.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.288 0.635 . . . . 0.0 111.692 171.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.92 -45.2 94.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 0.0 112.537 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.0 -42.11 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.404 0.681 . . . . 0.0 110.298 175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.68 -36.44 82.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 113.529 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -88.42 -33.9 17.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.44 -27.67 10.79 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.69 42.99 0.91 Allowed Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.687 1.195 . . . . 0.0 113.976 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 -27.24 61.24 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.131 2.554 . . . . 0.0 114.615 -170.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.22 3.6 34.51 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.64 1.176 . . . . 0.0 113.85 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.06 18.19 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.265 1.826 . . . . 0.0 111.959 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 126.087 1.755 . . . . 0.0 114.542 178.06 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.2 p -146.67 163.4 36.01 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.47 1.508 . . . . 0.0 112.564 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -134.76 154.63 51.51 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.449 1.499 . . . . 0.0 112.087 -176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.28 171.25 44.39 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.792 1.187 . . . . 0.0 113.328 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 t -153.52 -42.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.414 1.085 . . . . 0.0 113.007 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.4 m -55.36 130.66 43.36 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.754 1.222 . . . . 0.0 112.997 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.02 27.99 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.053 1.311 . . . . 0.0 115.718 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 58.28 173.86 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.637 2.375 . . . . 0.0 114.925 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -139.16 161.24 37.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.99 1.716 . . . . 0.0 111.79 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -135.31 154.44 51.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.102 1.761 . . . . 0.0 110.265 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -139.41 142.03 37.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -61.1 130.05 91.07 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.839 1.256 . . . . 0.0 112.31 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.17 -7.58 20.77 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.058 2.505 . . . . 0.0 113.525 177.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.88 -36.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.5 1.12 . . . . 0.0 113.055 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.85 3.5 4.46 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 62.16 12.91 5.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.907 2.083 . . . . 0.0 116.181 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.54 138.22 58.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.701 -1.249 . . . . 0.0 111.169 170.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -82.3 148.91 28.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.8 152.69 43.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.962 2.105 . . . . 0.0 111.458 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -96.49 -14.36 22.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -141.98 144.59 33.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.489 1.115 . . . . 0.0 112.32 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.42 -37.63 81.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.275 1.43 . . . . 0.0 113.156 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.44 -31.3 70.52 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.73 -43.59 46.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.39 0.676 . . . . 0.0 111.419 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.74 -38.83 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.135 0.425 . . . . 0.0 111.681 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -63.39 -41.22 98.76 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.674 1.125 . . . . 0.0 112.208 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -60.96 -43.66 98.41 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.615 . . . . 0.0 111.905 172.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -60.45 -48.47 81.61 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.836 0.855 . . . . 0.0 112.792 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.03 -41.99 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.997 0.919 . . . . 0.0 110.476 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -66.57 -36.77 83.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.909 1.284 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 t -95.01 -27.27 15.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -103.12 -28.62 11.84 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -130.58 32.89 0.23 Allowed Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -169.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.86 -28.93 50.52 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.301 2.001 . . . . 0.0 114.389 -172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.9 -4.08 41.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.245 1.018 . . . . 0.0 113.642 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.61 -21.27 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.053 1.741 . . . . 0.0 112.025 -172.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.301 1.84 . . . . 0.0 113.575 177.008 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.8 p -89.37 -7.07 55.99 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -67.22 151.64 47.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.178 1.391 . . . . 0.0 113.729 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.07 171.16 42.34 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.978 1.275 . . . . 0.0 115.116 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -132.78 6.51 4.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 114.113 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.5 p -82.32 20.64 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.516 1.926 . . . . 0.0 115.06 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.14 -18.76 67.38 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.693 1.139 . . . . 0.0 115.389 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -127.96 134.04 49.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.374 1.87 . . . . 0.0 110.673 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 m -141.43 160.76 39.47 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.006 1.723 . . . . 0.0 111.529 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -114.98 136.99 52.52 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 109.723 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -124.0 131.73 53.6 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.868 0.867 . . . . 0.0 112.24 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.9 t -56.22 131.34 75.23 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 112.45 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.16 -9.38 23.28 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.298 2.665 . . . . 0.0 113.923 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.57 -36.85 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.324 1.05 . . . . 0.0 113.253 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 p -132.51 10.11 4.38 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 60.17 12.0 3.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.923 2.489 . . . . 0.0 116.918 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -64.78 147.26 53.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.457 1.103 . . . . 0.0 111.922 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.9 t -101.73 145.62 28.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 113.282 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -141.58 149.28 40.56 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.178 2.191 . . . . 0.0 111.119 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -90.81 -14.99 30.82 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.654 1.354 . . . . 0.0 114.654 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -141.59 151.58 43.28 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.603 1.161 . . . . 0.0 112.73 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.328 1.451 . . . . 0.0 112.896 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -67.61 -28.68 67.96 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.05 -42.72 25.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.634 0.774 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 tt -66.02 -38.7 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.243 0.474 . . . . 0.0 111.414 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.42 -39.01 93.02 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.669 1.122 . . . . 0.0 112.33 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -61.86 -41.2 97.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.729 0.695 . . . . 0.0 111.944 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -64.13 -46.28 84.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.519 0.727 . . . . 0.0 112.578 174.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.56 -43.24 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 110.788 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -29.66 67.88 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 p -91.9 -30.92 15.89 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -113.71 -27.73 7.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -134.41 29.57 0.16 Allowed Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -169.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.09 -26.54 42.88 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.666 2.244 . . . . 0.0 114.677 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.77 2.18 56.88 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.878 1.271 . . . . 0.0 113.594 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.66 -38.96 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.159 1.383 . . . . 0.0 112.633 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 112.905 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.6 p -80.75 -19.87 43.96 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m 54.93 25.75 7.14 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.6 1.56 . . . . 0.0 114.029 -169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.72 -7.64 80.46 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.851 1.215 . . . . 0.0 115.781 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.0 p -144.59 157.84 44.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.601 1.561 . . . . 0.0 112.525 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.9 p -96.87 165.81 11.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.757 1.623 . . . . 0.0 112.869 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.05 -146.19 40.88 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.962 0.791 . . . . 0.0 113.567 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -140.22 160.83 39.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.654 1.582 . . . . 0.0 112.736 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.1 p -142.15 166.07 25.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.728 1.611 . . . . 0.0 111.917 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.66 153.27 47.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.425 1.89 . . . . 0.0 110.151 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -137.47 142.77 41.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.5 t -58.32 132.92 84.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.083 1.353 . . . . 0.0 112.684 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.9 -10.51 26.35 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.297 2.665 . . . . 0.0 113.973 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 -39.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.234 1.014 . . . . 0.0 113.039 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -129.69 9.9 5.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.94 10.7 2.26 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.071 2.548 . . . . 0.0 116.933 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -64.06 144.32 57.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.531 1.132 . . . . 0.0 111.771 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -98.27 143.85 28.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.464 1.106 . . . . 0.0 113.367 -172.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.26 145.98 39.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.157 1.783 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m -88.49 -15.15 36.04 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -140.82 148.72 41.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.797 1.239 . . . . 0.0 112.09 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.06 -37.64 83.39 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 112.684 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -67.52 -28.47 67.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.97 -43.91 33.2 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.438 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.79 -38.85 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.437 0.562 . . . . 0.0 111.573 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.39 -40.05 96.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.589 1.086 . . . . 0.0 112.19 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.9 m -61.67 -41.41 97.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.685 0.675 . . . . 0.0 111.882 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.51 -47.62 80.95 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.681 -0.637 . . . . 0.0 112.582 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.55 -43.6 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.406 0.683 . . . . 0.0 110.462 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -67.59 -31.5 71.59 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.9 p -91.47 -32.75 15.48 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 114.061 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -109.38 -27.47 9.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -135.62 60.59 37.93 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.435 1.094 . . . . 0.0 112.936 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -58.51 -29.72 89.57 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.193 2.595 . . . . 0.0 116.425 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 -9.42 53.44 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.46 -22.3 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.964 1.706 . . . . 0.0 112.081 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.042 1.737 . . . . 0.0 113.73 179.776 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 t -149.33 157.08 43.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.145 1.378 . . . . 0.0 111.808 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -137.5 145.1 42.6 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.846 1.658 . . . . 0.0 111.586 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.53 27.77 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 123.806 0.717 . . . . 0.0 113.153 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.1 p -91.34 -21.28 21.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.93 1.292 . . . . 0.0 113.982 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -74.34 155.46 38.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 112.831 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.82 -9.63 66.26 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.368 0.985 . . . . 0.0 115.247 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -135.93 144.67 45.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.765 2.026 . . . . 0.0 111.157 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 t -149.45 154.78 39.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.629 1.572 . . . . 0.0 110.874 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.92 137.82 49.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.432 1.493 . . . . 0.0 110.19 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 m -127.36 135.3 50.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.723 0.809 . . . . 0.0 112.418 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.02 133.66 74.12 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.529 1.532 . . . . 0.0 112.959 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -10.5 27.62 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.16 2.574 . . . . 0.0 114.021 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.15 -34.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.114 0.966 . . . . 0.0 113.51 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -129.02 2.88 5.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 60.38 10.22 2.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.247 2.219 . . . . 0.0 116.347 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -62.48 143.91 56.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.048 -1.032 . . . . 0.0 111.574 171.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.0 p -102.9 148.75 25.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.86 149.31 41.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.912 2.085 . . . . 0.0 111.161 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 p -89.48 -14.52 35.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.59 146.29 39.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.19 1.396 . . . . 0.0 112.349 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.19 -36.59 80.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.198 1.399 . . . . 0.0 113.146 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -69.23 -28.65 66.54 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.29 -42.75 44.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.359 0.663 . . . . 0.0 111.552 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.6 -39.53 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 118.407 0.549 . . . . 0.0 111.573 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -63.53 -41.28 98.48 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.704 1.138 . . . . 0.0 112.203 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -59.12 -45.54 90.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.145 0.578 . . . . 0.0 111.46 171.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -60.98 -47.55 85.95 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.334 -0.854 . . . . 0.0 112.86 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.75 -45.19 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.971 0.908 . . . . 0.0 110.778 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.83 -25.2 52.92 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -91.17 -36.75 13.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 113.895 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -104.9 -27.63 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.182 0.993 . . . . 0.0 113.488 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -135.64 39.44 0.45 Allowed Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.18 -19.32 56.47 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.829 2.353 . . . . 0.0 115.045 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.62 -17.95 61.27 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -16.75 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.601 1.16 . . . . 0.0 113.549 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.541 1.536 . . . . 0.0 111.886 -176.227 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -149.86 151.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.054 1.342 . . . . 0.0 112.116 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 p -83.06 -8.37 59.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.171 1.388 . . . . 0.0 113.466 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -2.68 54.37 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.242 1.401 . . . . 0.0 115.893 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 m -64.48 -17.36 63.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.005 1.403 . . . . 0.0 114.631 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.6 m -74.07 -19.61 60.55 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.57 160.73 15.54 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.443 1.021 . . . . 0.0 113.745 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -67.78 151.07 47.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.655 0.782 . . . . 0.0 112.868 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.8 p -135.45 156.82 48.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.721 1.608 . . . . 0.0 111.317 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -127.65 145.22 50.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.211 1.804 . . . . 0.0 109.366 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -137.09 146.61 45.33 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.01 129.51 86.3 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.523 1.129 . . . . 0.0 111.666 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 -7.32 19.0 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.122 2.548 . . . . 0.0 113.251 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 t -111.94 -38.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.691 1.196 . . . . 0.0 112.749 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 p -135.09 9.98 3.53 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.82 7.95 2.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.079 2.552 . . . . 0.0 117.04 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -66.19 147.31 53.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.43 1.092 . . . . 0.0 111.967 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.5 p -108.05 144.33 35.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.888 1.275 . . . . 0.0 113.796 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -141.73 156.59 45.6 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.686 1.995 . . . . 0.0 111.52 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.18 -18.99 34.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -172.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.57 155.99 43.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.212 1.005 . . . . 0.0 113.037 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.86 -35.72 80.9 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.5 -0.75 . . . . 0.0 112.253 173.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -66.32 -9.08 29.61 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -100.42 -44.45 5.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.624 1.17 . . . . 0.0 111.407 171.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.4 tp -67.72 -38.6 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.19 0.904 . . . . 0.0 112.985 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -65.52 -40.25 92.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.564 -0.71 . . . . 0.0 111.193 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 m -65.26 -40.21 93.66 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.1 -48.56 81.22 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.463 0.705 . . . . 0.0 112.019 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.08 -40.88 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 0.0 110.66 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.38 -40.36 89.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.769 1.228 . . . . 0.0 112.764 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 t -90.23 -28.02 19.12 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -101.63 -28.7 12.36 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.65 40.42 0.6 Allowed Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -63.14 -30.67 75.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.005 2.47 . . . . 0.0 114.693 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.2 -2.41 37.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.265 1.026 . . . . 0.0 113.753 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -110.2 -16.89 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.064 1.746 . . . . 0.0 112.234 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.462 1.905 . . . . 0.0 113.718 176.927 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.9 t -148.89 150.15 32.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.042 1.337 . . . . 0.0 111.896 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.8 p -83.52 -9.61 58.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.188 1.395 . . . . 0.0 113.698 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.21 17.76 80.16 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.46 1.029 . . . . 0.0 115.025 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.5 p -69.07 164.38 22.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 113.406 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.4 p -136.85 161.46 35.92 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.232 1.413 . . . . 0.0 113.038 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.12 6.76 48.41 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.871 1.225 . . . . 0.0 115.793 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.6 mtm-85 -80.79 -11.45 59.6 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.856 1.328 . . . . 0.0 114.391 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.4 m -95.87 148.27 22.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.973 1.309 . . . . 0.0 111.639 172.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.48 149.33 42.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.136 1.374 . . . . 0.0 110.747 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 p -144.73 143.28 30.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 0.0 112.664 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -59.84 129.11 87.6 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.55 1.14 . . . . 0.0 112.159 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -8.56 21.62 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.57 -38.07 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.159 . . . . 0.0 112.701 -176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.7 p -137.37 25.78 2.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 61.11 -20.36 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.996 3.318 . . . . 0.0 118.816 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -54.36 139.6 36.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.197 1.399 . . . . 0.0 113.629 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -92.94 148.58 21.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.769 1.228 . . . . 0.0 113.392 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.84 148.69 42.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.203 1.801 . . . . 0.0 111.688 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 m -88.95 -11.86 43.23 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -145.15 154.09 42.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.092 1.357 . . . . 0.0 111.741 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.09 -35.57 80.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.926 0.891 . . . . 0.0 112.693 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -67.95 -33.42 74.64 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.426 -0.796 . . . . 0.0 113.113 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.37 -45.53 69.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.386 0.674 . . . . 0.0 111.313 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.55 -36.82 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.183 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -63.33 -42.35 98.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.945 1.248 . . . . 0.0 112.21 174.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -61.42 -41.16 96.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.205 0.911 . . . . 0.0 112.198 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -62.4 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.01 0.823 . . . . 0.0 112.537 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.58 -42.67 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.655 0.782 . . . . 0.0 110.517 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -74.58 -21.65 59.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -94.22 -34.86 12.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.783 1.233 . . . . 0.0 113.975 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -106.74 -27.72 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.258 1.023 . . . . 0.0 113.656 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -134.89 48.43 2.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.489 1.516 . . . . 0.0 112.18 -172.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -61.12 -35.35 86.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.234 2.623 . . . . 0.0 114.918 -168.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.03 -2.59 18.86 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.2 -4.41 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 127.443 2.297 . . . . 0.0 111.696 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.479 1.512 . . . . 0.0 112.89 175.545 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 p -145.3 175.9 9.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.374 1.469 . . . . 0.0 112.243 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.2 p -70.85 -16.99 62.74 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -17.06 5.81 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.037 1.303 . . . . 0.0 113.988 -168.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -88.86 -25.43 22.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.129 1.372 . . . . 0.0 112.666 175.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -81.64 46.56 0.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.596 1.559 . . . . 0.0 112.141 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 121.85 8.01 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.918 1.247 . . . . 0.0 112.043 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -140.4 157.58 45.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.931 1.692 . . . . 0.0 111.479 -170.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -140.45 165.58 27.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.246 1.418 . . . . 0.0 112.992 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.04 149.09 51.91 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.89 2.076 . . . . 0.0 109.765 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -133.71 138.48 45.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.604 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.17 133.18 87.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.363 1.465 . . . . 0.0 112.83 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.19 -11.52 25.11 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.257 2.638 . . . . 0.0 113.692 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.7 -40.64 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.332 1.053 . . . . 0.0 112.876 -176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -128.24 1.28 5.77 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 60.33 16.8 6.52 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.644 1.978 . . . . 0.0 115.618 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -64.45 137.26 57.78 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.902 -1.124 . . . . 0.0 110.648 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.2 m -102.2 147.48 26.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.207 1.003 . . . . 0.0 113.537 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -140.66 149.61 42.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.624 1.97 . . . . 0.0 111.552 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -87.96 -18.25 29.48 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -142.61 152.1 42.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.952 1.301 . . . . 0.0 111.802 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.91 -37.43 86.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -23.1 62.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.66 -45.42 37.18 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.616 0.767 . . . . 0.0 111.063 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -68.11 -40.48 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.711 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.74 -43.68 90.29 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.581 1.082 . . . . 0.0 111.75 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -62.89 -43.91 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.164 0.586 . . . . 0.0 111.95 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -59.76 -52.28 66.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.737 0.699 . . . . 0.0 112.41 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.37 -40.55 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.153 0.433 . . . . 0.0 110.202 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -71.09 -32.43 69.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.133 0.973 . . . . 0.0 113.398 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -88.86 -27.58 20.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.24 -25.03 11.69 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.99 71.76 79.9 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.533 1.133 . . . . 0.0 111.625 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -56.75 -24.93 57.97 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.454 3.436 . . . . 0.0 117.074 -171.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.78 -3.6 35.87 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.97 -42.25 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.53 1.532 . . . . 0.0 112.494 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.484 1.914 . . . . 0.0 113.069 -179.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 p -64.13 -21.04 66.39 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -65.26 -14.94 61.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.125 1.37 . . . . 0.0 113.922 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.85 60.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.7 1.143 . . . . 0.0 115.25 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.6 m 57.97 28.79 16.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.716 1.606 . . . . 0.0 115.038 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 m -77.49 64.1 2.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.908 1.683 . . . . 0.0 112.044 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.26 169.02 39.09 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.873 1.225 . . . . 0.0 112.697 -169.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 155.03 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.99 1.316 . . . . 0.0 111.94 -176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.8 t -97.63 148.06 23.68 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.891 1.277 . . . . 0.0 111.047 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.4 147.0 50.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.121 1.768 . . . . 0.0 111.201 -174.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -121.04 133.29 55.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.369 1.068 . . . . 0.0 112.114 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.55 131.12 71.14 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.897 1.279 . . . . 0.0 112.164 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.38 -6.21 18.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.294 2.663 . . . . 0.0 113.784 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.86 -37.61 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.287 1.035 . . . . 0.0 113.244 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.04 8.96 4.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 59.7 16.37 5.44 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.906 2.482 . . . . 0.0 116.679 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -68.09 150.21 48.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.469 1.108 . . . . 0.0 112.078 172.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -103.28 142.06 34.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.699 1.2 . . . . 0.0 113.249 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -140.0 133.03 29.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.429 1.491 . . . . 0.0 111.633 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -82.84 -1.23 51.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -141.33 141.7 33.85 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.429 1.892 . . . . 0.0 110.544 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.19 -33.77 76.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.244 0.618 . . . . 0.0 112.453 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -66.84 -29.55 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.186 0.995 . . . . 0.0 113.471 173.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.5 mt -78.69 -40.34 34.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.959 0.8 . . . . 0.0 112.114 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.73 -40.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.268 0.94 . . . . 0.0 111.292 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.97 -40.0 94.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.801 1.182 . . . . 0.0 111.897 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.8 m -63.43 -42.41 98.69 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.786 0.721 . . . . 0.0 112.223 173.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -62.49 -45.85 91.13 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.486 -0.759 . . . . 0.0 112.227 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.09 -44.23 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.328 0.651 . . . . 0.0 109.934 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -68.67 -31.29 70.31 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.065 1.302 . . . . 0.0 113.958 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 p -91.39 -40.27 11.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.612 1.165 . . . . 0.0 113.847 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -102.8 -30.9 10.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.505 1.122 . . . . 0.0 112.536 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.02 49.78 5.01 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 36' ' ' VAL . 47.2 Cg_endo -68.56 -172.98 0.5 Allowed 'Trans proline' 0 N--CA 1.421 -2.759 0 N-CA-C 101.737 -3.986 . . . . 0.0 101.737 152.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.261 10.1 pt-20 48.65 -10.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 131.139 3.776 . . . . 0.0 116.004 -167.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 34' ' ' PRO . 2.3 t -103.98 -37.2 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.413 2.285 . . . . 0.0 112.109 175.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.048 1.739 . . . . 0.0 112.186 -176.217 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 m -136.43 135.09 38.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.445 1.098 . . . . 0.0 111.399 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -57.96 127.8 80.03 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.446 1.098 . . . . 0.0 112.104 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.62 -6.83 19.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.952 2.435 . . . . 0.0 113.587 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -115.9 -34.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.41 1.084 . . . . 0.0 113.092 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -132.71 5.57 3.97 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 61.72 12.9 4.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.93 2.092 . . . . 0.0 116.0 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -61.66 139.12 58.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.705 -1.247 . . . . 0.0 111.258 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.6 m -81.49 148.0 29.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.354 1.062 . . . . 0.0 113.236 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -141.13 147.63 38.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.96 2.104 . . . . 0.0 111.679 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 p -92.86 -17.21 24.35 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -142.67 150.04 39.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.656 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.52 -37.62 81.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.227 1.411 . . . . 0.0 112.899 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -66.33 -30.14 70.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.21 -42.72 25.35 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.601 0.761 . . . . 0.0 111.465 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -66.59 -38.24 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 118.329 0.513 . . . . 0.0 111.548 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.83 -40.85 97.58 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.902 -1.124 . . . . 0.0 112.198 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -61.6 -40.77 96.0 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.558 0.617 . . . . 0.0 111.916 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.0 -46.41 84.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.689 0.795 . . . . 0.0 112.674 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.0 -42.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.607 -0.683 . . . . 0.0 110.487 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -68.15 -32.5 72.82 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.8 p -91.97 -35.89 13.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -107.36 -26.4 11.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.48 1.112 . . . . 0.0 113.425 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 . . . . . 0 CA--C 1.556 1.203 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 -172.73 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.856 -0.053 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -131.39 136.74 48.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.932 0.893 . . . . 0.0 112.11 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.0 t -61.18 131.77 92.23 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.122 0.969 . . . . 0.0 111.967 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.01 -7.54 20.04 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.405 2.736 . . . . 0.0 113.935 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.02 -37.06 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.28 1.032 . . . . 0.0 113.492 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -129.82 14.1 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 61.53 4.69 1.05 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.351 2.661 . . . . 0.0 117.285 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.27 147.45 53.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.728 1.211 . . . . 0.0 112.794 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 m -96.39 140.71 30.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.959 1.304 . . . . 0.0 112.954 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -137.66 147.62 45.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 111.605 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 m -89.51 -13.89 36.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -142.54 151.39 41.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.649 1.18 . . . . 0.0 111.954 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -14.94 63.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -81.98 -32.99 30.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.121 0.968 . . . . 0.0 112.86 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.57 -39.45 70.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.565 0.746 . . . . 0.0 111.365 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 118.094 0.406 . . . . 0.0 111.789 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -62.89 -46.29 88.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.656 0.782 . . . . 0.0 111.407 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -59.23 -42.67 91.62 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.391 0.541 . . . . 0.0 112.248 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -64.18 -46.76 82.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.106 0.866 . . . . 0.0 112.542 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.04 -42.61 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.692 -0.63 . . . . 0.0 110.655 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.84 -34.17 73.27 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 p -85.86 -35.56 20.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -109.42 -28.19 9.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -169.962 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -139.62 143.21 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.6 130.64 81.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.344 1.458 . . . . 0.0 112.471 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.79 -8.42 22.35 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.119 2.546 . . . . 0.0 113.557 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -113.88 -37.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.547 1.139 . . . . 0.0 112.826 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -135.22 11.63 3.55 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.2 6.71 1.39 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.192 2.597 . . . . 0.0 117.407 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -63.56 142.64 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.895 -1.128 . . . . 0.0 111.649 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 p -95.29 146.4 24.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.513 1.125 . . . . 0.0 114.006 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.87 144.4 33.82 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.923 1.689 . . . . 0.0 111.685 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.2 m -81.9 -20.24 39.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -142.82 151.68 41.39 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.962 1.305 . . . . 0.0 112.104 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.85 -34.88 76.77 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.333 1.053 . . . . 0.0 112.896 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -67.8 -31.05 70.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.98 -43.62 57.5 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.381 0.672 . . . . 0.0 111.372 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.09 -37.58 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.671 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -60.84 -43.55 98.14 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.957 1.253 . . . . 0.0 112.227 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -63.15 -37.33 86.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.227 0.921 . . . . 0.0 112.738 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.51 -46.12 87.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.21 0.913 . . . . 0.0 112.547 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.94 -41.78 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.549 -0.719 . . . . 0.0 110.725 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.32 -34.89 78.3 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 p -88.66 -34.26 17.31 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -109.61 -27.16 9.53 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 . . . . . 0 CA--C 1.557 1.222 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -171.109 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 p -142.35 141.92 32.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.681 0.792 . . . . 0.0 112.352 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -57.34 132.4 81.27 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.758 1.223 . . . . 0.0 112.72 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.85 -10.12 27.07 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.165 2.577 . . . . 0.0 113.833 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.93 -37.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.318 1.047 . . . . 0.0 113.184 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.21 4.91 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 60.23 12.1 3.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.264 2.226 . . . . 0.0 116.14 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.79 133.2 54.06 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.824 1.249 . . . . 0.0 111.119 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.8 m -85.86 145.32 27.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.214 1.006 . . . . 0.0 112.87 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.31 152.13 46.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.986 1.714 . . . . 0.0 111.763 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.1 p -97.69 -11.74 23.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.54 151.41 43.22 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.24 1.416 . . . . 0.0 111.484 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -36.45 83.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.198 0.599 . . . . 0.0 112.456 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -65.06 -28.78 69.71 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.57 -44.66 33.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.461 0.705 . . . . 0.0 111.617 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -68.27 -37.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.562 0.619 . . . . 0.0 111.737 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -60.01 -44.81 94.32 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.594 1.088 . . . . 0.0 111.512 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 m -61.07 -41.82 97.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.03 0.532 . . . . 0.0 112.053 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.28 -46.91 84.57 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.573 -0.705 . . . . 0.0 112.691 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.63 -44.48 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.592 -0.692 . . . . 0.0 110.265 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -68.25 -30.33 69.34 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.3 p -92.35 -35.2 13.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -107.99 -26.53 10.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.073 0.949 . . . . 0.0 113.116 -172.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 110.707 -0.109 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -137.73 134.29 35.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.797 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.43 130.19 80.81 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.798 1.239 . . . . 0.0 112.413 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.12 -9.98 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.158 2.572 . . . . 0.0 113.67 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -111.97 -37.07 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.379 1.072 . . . . 0.0 113.026 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -130.91 3.03 4.4 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 58.29 22.96 9.87 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.59 1.956 . . . . 0.0 115.45 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.53 135.62 51.85 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.726 169.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 m -87.05 144.83 26.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 113.235 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.88 145.98 38.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.643 1.577 . . . . 0.0 112.251 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 -18.41 37.23 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -142.26 148.62 38.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.65 1.58 . . . . 0.0 112.091 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.28 -34.27 73.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.49 1.116 . . . . 0.0 112.843 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -67.32 -29.81 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.881 0.873 . . . . 0.0 113.274 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.68 -37.29 27.65 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.319 1.048 . . . . 0.0 111.969 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.61 -38.58 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.748 -0.595 . . . . 0.0 110.955 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -60.53 -46.86 88.61 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.885 1.22 . . . . 0.0 112.387 174.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.8 p -65.22 -36.39 84.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.097 0.862 . . . . 0.0 112.385 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.8 -50.32 73.91 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.978 0.808 . . . . 0.0 112.52 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.09 -42.13 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 10.1 mmpt? -75.14 -16.13 60.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -99.25 -34.37 10.37 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.581 1.152 . . . . 0.0 113.73 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -106.15 -28.01 10.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.644 1.178 . . . . 0.0 113.465 -173.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 125.196 1.398 . . . . 0.0 111.623 -176.431 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p -140.09 142.55 36.09 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.11 131.39 87.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.25 1.42 . . . . 0.0 112.599 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 -10.13 23.87 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.262 2.642 . . . . 0.0 113.686 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.6 t -113.18 -36.34 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.598 1.159 . . . . 0.0 112.897 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -134.96 10.61 3.6 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 60.89 9.45 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.011 2.524 . . . . 0.0 117.18 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.65 144.8 56.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.439 1.096 . . . . 0.0 112.003 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.8 m -96.64 143.74 27.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.43 1.092 . . . . 0.0 113.633 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -140.16 154.25 46.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.348 1.859 . . . . 0.0 111.54 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.3 p -97.83 -10.2 25.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -142.01 151.78 42.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.498 1.119 . . . . 0.0 112.818 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.71 -39.13 76.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.245 1.418 . . . . 0.0 112.448 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.112 0.965 . . . . 0.0 113.541 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.83 -44.24 41.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.469 0.708 . . . . 0.0 111.415 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -67.43 -38.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.717 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.29 -42.98 99.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.809 1.186 . . . . 0.0 112.072 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.7 t -57.79 -45.18 86.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.667 0.667 . . . . 0.0 111.596 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -60.69 -49.14 78.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.712 0.805 . . . . 0.0 112.947 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.12 -42.39 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -72.7 -23.86 60.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 t -104.01 -15.82 15.49 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -116.03 -28.62 6.57 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 . . . . . 0 CA--C 1.557 1.238 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.274 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -137.86 134.15 34.75 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 0.0 112.148 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.5 t -56.84 128.96 77.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.133 1.373 . . . . 0.0 112.185 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.52 -8.52 22.71 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.107 2.538 . . . . 0.0 113.481 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.25 -37.13 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.614 1.166 . . . . 0.0 112.682 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 p -136.5 7.56 3.06 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 58.55 22.26 9.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.103 2.161 . . . . 0.0 116.073 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -72.71 142.44 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.003 -1.061 . . . . 0.0 111.129 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 p -96.24 145.03 25.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.445 1.098 . . . . 0.0 113.923 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -141.26 157.61 44.99 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.2 1.8 . . . . 0.0 111.668 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -106.2 -2.77 22.11 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -146.14 150.71 36.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.469 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.64 -35.25 79.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.729 0.812 . . . . 0.0 112.626 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -68.84 -29.45 67.78 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.11 -44.59 53.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.676 0.671 . . . . 0.0 111.398 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.87 -38.94 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.805 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -60.92 -42.71 98.66 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.016 1.28 . . . . 0.0 112.095 172.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.47 -42.34 98.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.357 0.526 . . . . 0.0 111.765 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -62.5 -48.51 79.23 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.687 -0.633 . . . . 0.0 112.628 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.4 mt -57.71 -44.49 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.431 0.692 . . . . 0.0 110.441 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.98 -32.67 71.0 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 p -89.43 -37.46 14.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.62 -24.75 14.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.438 1.095 . . . . 0.0 113.168 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 125.019 1.328 . . . . 0.0 112.772 -175.554 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.3 p -115.19 141.37 48.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.186 0.994 . . . . 0.0 113.06 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.36 129.49 86.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.308 . . . . 0.0 112.198 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.83 -8.96 23.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.309 2.673 . . . . 0.0 113.424 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.4 t -113.28 -38.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.601 1.16 . . . . 0.0 112.59 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 p -137.51 20.74 2.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 58.26 -6.58 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.756 3.222 . . . . 0.0 119.221 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -62.25 146.23 51.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.055 1.298 . . . . 0.0 112.531 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.4 m -108.11 146.52 32.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.529 1.132 . . . . 0.0 113.855 -171.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -137.71 145.12 42.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.829 2.051 . . . . 0.0 110.972 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -87.39 -8.27 56.76 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -143.32 152.54 41.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.008 1.323 . . . . 0.0 111.471 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.31 -33.65 75.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.818 0.847 . . . . 0.0 112.828 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.5 -29.6 69.06 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.309 -0.869 . . . . 0.0 113.181 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.21 -42.05 47.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.613 0.765 . . . . 0.0 111.389 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -68.61 -38.71 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.493 0.588 . . . . 0.0 111.846 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -63.58 -39.99 95.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.903 1.229 . . . . 0.0 112.174 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -60.65 -44.53 96.32 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.358 0.663 . . . . 0.0 111.78 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.44 -47.99 83.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 112.532 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.2 mt -60.24 -42.49 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 110.79 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.2 -20.12 60.3 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 p -99.02 -27.6 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.812 1.245 . . . . 0.0 114.014 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -111.08 -28.74 8.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.294 1.038 . . . . 0.0 113.776 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 CA--C 1.557 1.221 0 C-N-CA 125.352 1.461 . . . . 0.0 112.77 -173.715 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.048 -0.025 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.3 p -137.83 140.8 40.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.752 0.821 . . . . 0.0 112.973 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.3 t -56.87 131.96 79.25 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.06 1.344 . . . . 0.0 112.592 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.67 -9.61 25.24 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.149 2.566 . . . . 0.0 113.774 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.15 -38.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 113.009 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.2 p -132.72 10.73 4.34 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 60.56 7.17 1.28 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.295 2.638 . . . . 0.0 117.208 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -62.21 142.78 57.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.423 1.089 . . . . 0.0 111.658 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 p -96.1 146.26 24.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.634 1.173 . . . . 0.0 113.983 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.36 144.27 33.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.996 1.719 . . . . 0.0 111.774 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 m -84.38 -19.08 34.16 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -143.63 153.78 42.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.173 1.389 . . . . 0.0 111.78 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.54 -40.39 87.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.633 0.773 . . . . 0.0 112.435 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -60.56 -30.01 69.52 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.149 -0.969 . . . . 0.0 113.565 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.58 -44.89 26.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.8 -38.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.37 0.532 . . . . 0.0 111.942 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.751 1.16 . . . . 0.0 111.474 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 t -59.03 -44.93 91.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.396 0.544 . . . . 0.0 111.792 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.82 -46.03 92.15 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.383 -0.823 . . . . 0.0 112.981 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.51 -44.02 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.726 0.811 . . . . 0.0 110.588 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -72.79 -28.63 62.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -90.15 -35.72 15.23 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -108.35 -26.4 10.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.393 1.077 . . . . 0.0 113.662 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 113.797 -173.953 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -136.68 134.44 37.25 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 112.468 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.59 132.75 82.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.155 1.382 . . . . 0.0 112.695 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.06 -10.72 26.43 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.161 2.574 . . . . 0.0 113.569 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.16 -41.08 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.399 1.08 . . . . 0.0 112.91 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.9 p -124.9 7.12 8.03 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 58.43 10.96 1.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.423 2.289 . . . . 0.0 115.392 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -66.49 135.7 54.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.486 2.315 . . . . 0.0 111.372 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 p -97.12 145.54 25.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -142.31 153.94 44.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.501 1.92 . . . . 0.0 111.808 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -87.22 -23.3 24.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -141.52 155.49 45.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.677 1.191 . . . . 0.0 113.085 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.56 -39.75 74.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.965 1.306 . . . . 0.0 112.652 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -64.48 -30.64 71.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.21 -44.31 26.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.937 0.895 . . . . 0.0 111.2 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.27 -41.22 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.543 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -63.38 -40.27 96.8 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.078 1.308 . . . . 0.0 111.85 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -60.57 -40.48 91.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.994 0.816 . . . . 0.0 112.01 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -63.41 -51.76 64.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.558 0.617 . . . . 0.0 112.657 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.83 -40.83 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.488 0.586 . . . . 0.0 110.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.3 -33.84 76.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -92.97 -29.8 15.67 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 113.959 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -106.86 -25.57 11.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.421 1.088 . . . . 0.0 113.766 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 . . . . . 0 CA--C 1.556 1.197 0 C-N-CA 124.755 1.222 . . . . 0.0 111.307 -172.643 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -134.75 141.0 46.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.719 0.808 . . . . 0.0 112.926 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.73 129.3 81.27 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.394 1.478 . . . . 0.0 112.608 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.02 -9.07 21.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.323 2.682 . . . . 0.0 113.387 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.4 t -112.34 -37.91 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.703 1.201 . . . . 0.0 112.693 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.4 p -137.72 19.92 2.87 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -172.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.51 -5.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 129.55 3.14 . . . . 0.0 119.05 168.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -62.18 143.66 56.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.916 1.235 . . . . 0.0 112.48 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.0 p -101.07 150.36 23.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.697 1.199 . . . . 0.0 113.891 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -140.03 147.82 40.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.009 2.124 . . . . 0.0 110.685 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 p -89.81 -10.4 45.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -150.92 158.95 44.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 111.652 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.38 -33.32 75.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -67.21 -24.91 65.89 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.057 -1.027 . . . . 0.0 112.931 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.43 -42.82 34.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 111.497 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -67.8 -38.59 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.428 0.558 . . . . 0.0 111.623 171.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.49 -39.72 94.37 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.853 1.206 . . . . 0.0 111.888 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -62.82 -42.07 99.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.571 0.623 . . . . 0.0 111.991 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.62 -46.69 88.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.635 0.774 . . . . 0.0 112.419 174.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.64 -42.49 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.038 0.935 . . . . 0.0 110.675 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -30.39 68.76 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -92.94 -25.84 17.84 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -114.18 -28.46 7.29 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 . . . . . 0 CA--C 1.554 1.124 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.916 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -137.18 139.23 40.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.862 0.865 . . . . 0.0 112.067 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.8 129.64 71.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.576 1.55 . . . . 0.0 112.294 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.51 -7.87 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 113.469 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -113.02 -37.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 112.756 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -135.78 11.49 3.4 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 61.66 10.07 3.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.871 2.468 . . . . 0.0 117.024 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.59 141.17 55.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.609 -1.307 . . . . 0.0 111.773 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -99.57 147.14 25.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -139.91 148.11 41.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.953 2.101 . . . . 0.0 111.329 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -88.11 -20.58 25.48 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -141.33 151.03 43.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.615 1.166 . . . . 0.0 112.699 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -61.72 -36.59 81.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.346 1.458 . . . . 0.0 113.769 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -68.2 -26.35 65.68 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.147 -0.971 . . . . 0.0 113.107 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.45 -43.24 33.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.679 0.792 . . . . 0.0 111.345 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.49 -39.57 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.115 0.416 . . . . 0.0 111.448 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -63.72 -38.27 90.49 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.983 -1.073 . . . . 0.0 112.373 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.2 m -62.59 -43.67 98.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.288 0.635 . . . . 0.0 111.692 171.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.92 -45.2 94.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 0.0 112.537 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.0 -42.11 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.404 0.681 . . . . 0.0 110.298 175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.68 -36.44 82.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 113.529 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -88.42 -33.9 17.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.44 -27.67 10.79 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 124.687 1.195 . . . . 0.0 113.976 -171.224 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -139.41 142.03 37.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -61.1 130.05 91.07 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.839 1.256 . . . . 0.0 112.31 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.17 -7.58 20.77 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.058 2.505 . . . . 0.0 113.525 177.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.88 -36.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.5 1.12 . . . . 0.0 113.055 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.85 3.5 4.46 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 62.16 12.91 5.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.907 2.083 . . . . 0.0 116.181 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.54 138.22 58.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.701 -1.249 . . . . 0.0 111.169 170.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -82.3 148.91 28.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.8 152.69 43.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.962 2.105 . . . . 0.0 111.458 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -96.49 -14.36 22.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -141.98 144.59 33.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.489 1.115 . . . . 0.0 112.32 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.42 -37.63 81.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.275 1.43 . . . . 0.0 113.156 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.44 -31.3 70.52 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.73 -43.59 46.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.39 0.676 . . . . 0.0 111.419 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.74 -38.83 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.135 0.425 . . . . 0.0 111.681 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -63.39 -41.22 98.76 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.674 1.125 . . . . 0.0 112.208 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -60.96 -43.66 98.41 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.615 . . . . 0.0 111.905 172.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -60.45 -48.47 81.61 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.836 0.855 . . . . 0.0 112.792 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.03 -41.99 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.997 0.919 . . . . 0.0 110.476 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -66.57 -36.77 83.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.909 1.284 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 t -95.01 -27.27 15.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -103.12 -28.62 11.84 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -169.882 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -124.0 131.73 53.6 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.868 0.867 . . . . 0.0 112.24 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.9 t -56.22 131.34 75.23 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 112.45 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.16 -9.38 23.28 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.298 2.665 . . . . 0.0 113.923 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.57 -36.85 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.324 1.05 . . . . 0.0 113.253 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 p -132.51 10.11 4.38 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 60.17 12.0 3.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.923 2.489 . . . . 0.0 116.918 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -64.78 147.26 53.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.457 1.103 . . . . 0.0 111.922 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.9 t -101.73 145.62 28.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 113.282 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -141.58 149.28 40.56 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.178 2.191 . . . . 0.0 111.119 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -90.81 -14.99 30.82 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.654 1.354 . . . . 0.0 114.654 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -141.59 151.58 43.28 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.603 1.161 . . . . 0.0 112.73 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.328 1.451 . . . . 0.0 112.896 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -67.61 -28.68 67.96 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.05 -42.72 25.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.634 0.774 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 tt -66.02 -38.7 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.243 0.474 . . . . 0.0 111.414 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.42 -39.01 93.02 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.669 1.122 . . . . 0.0 112.33 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -61.86 -41.2 97.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.729 0.695 . . . . 0.0 111.944 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -64.13 -46.28 84.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.519 0.727 . . . . 0.0 112.578 174.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.56 -43.24 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 110.788 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -29.66 67.88 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 p -91.9 -30.92 15.89 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -113.71 -27.73 7.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 CA--C 1.558 1.287 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -169.922 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -137.47 142.77 41.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.5 t -58.32 132.92 84.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.083 1.353 . . . . 0.0 112.684 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.9 -10.51 26.35 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.297 2.665 . . . . 0.0 113.973 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 -39.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.234 1.014 . . . . 0.0 113.039 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -129.69 9.9 5.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.94 10.7 2.26 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.071 2.548 . . . . 0.0 116.933 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -64.06 144.32 57.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.531 1.132 . . . . 0.0 111.771 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -98.27 143.85 28.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.464 1.106 . . . . 0.0 113.367 -172.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.26 145.98 39.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.157 1.783 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m -88.49 -15.15 36.04 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -140.82 148.72 41.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.797 1.239 . . . . 0.0 112.09 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.06 -37.64 83.39 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 112.684 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -67.52 -28.47 67.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.97 -43.91 33.2 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.438 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.79 -38.85 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.437 0.562 . . . . 0.0 111.573 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.39 -40.05 96.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.589 1.086 . . . . 0.0 112.19 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.9 m -61.67 -41.41 97.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.685 0.675 . . . . 0.0 111.882 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.51 -47.62 80.95 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.681 -0.637 . . . . 0.0 112.582 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.55 -43.6 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.406 0.683 . . . . 0.0 110.462 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -67.59 -31.5 71.59 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.9 p -91.47 -32.75 15.48 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 114.061 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -109.38 -27.47 9.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 CA--C 1.555 1.17 0 C-N-CA 124.435 1.094 . . . . 0.0 112.936 -172.737 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 m -127.36 135.3 50.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.723 0.809 . . . . 0.0 112.418 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.02 133.66 74.12 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.529 1.532 . . . . 0.0 112.959 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -10.5 27.62 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.16 2.574 . . . . 0.0 114.021 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.15 -34.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.114 0.966 . . . . 0.0 113.51 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -129.02 2.88 5.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 60.38 10.22 2.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.247 2.219 . . . . 0.0 116.347 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -62.48 143.91 56.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.048 -1.032 . . . . 0.0 111.574 171.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.0 p -102.9 148.75 25.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.86 149.31 41.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.912 2.085 . . . . 0.0 111.161 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 p -89.48 -14.52 35.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.59 146.29 39.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.19 1.396 . . . . 0.0 112.349 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.19 -36.59 80.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.198 1.399 . . . . 0.0 113.146 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -69.23 -28.65 66.54 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.29 -42.75 44.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.359 0.663 . . . . 0.0 111.552 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.6 -39.53 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 118.407 0.549 . . . . 0.0 111.573 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -63.53 -41.28 98.48 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.704 1.138 . . . . 0.0 112.203 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -59.12 -45.54 90.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.145 0.578 . . . . 0.0 111.46 171.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -60.98 -47.55 85.95 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.334 -0.854 . . . . 0.0 112.86 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.75 -45.19 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.971 0.908 . . . . 0.0 110.778 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.83 -25.2 52.92 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -91.17 -36.75 13.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 113.895 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -104.9 -27.63 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.182 0.993 . . . . 0.0 113.488 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 . . . . . 0 CA--C 1.552 1.05 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.23 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -137.09 146.61 45.33 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.01 129.51 86.3 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.523 1.129 . . . . 0.0 111.666 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 -7.32 19.0 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.122 2.548 . . . . 0.0 113.251 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 t -111.94 -38.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.691 1.196 . . . . 0.0 112.749 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 p -135.09 9.98 3.53 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.82 7.95 2.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.079 2.552 . . . . 0.0 117.04 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -66.19 147.31 53.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.43 1.092 . . . . 0.0 111.967 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.5 p -108.05 144.33 35.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.888 1.275 . . . . 0.0 113.796 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -141.73 156.59 45.6 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.686 1.995 . . . . 0.0 111.52 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.18 -18.99 34.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -172.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.57 155.99 43.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.212 1.005 . . . . 0.0 113.037 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 25' ' ' ILE . 37.8 t70 -62.86 -35.72 80.9 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.5 -0.75 . . . . 0.0 112.253 173.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -66.32 -9.08 29.61 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -100.42 -44.45 5.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.624 1.17 . . . . 0.0 111.407 171.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 22' ' ' ASP . 8.4 tp -67.72 -38.6 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.19 0.904 . . . . 0.0 112.985 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -65.52 -40.25 92.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.564 -0.71 . . . . 0.0 111.193 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 m -65.26 -40.21 93.66 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.1 -48.56 81.22 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.463 0.705 . . . . 0.0 112.019 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.08 -40.88 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 0.0 110.66 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.38 -40.36 89.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.769 1.228 . . . . 0.0 112.764 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 t -90.23 -28.02 19.12 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -101.63 -28.7 12.36 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 . . . . . 0 CA--C 1.558 1.286 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.651 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 p -144.73 143.28 30.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 0.0 112.664 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -59.84 129.11 87.6 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.55 1.14 . . . . 0.0 112.159 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -8.56 21.62 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.57 -38.07 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.159 . . . . 0.0 112.701 -176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.7 p -137.37 25.78 2.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 61.11 -20.36 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.996 3.318 . . . . 0.0 118.816 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -54.36 139.6 36.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.197 1.399 . . . . 0.0 113.629 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -92.94 148.58 21.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.769 1.228 . . . . 0.0 113.392 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.84 148.69 42.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.203 1.801 . . . . 0.0 111.688 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 m -88.95 -11.86 43.23 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -145.15 154.09 42.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.092 1.357 . . . . 0.0 111.741 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.09 -35.57 80.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.926 0.891 . . . . 0.0 112.693 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -67.95 -33.42 74.64 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.426 -0.796 . . . . 0.0 113.113 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.37 -45.53 69.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.386 0.674 . . . . 0.0 111.313 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.55 -36.82 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.183 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -63.33 -42.35 98.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.945 1.248 . . . . 0.0 112.21 174.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -61.42 -41.16 96.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.205 0.911 . . . . 0.0 112.198 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -62.4 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.01 0.823 . . . . 0.0 112.537 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.58 -42.67 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.655 0.782 . . . . 0.0 110.517 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -74.58 -21.65 59.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -94.22 -34.86 12.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.783 1.233 . . . . 0.0 113.975 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -106.74 -27.72 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.258 1.023 . . . . 0.0 113.656 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 125.489 1.516 . . . . 0.0 112.18 -172.232 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -133.71 138.48 45.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.604 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.17 133.18 87.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.363 1.465 . . . . 0.0 112.83 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.19 -11.52 25.11 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.257 2.638 . . . . 0.0 113.692 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.7 -40.64 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.332 1.053 . . . . 0.0 112.876 -176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -128.24 1.28 5.77 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 60.33 16.8 6.52 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.644 1.978 . . . . 0.0 115.618 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -64.45 137.26 57.78 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.902 -1.124 . . . . 0.0 110.648 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.2 m -102.2 147.48 26.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.207 1.003 . . . . 0.0 113.537 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -140.66 149.61 42.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.624 1.97 . . . . 0.0 111.552 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -87.96 -18.25 29.48 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -142.61 152.1 42.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.952 1.301 . . . . 0.0 111.802 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.91 -37.43 86.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -23.1 62.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.66 -45.42 37.18 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.616 0.767 . . . . 0.0 111.063 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -68.11 -40.48 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.711 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.74 -43.68 90.29 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.581 1.082 . . . . 0.0 111.75 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -62.89 -43.91 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.164 0.586 . . . . 0.0 111.95 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -59.76 -52.28 66.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.737 0.699 . . . . 0.0 112.41 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.37 -40.55 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.153 0.433 . . . . 0.0 110.202 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -71.09 -32.43 69.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.133 0.973 . . . . 0.0 113.398 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -88.86 -27.58 20.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.24 -25.03 11.69 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 124.533 1.133 . . . . 0.0 111.625 -172.167 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 111.201 0.075 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -121.04 133.29 55.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.369 1.068 . . . . 0.0 112.114 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.55 131.12 71.14 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.897 1.279 . . . . 0.0 112.164 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.38 -6.21 18.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.294 2.663 . . . . 0.0 113.784 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.86 -37.61 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.287 1.035 . . . . 0.0 113.244 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.04 8.96 4.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 59.7 16.37 5.44 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.906 2.482 . . . . 0.0 116.679 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -68.09 150.21 48.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.469 1.108 . . . . 0.0 112.078 172.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -103.28 142.06 34.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.699 1.2 . . . . 0.0 113.249 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -140.0 133.03 29.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.429 1.491 . . . . 0.0 111.633 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -82.84 -1.23 51.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -141.33 141.7 33.85 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.429 1.892 . . . . 0.0 110.544 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.19 -33.77 76.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.244 0.618 . . . . 0.0 112.453 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -66.84 -29.55 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.186 0.995 . . . . 0.0 113.471 173.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.5 mt -78.69 -40.34 34.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.959 0.8 . . . . 0.0 112.114 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.73 -40.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.268 0.94 . . . . 0.0 111.292 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.97 -40.0 94.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.801 1.182 . . . . 0.0 111.897 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.8 m -63.43 -42.41 98.69 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.786 0.721 . . . . 0.0 112.223 173.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -62.49 -45.85 91.13 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.486 -0.759 . . . . 0.0 112.227 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.09 -44.23 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.328 0.651 . . . . 0.0 109.934 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -68.67 -31.29 70.31 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.065 1.302 . . . . 0.0 113.958 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 p -91.39 -40.27 11.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.612 1.165 . . . . 0.0 113.847 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -102.8 -30.9 10.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.505 1.122 . . . . 0.0 112.536 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 . . . . . 0 C--O 1.242 0.695 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 -177.543 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -75.27 154.87 37.24 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.06 0.944 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -68.79 144.13 54.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.784 1.234 . . . . 0.0 113.142 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.01 -178.32 50.72 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.394 0.997 . . . . 0.0 113.898 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 m -63.14 148.26 48.48 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.503 1.121 . . . . 0.0 112.413 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 t -146.48 154.45 41.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.532 1.133 . . . . 0.0 112.71 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.42 141.51 5.93 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.392 1.949 . . . . 0.0 110.941 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.59 155.64 46.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.794 1.238 . . . . 0.0 113.051 -170.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -107.03 165.32 11.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.479 1.912 . . . . 0.0 110.91 169.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -133.88 157.04 46.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.808 1.243 . . . . 0.0 111.851 -169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 m -136.43 135.09 38.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.445 1.098 . . . . 0.0 111.399 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -57.96 127.8 80.03 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.446 1.098 . . . . 0.0 112.104 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.62 -6.83 19.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.952 2.435 . . . . 0.0 113.587 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -115.9 -34.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.41 1.084 . . . . 0.0 113.092 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -132.71 5.57 3.97 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 61.72 12.9 4.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.93 2.092 . . . . 0.0 116.0 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -61.66 139.12 58.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.705 -1.247 . . . . 0.0 111.258 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.6 m -81.49 148.0 29.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.354 1.062 . . . . 0.0 113.236 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -141.13 147.63 38.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.96 2.104 . . . . 0.0 111.679 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 p -92.86 -17.21 24.35 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -142.67 150.04 39.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.656 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.52 -37.62 81.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.227 1.411 . . . . 0.0 112.899 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -66.33 -30.14 70.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.21 -42.72 25.35 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.601 0.761 . . . . 0.0 111.465 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -66.59 -38.24 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 118.329 0.513 . . . . 0.0 111.548 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.83 -40.85 97.58 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.902 -1.124 . . . . 0.0 112.198 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -61.6 -40.77 96.0 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.558 0.617 . . . . 0.0 111.916 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.0 -46.41 84.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.689 0.795 . . . . 0.0 112.674 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.0 -42.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.607 -0.683 . . . . 0.0 110.487 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -68.15 -32.5 72.82 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.8 p -91.97 -35.89 13.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -107.36 -26.4 11.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.48 1.112 . . . . 0.0 113.425 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -134.28 40.82 0.59 Allowed Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.2 -36.21 70.25 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.797 2.331 . . . . 0.0 114.474 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.53 -2.91 27.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -113.56 -4.22 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.943 2.097 . . . . 0.0 112.042 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.254 1.312 0 C-N-CA 126.387 1.875 . . . . 0.0 112.62 179.193 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m -67.15 152.17 46.23 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.454 1.101 . . . . 0.0 113.152 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -70.81 -16.8 62.75 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.92 179.94 48.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.493 1.52 . . . . 0.0 112.828 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 86.4 p -149.25 167.69 25.34 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.174 1.389 . . . . 0.0 112.265 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -79.33 -6.29 56.41 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.91 168.34 53.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.011 1.291 . . . . 0.0 114.754 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -134.2 155.69 49.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.826 1.65 . . . . 0.0 112.153 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -127.3 165.43 19.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.419 1.888 . . . . 0.0 111.537 172.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -125.8 146.63 49.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 110.856 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -131.39 136.74 48.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.932 0.893 . . . . 0.0 112.11 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.0 t -61.18 131.77 92.23 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.122 0.969 . . . . 0.0 111.967 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.01 -7.54 20.04 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.405 2.736 . . . . 0.0 113.935 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.02 -37.06 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.28 1.032 . . . . 0.0 113.492 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -129.82 14.1 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 61.53 4.69 1.05 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.351 2.661 . . . . 0.0 117.285 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.27 147.45 53.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.728 1.211 . . . . 0.0 112.794 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 m -96.39 140.71 30.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.959 1.304 . . . . 0.0 112.954 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -137.66 147.62 45.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 111.605 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 m -89.51 -13.89 36.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -142.54 151.39 41.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.649 1.18 . . . . 0.0 111.954 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -14.94 63.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -81.98 -32.99 30.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.121 0.968 . . . . 0.0 112.86 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.57 -39.45 70.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.565 0.746 . . . . 0.0 111.365 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 118.094 0.406 . . . . 0.0 111.789 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -62.89 -46.29 88.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.656 0.782 . . . . 0.0 111.407 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -59.23 -42.67 91.62 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.391 0.541 . . . . 0.0 112.248 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -64.18 -46.76 82.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.106 0.866 . . . . 0.0 112.542 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.04 -42.61 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.692 -0.63 . . . . 0.0 110.655 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.84 -34.17 73.27 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 p -85.86 -35.56 20.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -109.42 -28.19 9.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -137.48 38.57 0.37 Allowed Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -169.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.76 -20.04 67.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.762 2.308 . . . . 0.0 114.338 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.19 -14.61 63.11 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.14 -19.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 119.203 0.911 . . . . 0.0 113.233 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.05 1.74 . . . . 0.0 113.357 -178.338 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.2 p -77.06 162.61 27.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.704 1.202 . . . . 0.0 113.069 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -73.18 -16.35 61.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.39 175.91 40.77 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.037 1.303 . . . . 0.0 113.538 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 m -86.13 23.72 1.47 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.405 1.482 . . . . 0.0 114.225 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 p -72.34 156.87 38.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.207 1.403 . . . . 0.0 113.66 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.96 -177.56 48.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.012 1.291 . . . . 0.0 113.184 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -86.71 -6.05 58.95 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -66.86 157.79 32.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.971 1.308 . . . . 0.0 113.188 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -107.55 154.86 20.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.334 1.854 . . . . 0.0 110.851 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -139.62 143.21 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.6 130.64 81.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.344 1.458 . . . . 0.0 112.471 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.79 -8.42 22.35 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.119 2.546 . . . . 0.0 113.557 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -113.88 -37.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.547 1.139 . . . . 0.0 112.826 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -135.22 11.63 3.55 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.2 6.71 1.39 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.192 2.597 . . . . 0.0 117.407 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -63.56 142.64 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.895 -1.128 . . . . 0.0 111.649 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 p -95.29 146.4 24.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.513 1.125 . . . . 0.0 114.006 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.87 144.4 33.82 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.923 1.689 . . . . 0.0 111.685 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.2 m -81.9 -20.24 39.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -142.82 151.68 41.39 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.962 1.305 . . . . 0.0 112.104 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.85 -34.88 76.77 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.333 1.053 . . . . 0.0 112.896 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -67.8 -31.05 70.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.98 -43.62 57.5 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.381 0.672 . . . . 0.0 111.372 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.09 -37.58 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.671 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -60.84 -43.55 98.14 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.957 1.253 . . . . 0.0 112.227 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -63.15 -37.33 86.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.227 0.921 . . . . 0.0 112.738 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.51 -46.12 87.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.21 0.913 . . . . 0.0 112.547 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.94 -41.78 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.549 -0.719 . . . . 0.0 110.725 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.32 -34.89 78.3 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 p -88.66 -34.26 17.31 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -109.61 -27.16 9.53 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -134.72 40.0 0.51 Allowed Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -171.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.67 -23.35 56.57 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.003 2.469 . . . . 0.0 114.769 -170.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -90.52 3.93 52.6 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.756 1.222 . . . . 0.0 113.804 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.25 -0.81 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.806 1.643 . . . . 0.0 112.817 -170.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.686 1.594 . . . . 0.0 114.536 179.134 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -76.0 167.28 22.15 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.944 1.298 . . . . 0.0 113.14 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -80.93 -10.31 59.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.084 1.354 . . . . 0.0 113.296 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.0 -140.55 48.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.554 1.074 . . . . 0.0 113.056 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.2 m -71.21 -12.14 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.2 m -84.15 -11.18 57.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.31 -174.9 46.15 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.156 0.889 . . . . 0.0 114.656 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.5 tpp85 -61.31 137.13 58.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.032 1.333 . . . . 0.0 111.516 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.6 m -127.13 152.7 46.98 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.849 1.66 . . . . 0.0 111.67 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -134.27 137.38 44.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.977 1.311 . . . . 0.0 109.78 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 p -142.35 141.92 32.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.681 0.792 . . . . 0.0 112.352 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -57.34 132.4 81.27 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.758 1.223 . . . . 0.0 112.72 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.85 -10.12 27.07 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.165 2.577 . . . . 0.0 113.833 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.93 -37.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.318 1.047 . . . . 0.0 113.184 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.21 4.91 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 60.23 12.1 3.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.264 2.226 . . . . 0.0 116.14 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.79 133.2 54.06 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.824 1.249 . . . . 0.0 111.119 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.8 m -85.86 145.32 27.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.214 1.006 . . . . 0.0 112.87 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.31 152.13 46.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.986 1.714 . . . . 0.0 111.763 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.1 p -97.69 -11.74 23.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.54 151.41 43.22 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.24 1.416 . . . . 0.0 111.484 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -36.45 83.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.198 0.599 . . . . 0.0 112.456 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -65.06 -28.78 69.71 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.57 -44.66 33.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.461 0.705 . . . . 0.0 111.617 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -68.27 -37.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.562 0.619 . . . . 0.0 111.737 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -60.01 -44.81 94.32 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.594 1.088 . . . . 0.0 111.512 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 m -61.07 -41.82 97.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.03 0.532 . . . . 0.0 112.053 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.28 -46.91 84.57 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.573 -0.705 . . . . 0.0 112.691 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.63 -44.48 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.592 -0.692 . . . . 0.0 110.265 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -68.25 -30.33 69.34 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.3 p -92.35 -35.2 13.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -107.99 -26.53 10.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -135.74 62.38 47.53 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.073 0.949 . . . . 0.0 113.116 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -66.23 -19.64 56.31 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.401 2.068 . . . . 0.0 115.798 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.07 -2.38 27.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.49 145.47 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.355 1.862 . . . . 0.0 111.527 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.172 1.789 . . . . 0.0 112.852 -178.453 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -148.39 161.22 42.03 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.322 1.449 . . . . 0.0 111.707 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -136.55 153.59 50.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 -173.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.41 177.62 50.31 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.758 1.17 . . . . 0.0 114.549 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -85.56 -10.35 56.06 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m 54.27 30.13 11.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.834 1.654 . . . . 0.0 114.993 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.17 171.87 44.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.962 1.268 . . . . 0.0 113.385 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -120.62 12.06 11.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.429 1.892 . . . . 0.0 113.588 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 m -66.92 154.51 40.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.946 1.298 . . . . 0.0 113.612 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -102.55 155.55 18.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 110.707 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -137.73 134.29 35.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.797 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.43 130.19 80.81 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.798 1.239 . . . . 0.0 112.413 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.12 -9.98 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.158 2.572 . . . . 0.0 113.67 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -111.97 -37.07 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.379 1.072 . . . . 0.0 113.026 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -130.91 3.03 4.4 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 58.29 22.96 9.87 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.59 1.956 . . . . 0.0 115.45 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.53 135.62 51.85 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.726 169.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 m -87.05 144.83 26.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 113.235 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.88 145.98 38.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.643 1.577 . . . . 0.0 112.251 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 -18.41 37.23 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -142.26 148.62 38.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.65 1.58 . . . . 0.0 112.091 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.28 -34.27 73.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.49 1.116 . . . . 0.0 112.843 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -67.32 -29.81 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.881 0.873 . . . . 0.0 113.274 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.68 -37.29 27.65 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.319 1.048 . . . . 0.0 111.969 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.61 -38.58 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.748 -0.595 . . . . 0.0 110.955 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -60.53 -46.86 88.61 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.885 1.22 . . . . 0.0 112.387 174.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.8 p -65.22 -36.39 84.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.097 0.862 . . . . 0.0 112.385 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.8 -50.32 73.91 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.978 0.808 . . . . 0.0 112.52 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.09 -42.13 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 30' ' ' LYS . 10.1 mmpt? -75.14 -16.13 60.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -99.25 -34.37 10.37 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.581 1.152 . . . . 0.0 113.73 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -106.15 -28.01 10.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.644 1.178 . . . . 0.0 113.465 -173.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -135.96 56.81 15.76 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.196 1.398 . . . . 0.0 111.623 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -58.33 -32.45 96.09 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.758 2.305 . . . . 0.0 116.748 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.16 -4.8 38.02 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -172.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 p -126.75 141.58 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.358 1.863 . . . . 0.0 110.387 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.906 1.682 . . . . 0.0 112.012 -176.291 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -135.74 153.64 51.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.151 1.38 . . . . 0.0 112.079 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.9 m -71.6 153.2 42.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 113.019 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.49 177.51 46.64 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.632 1.11 . . . . 0.0 114.727 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -82.84 -22.77 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.304 1.042 . . . . 0.0 113.808 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -132.31 155.68 47.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.464 1.505 . . . . 0.0 112.795 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.43 178.57 43.7 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.425 1.488 . . . . 0.0 112.688 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -135.7 157.03 47.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.166 1.386 . . . . 0.0 112.58 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.2 p -135.01 157.5 46.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.871 1.668 . . . . 0.0 111.456 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -131.62 148.5 52.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p -140.09 142.55 36.09 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.11 131.39 87.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.25 1.42 . . . . 0.0 112.599 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 -10.13 23.87 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.262 2.642 . . . . 0.0 113.686 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.6 t -113.18 -36.34 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.598 1.159 . . . . 0.0 112.897 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -134.96 10.61 3.6 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 60.89 9.45 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.011 2.524 . . . . 0.0 117.18 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.65 144.8 56.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.439 1.096 . . . . 0.0 112.003 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.8 m -96.64 143.74 27.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.43 1.092 . . . . 0.0 113.633 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -140.16 154.25 46.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.348 1.859 . . . . 0.0 111.54 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.3 p -97.83 -10.2 25.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -142.01 151.78 42.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.498 1.119 . . . . 0.0 112.818 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.71 -39.13 76.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.245 1.418 . . . . 0.0 112.448 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.112 0.965 . . . . 0.0 113.541 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.83 -44.24 41.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.469 0.708 . . . . 0.0 111.415 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -67.43 -38.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.717 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.29 -42.98 99.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.809 1.186 . . . . 0.0 112.072 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.7 t -57.79 -45.18 86.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.667 0.667 . . . . 0.0 111.596 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -60.69 -49.14 78.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.712 0.805 . . . . 0.0 112.947 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.12 -42.39 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -72.7 -23.86 60.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 t -104.01 -15.82 15.49 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -116.03 -28.62 6.57 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -132.33 26.16 0.12 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.45 -22.75 51.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.689 2.259 . . . . 0.0 114.689 -169.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.58 10.09 31.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.711 1.604 . . . . 0.0 113.222 174.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.49 -28.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.393 1.477 . . . . 0.0 112.902 -169.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.256 1.41 0 C-N-CA 125.455 1.502 . . . . 0.0 114.652 176.468 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 t -147.97 158.45 44.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.331 . . . . 0.0 111.684 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -70.27 148.21 48.81 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.91 1.284 . . . . 0.0 113.313 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.89 162.5 28.42 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.971 1.272 . . . . 0.0 113.097 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t -153.78 153.53 32.35 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.881 1.272 . . . . 0.0 111.773 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.0 t 61.38 -58.0 0.1 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.506 2.722 . . . . 0.0 116.068 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.57 162.6 53.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.97 1.272 . . . . 0.0 114.008 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -144.56 145.75 31.98 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.026 1.73 . . . . 0.0 110.844 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -91.77 137.07 32.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.128 0.971 . . . . 0.0 111.673 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -127.53 149.45 50.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.367 1.867 . . . . 0.0 109.777 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -137.86 134.15 34.75 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 0.0 112.148 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.5 t -56.84 128.96 77.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.133 1.373 . . . . 0.0 112.185 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.52 -8.52 22.71 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.107 2.538 . . . . 0.0 113.481 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.25 -37.13 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.614 1.166 . . . . 0.0 112.682 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 p -136.5 7.56 3.06 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 58.55 22.26 9.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.103 2.161 . . . . 0.0 116.073 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -72.71 142.44 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.003 -1.061 . . . . 0.0 111.129 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 p -96.24 145.03 25.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.445 1.098 . . . . 0.0 113.923 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -141.26 157.61 44.99 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.2 1.8 . . . . 0.0 111.668 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -106.2 -2.77 22.11 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -146.14 150.71 36.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.469 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.64 -35.25 79.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.729 0.812 . . . . 0.0 112.626 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -68.84 -29.45 67.78 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.11 -44.59 53.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.676 0.671 . . . . 0.0 111.398 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.87 -38.94 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.805 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -60.92 -42.71 98.66 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.016 1.28 . . . . 0.0 112.095 172.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.47 -42.34 98.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.357 0.526 . . . . 0.0 111.765 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -62.5 -48.51 79.23 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.687 -0.633 . . . . 0.0 112.628 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.4 mt -57.71 -44.49 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.431 0.692 . . . . 0.0 110.441 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.98 -32.67 71.0 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 p -89.43 -37.46 14.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.62 -24.75 14.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.438 1.095 . . . . 0.0 113.168 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -130.88 48.5 3.78 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 125.019 1.328 . . . . 0.0 112.772 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -62.44 -29.69 79.32 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.493 2.795 . . . . 0.0 115.075 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.8 0.34 31.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.289 1.036 . . . . 0.0 113.153 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.9 -3.37 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 127.462 2.305 . . . . 0.0 111.827 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.489 1.916 . . . . 0.0 113.072 -179.469 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.6 m -72.07 149.01 45.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.332 1.053 . . . . 0.0 113.019 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -137.61 147.41 44.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.404 1.481 . . . . 0.0 111.74 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.44 -5.94 33.38 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.058 1.313 . . . . 0.0 116.376 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -141.34 150.23 42.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.931 1.692 . . . . 0.0 111.737 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.1 m -137.81 154.66 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.584 1.554 . . . . 0.0 111.807 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.62 -178.41 48.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.48 1.038 . . . . 0.0 113.336 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -142.11 146.46 35.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.647 1.579 . . . . 0.0 111.656 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -124.75 157.55 35.44 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.756 1.623 . . . . 0.0 110.845 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -128.29 134.87 49.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.705 1.602 . . . . 0.0 110.126 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.3 p -115.19 141.37 48.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.186 0.994 . . . . 0.0 113.06 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.36 129.49 86.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.308 . . . . 0.0 112.198 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.83 -8.96 23.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.309 2.673 . . . . 0.0 113.424 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.4 t -113.28 -38.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.601 1.16 . . . . 0.0 112.59 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 p -137.51 20.74 2.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 58.26 -6.58 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.756 3.222 . . . . 0.0 119.221 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -62.25 146.23 51.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.055 1.298 . . . . 0.0 112.531 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.4 m -108.11 146.52 32.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.529 1.132 . . . . 0.0 113.855 -171.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -137.71 145.12 42.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.829 2.051 . . . . 0.0 110.972 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -87.39 -8.27 56.76 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -143.32 152.54 41.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.008 1.323 . . . . 0.0 111.471 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.31 -33.65 75.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.818 0.847 . . . . 0.0 112.828 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.5 -29.6 69.06 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.309 -0.869 . . . . 0.0 113.181 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.21 -42.05 47.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.613 0.765 . . . . 0.0 111.389 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -68.61 -38.71 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.493 0.588 . . . . 0.0 111.846 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -63.58 -39.99 95.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.903 1.229 . . . . 0.0 112.174 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -60.65 -44.53 96.32 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.358 0.663 . . . . 0.0 111.78 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.44 -47.99 83.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 112.532 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.2 mt -60.24 -42.49 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 110.79 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.2 -20.12 60.3 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 p -99.02 -27.6 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.812 1.245 . . . . 0.0 114.014 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -111.08 -28.74 8.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.294 1.038 . . . . 0.0 113.776 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -133.59 42.59 0.86 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 125.352 1.461 . . . . 0.0 112.77 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -60.25 -19.92 59.79 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.7 2.933 . . . . 0.0 115.46 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.15 -17.74 42.71 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 p -93.0 -9.57 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.463 1.105 . . . . 0.0 113.59 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.466 1.506 . . . . 0.0 112.539 -178.051 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 m -67.91 151.32 47.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.575 1.15 . . . . 0.0 113.174 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 p -77.29 162.16 27.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.924 1.29 . . . . 0.0 113.146 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.73 178.72 48.43 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.941 1.258 . . . . 0.0 113.203 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 t -149.96 144.27 25.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.823 1.249 . . . . 0.0 111.864 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -68.51 -23.2 64.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.402 1.081 . . . . 0.0 112.879 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.4 -9.78 86.11 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.001 1.286 . . . . 0.0 114.311 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.6 mmt-85 60.48 163.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.526 2.731 . . . . 0.0 115.525 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -127.6 160.79 30.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.413 1.885 . . . . 0.0 110.865 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.04 152.4 26.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.45 1.5 . . . . 0.0 110.975 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.3 p -137.83 140.8 40.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.752 0.821 . . . . 0.0 112.973 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.3 t -56.87 131.96 79.25 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.06 1.344 . . . . 0.0 112.592 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.67 -9.61 25.24 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.149 2.566 . . . . 0.0 113.774 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.15 -38.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 113.009 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.2 p -132.72 10.73 4.34 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 60.56 7.17 1.28 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.295 2.638 . . . . 0.0 117.208 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -62.21 142.78 57.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.423 1.089 . . . . 0.0 111.658 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 p -96.1 146.26 24.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.634 1.173 . . . . 0.0 113.983 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.36 144.27 33.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.996 1.719 . . . . 0.0 111.774 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 m -84.38 -19.08 34.16 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -143.63 153.78 42.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.173 1.389 . . . . 0.0 111.78 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.54 -40.39 87.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.633 0.773 . . . . 0.0 112.435 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -60.56 -30.01 69.52 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.149 -0.969 . . . . 0.0 113.565 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.58 -44.89 26.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.8 -38.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.37 0.532 . . . . 0.0 111.942 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.751 1.16 . . . . 0.0 111.474 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 t -59.03 -44.93 91.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.396 0.544 . . . . 0.0 111.792 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.82 -46.03 92.15 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.383 -0.823 . . . . 0.0 112.981 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.51 -44.02 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.726 0.811 . . . . 0.0 110.588 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -72.79 -28.63 62.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -90.15 -35.72 15.23 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -108.35 -26.4 10.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.393 1.077 . . . . 0.0 113.662 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -134.08 44.73 1.3 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 113.797 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.66 -23.97 41.94 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.803 1.668 . . . . 0.0 114.514 -174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -66.15 -12.16 54.04 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -117.61 -7.49 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.739 2.016 . . . . 0.0 112.821 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--O 1.255 1.366 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.944 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m 57.71 -71.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 127.896 2.479 . . . . 0.0 116.014 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.9 m -80.31 -12.71 59.57 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.153 1.381 . . . . 0.0 113.635 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.13 165.67 39.09 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.573 1.559 . . . . 0.0 112.514 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.3 p -78.57 -7.6 57.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 m -61.15 135.17 57.67 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.936 1.294 . . . . 0.0 112.879 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.13 -6.33 78.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.64 1.114 . . . . 0.0 115.345 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -138.5 118.93 13.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.138 1.775 . . . . 0.0 110.621 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -144.24 150.83 38.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.093 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -132.05 148.02 52.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.319 1.848 . . . . 0.0 109.483 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -136.68 134.44 37.25 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 112.468 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.59 132.75 82.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.155 1.382 . . . . 0.0 112.695 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.06 -10.72 26.43 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.161 2.574 . . . . 0.0 113.569 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.16 -41.08 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.399 1.08 . . . . 0.0 112.91 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.9 p -124.9 7.12 8.03 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 58.43 10.96 1.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.423 2.289 . . . . 0.0 115.392 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -66.49 135.7 54.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.486 2.315 . . . . 0.0 111.372 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 p -97.12 145.54 25.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -142.31 153.94 44.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.501 1.92 . . . . 0.0 111.808 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -87.22 -23.3 24.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -141.52 155.49 45.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.677 1.191 . . . . 0.0 113.085 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.56 -39.75 74.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.965 1.306 . . . . 0.0 112.652 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -64.48 -30.64 71.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.21 -44.31 26.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.937 0.895 . . . . 0.0 111.2 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.27 -41.22 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.543 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -63.38 -40.27 96.8 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.078 1.308 . . . . 0.0 111.85 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -60.57 -40.48 91.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.994 0.816 . . . . 0.0 112.01 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -63.41 -51.76 64.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.558 0.617 . . . . 0.0 112.657 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.83 -40.83 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.488 0.586 . . . . 0.0 110.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.3 -33.84 76.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -92.97 -29.8 15.67 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 113.959 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -106.86 -25.57 11.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.421 1.088 . . . . 0.0 113.766 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -133.88 68.15 74.82 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.755 1.222 . . . . 0.0 111.307 -172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -56.68 -28.41 75.32 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.954 3.102 . . . . 0.0 117.103 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.84 -3.58 42.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.28 -23.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.827 1.651 . . . . 0.0 112.465 -170.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.251 1.161 0 C-N-CA 126.331 1.852 . . . . 0.0 111.777 169.697 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m -72.19 -22.43 61.28 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -150.53 153.48 35.88 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.359 1.464 . . . . 0.0 112.39 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.59 158.01 48.3 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.253 0.93 . . . . 0.0 113.454 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.3 m 52.35 36.51 20.03 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.495 1.518 . . . . 0.0 114.442 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.9 t -144.6 173.84 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.493 1.517 . . . . 0.0 112.248 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.81 179.75 43.16 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.506 1.527 . . . . 0.0 114.948 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -105.55 5.28 31.26 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.555 1.942 . . . . 0.0 113.584 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.8 m -81.42 146.78 30.1 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.211 -0.931 . . . . 0.0 112.644 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.3 154.05 51.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.186 1.794 . . . . 0.0 110.418 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -134.75 141.0 46.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.719 0.808 . . . . 0.0 112.926 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.73 129.3 81.27 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.394 1.478 . . . . 0.0 112.608 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.02 -9.07 21.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.323 2.682 . . . . 0.0 113.387 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.4 t -112.34 -37.91 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.703 1.201 . . . . 0.0 112.693 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.4 p -137.72 19.92 2.87 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -172.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.51 -5.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 129.55 3.14 . . . . 0.0 119.05 168.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -62.18 143.66 56.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.916 1.235 . . . . 0.0 112.48 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.0 p -101.07 150.36 23.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.697 1.199 . . . . 0.0 113.891 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -140.03 147.82 40.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.009 2.124 . . . . 0.0 110.685 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 p -89.81 -10.4 45.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -150.92 158.95 44.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 111.652 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.38 -33.32 75.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -67.21 -24.91 65.89 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.057 -1.027 . . . . 0.0 112.931 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.43 -42.82 34.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 111.497 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -67.8 -38.59 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.428 0.558 . . . . 0.0 111.623 171.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.49 -39.72 94.37 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.853 1.206 . . . . 0.0 111.888 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -62.82 -42.07 99.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.571 0.623 . . . . 0.0 111.991 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.62 -46.69 88.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.635 0.774 . . . . 0.0 112.419 174.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.64 -42.49 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.038 0.935 . . . . 0.0 110.675 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -30.39 68.76 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -92.94 -25.84 17.84 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -114.18 -28.46 7.29 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -135.52 36.53 0.31 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.08 -21.75 72.57 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.641 2.228 . . . . 0.0 114.352 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.71 -14.25 62.3 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -13.85 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.232 1.013 . . . . 0.0 113.31 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.58 1.552 . . . . 0.0 113.088 -179.648 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -64.74 -26.52 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -93.26 -8.71 41.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.953 1.301 . . . . 0.0 114.373 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.93 162.42 15.94 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.183 0.897 . . . . 0.0 114.365 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.0 p -150.09 160.04 43.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.696 1.598 . . . . 0.0 112.286 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -94.58 -31.89 13.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.089 1.356 . . . . 0.0 113.726 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.8 160.65 47.09 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.852 1.215 . . . . 0.0 113.34 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -136.59 149.61 48.13 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 111.473 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -127.8 168.97 14.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.424 1.89 . . . . 0.0 111.764 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -130.6 150.18 51.92 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.494 1.518 . . . . 0.0 110.695 -172.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -137.18 139.23 40.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.862 0.865 . . . . 0.0 112.067 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.8 129.64 71.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.576 1.55 . . . . 0.0 112.294 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.51 -7.87 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 113.469 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -113.02 -37.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 112.756 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -135.78 11.49 3.4 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 61.66 10.07 3.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.871 2.468 . . . . 0.0 117.024 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.59 141.17 55.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.609 -1.307 . . . . 0.0 111.773 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -99.57 147.14 25.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -139.91 148.11 41.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.953 2.101 . . . . 0.0 111.329 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -88.11 -20.58 25.48 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -141.33 151.03 43.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.615 1.166 . . . . 0.0 112.699 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -61.72 -36.59 81.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.346 1.458 . . . . 0.0 113.769 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -68.2 -26.35 65.68 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.147 -0.971 . . . . 0.0 113.107 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.45 -43.24 33.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.679 0.792 . . . . 0.0 111.345 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.49 -39.57 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.115 0.416 . . . . 0.0 111.448 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -63.72 -38.27 90.49 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.983 -1.073 . . . . 0.0 112.373 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.2 m -62.59 -43.67 98.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.288 0.635 . . . . 0.0 111.692 171.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.92 -45.2 94.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 0.0 112.537 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.0 -42.11 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.404 0.681 . . . . 0.0 110.298 175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.68 -36.44 82.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 113.529 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -88.42 -33.9 17.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.44 -27.67 10.79 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.69 42.99 0.91 Allowed Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.687 1.195 . . . . 0.0 113.976 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 -27.24 61.24 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.131 2.554 . . . . 0.0 114.615 -170.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.22 3.6 34.51 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.64 1.176 . . . . 0.0 113.85 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.06 18.19 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.265 1.826 . . . . 0.0 111.959 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 126.087 1.755 . . . . 0.0 114.542 178.06 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.2 p -146.67 163.4 36.01 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.47 1.508 . . . . 0.0 112.564 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -134.76 154.63 51.51 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.449 1.499 . . . . 0.0 112.087 -176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.28 171.25 44.39 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.792 1.187 . . . . 0.0 113.328 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 t -153.52 -42.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.414 1.085 . . . . 0.0 113.007 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.4 m -55.36 130.66 43.36 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.754 1.222 . . . . 0.0 112.997 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.02 27.99 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.053 1.311 . . . . 0.0 115.718 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 58.28 173.86 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.637 2.375 . . . . 0.0 114.925 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -139.16 161.24 37.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.99 1.716 . . . . 0.0 111.79 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -135.31 154.44 51.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.102 1.761 . . . . 0.0 110.265 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -139.41 142.03 37.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -61.1 130.05 91.07 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.839 1.256 . . . . 0.0 112.31 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.17 -7.58 20.77 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.058 2.505 . . . . 0.0 113.525 177.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.88 -36.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.5 1.12 . . . . 0.0 113.055 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.85 3.5 4.46 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 62.16 12.91 5.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.907 2.083 . . . . 0.0 116.181 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.54 138.22 58.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.701 -1.249 . . . . 0.0 111.169 170.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -82.3 148.91 28.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.8 152.69 43.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.962 2.105 . . . . 0.0 111.458 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -96.49 -14.36 22.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -141.98 144.59 33.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.489 1.115 . . . . 0.0 112.32 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.42 -37.63 81.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.275 1.43 . . . . 0.0 113.156 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.44 -31.3 70.52 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.73 -43.59 46.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.39 0.676 . . . . 0.0 111.419 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.74 -38.83 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.135 0.425 . . . . 0.0 111.681 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -63.39 -41.22 98.76 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.674 1.125 . . . . 0.0 112.208 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -60.96 -43.66 98.41 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.615 . . . . 0.0 111.905 172.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -60.45 -48.47 81.61 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.836 0.855 . . . . 0.0 112.792 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.03 -41.99 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.997 0.919 . . . . 0.0 110.476 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -66.57 -36.77 83.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.909 1.284 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 t -95.01 -27.27 15.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -103.12 -28.62 11.84 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -130.58 32.89 0.23 Allowed Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -169.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.86 -28.93 50.52 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.301 2.001 . . . . 0.0 114.389 -172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.9 -4.08 41.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.245 1.018 . . . . 0.0 113.642 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.61 -21.27 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.053 1.741 . . . . 0.0 112.025 -172.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.301 1.84 . . . . 0.0 113.575 177.008 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.8 p -89.37 -7.07 55.99 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -67.22 151.64 47.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.178 1.391 . . . . 0.0 113.729 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.07 171.16 42.34 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.978 1.275 . . . . 0.0 115.116 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -132.78 6.51 4.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 114.113 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.5 p -82.32 20.64 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.516 1.926 . . . . 0.0 115.06 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.14 -18.76 67.38 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.693 1.139 . . . . 0.0 115.389 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -127.96 134.04 49.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.374 1.87 . . . . 0.0 110.673 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 m -141.43 160.76 39.47 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.006 1.723 . . . . 0.0 111.529 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -114.98 136.99 52.52 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 109.723 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -124.0 131.73 53.6 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.868 0.867 . . . . 0.0 112.24 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.9 t -56.22 131.34 75.23 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 112.45 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.16 -9.38 23.28 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.298 2.665 . . . . 0.0 113.923 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.57 -36.85 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.324 1.05 . . . . 0.0 113.253 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 p -132.51 10.11 4.38 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 60.17 12.0 3.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.923 2.489 . . . . 0.0 116.918 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -64.78 147.26 53.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.457 1.103 . . . . 0.0 111.922 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.9 t -101.73 145.62 28.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 113.282 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -141.58 149.28 40.56 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.178 2.191 . . . . 0.0 111.119 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -90.81 -14.99 30.82 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.654 1.354 . . . . 0.0 114.654 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -141.59 151.58 43.28 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.603 1.161 . . . . 0.0 112.73 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.328 1.451 . . . . 0.0 112.896 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -67.61 -28.68 67.96 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.05 -42.72 25.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.634 0.774 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 tt -66.02 -38.7 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.243 0.474 . . . . 0.0 111.414 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.42 -39.01 93.02 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.669 1.122 . . . . 0.0 112.33 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -61.86 -41.2 97.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.729 0.695 . . . . 0.0 111.944 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -64.13 -46.28 84.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.519 0.727 . . . . 0.0 112.578 174.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.56 -43.24 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 110.788 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -29.66 67.88 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 p -91.9 -30.92 15.89 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -113.71 -27.73 7.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -134.41 29.57 0.16 Allowed Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -169.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.09 -26.54 42.88 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.666 2.244 . . . . 0.0 114.677 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.77 2.18 56.88 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.878 1.271 . . . . 0.0 113.594 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.66 -38.96 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.159 1.383 . . . . 0.0 112.633 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 112.905 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.6 p -80.75 -19.87 43.96 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m 54.93 25.75 7.14 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.6 1.56 . . . . 0.0 114.029 -169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.72 -7.64 80.46 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.851 1.215 . . . . 0.0 115.781 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.0 p -144.59 157.84 44.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.601 1.561 . . . . 0.0 112.525 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.9 p -96.87 165.81 11.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.757 1.623 . . . . 0.0 112.869 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.05 -146.19 40.88 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.962 0.791 . . . . 0.0 113.567 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -140.22 160.83 39.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.654 1.582 . . . . 0.0 112.736 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.1 p -142.15 166.07 25.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.728 1.611 . . . . 0.0 111.917 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.66 153.27 47.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.425 1.89 . . . . 0.0 110.151 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -137.47 142.77 41.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.5 t -58.32 132.92 84.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.083 1.353 . . . . 0.0 112.684 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.9 -10.51 26.35 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.297 2.665 . . . . 0.0 113.973 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 -39.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.234 1.014 . . . . 0.0 113.039 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -129.69 9.9 5.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.94 10.7 2.26 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.071 2.548 . . . . 0.0 116.933 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -64.06 144.32 57.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.531 1.132 . . . . 0.0 111.771 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -98.27 143.85 28.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.464 1.106 . . . . 0.0 113.367 -172.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.26 145.98 39.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.157 1.783 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m -88.49 -15.15 36.04 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -140.82 148.72 41.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.797 1.239 . . . . 0.0 112.09 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.06 -37.64 83.39 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 112.684 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -67.52 -28.47 67.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.97 -43.91 33.2 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.438 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.79 -38.85 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.437 0.562 . . . . 0.0 111.573 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.39 -40.05 96.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.589 1.086 . . . . 0.0 112.19 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.9 m -61.67 -41.41 97.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.685 0.675 . . . . 0.0 111.882 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.51 -47.62 80.95 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.681 -0.637 . . . . 0.0 112.582 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.55 -43.6 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.406 0.683 . . . . 0.0 110.462 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -67.59 -31.5 71.59 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.9 p -91.47 -32.75 15.48 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 114.061 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -109.38 -27.47 9.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -135.62 60.59 37.93 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.435 1.094 . . . . 0.0 112.936 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -58.51 -29.72 89.57 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.193 2.595 . . . . 0.0 116.425 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 -9.42 53.44 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.46 -22.3 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.964 1.706 . . . . 0.0 112.081 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.042 1.737 . . . . 0.0 113.73 179.776 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 t -149.33 157.08 43.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.145 1.378 . . . . 0.0 111.808 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -137.5 145.1 42.6 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.846 1.658 . . . . 0.0 111.586 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.53 27.77 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 123.806 0.717 . . . . 0.0 113.153 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.1 p -91.34 -21.28 21.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.93 1.292 . . . . 0.0 113.982 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -74.34 155.46 38.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 112.831 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.82 -9.63 66.26 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.368 0.985 . . . . 0.0 115.247 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -135.93 144.67 45.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.765 2.026 . . . . 0.0 111.157 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 t -149.45 154.78 39.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.629 1.572 . . . . 0.0 110.874 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.92 137.82 49.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.432 1.493 . . . . 0.0 110.19 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 m -127.36 135.3 50.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.723 0.809 . . . . 0.0 112.418 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.02 133.66 74.12 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.529 1.532 . . . . 0.0 112.959 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -10.5 27.62 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.16 2.574 . . . . 0.0 114.021 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.15 -34.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.114 0.966 . . . . 0.0 113.51 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -129.02 2.88 5.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 60.38 10.22 2.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.247 2.219 . . . . 0.0 116.347 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -62.48 143.91 56.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.048 -1.032 . . . . 0.0 111.574 171.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.0 p -102.9 148.75 25.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.86 149.31 41.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.912 2.085 . . . . 0.0 111.161 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 p -89.48 -14.52 35.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.59 146.29 39.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.19 1.396 . . . . 0.0 112.349 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.19 -36.59 80.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.198 1.399 . . . . 0.0 113.146 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -69.23 -28.65 66.54 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.29 -42.75 44.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.359 0.663 . . . . 0.0 111.552 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.6 -39.53 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 118.407 0.549 . . . . 0.0 111.573 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -63.53 -41.28 98.48 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.704 1.138 . . . . 0.0 112.203 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -59.12 -45.54 90.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.145 0.578 . . . . 0.0 111.46 171.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -60.98 -47.55 85.95 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.334 -0.854 . . . . 0.0 112.86 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.75 -45.19 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.971 0.908 . . . . 0.0 110.778 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.83 -25.2 52.92 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -91.17 -36.75 13.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 113.895 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -104.9 -27.63 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.182 0.993 . . . . 0.0 113.488 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -135.64 39.44 0.45 Allowed Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.18 -19.32 56.47 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.829 2.353 . . . . 0.0 115.045 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.62 -17.95 61.27 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -16.75 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.601 1.16 . . . . 0.0 113.549 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.541 1.536 . . . . 0.0 111.886 -176.227 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -149.86 151.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.054 1.342 . . . . 0.0 112.116 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 p -83.06 -8.37 59.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.171 1.388 . . . . 0.0 113.466 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -2.68 54.37 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.242 1.401 . . . . 0.0 115.893 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 m -64.48 -17.36 63.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.005 1.403 . . . . 0.0 114.631 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.6 m -74.07 -19.61 60.55 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.57 160.73 15.54 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.443 1.021 . . . . 0.0 113.745 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -67.78 151.07 47.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.655 0.782 . . . . 0.0 112.868 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.8 p -135.45 156.82 48.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.721 1.608 . . . . 0.0 111.317 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -127.65 145.22 50.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.211 1.804 . . . . 0.0 109.366 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -137.09 146.61 45.33 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.01 129.51 86.3 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.523 1.129 . . . . 0.0 111.666 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 -7.32 19.0 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.122 2.548 . . . . 0.0 113.251 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 t -111.94 -38.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.691 1.196 . . . . 0.0 112.749 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 p -135.09 9.98 3.53 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.82 7.95 2.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.079 2.552 . . . . 0.0 117.04 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -66.19 147.31 53.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.43 1.092 . . . . 0.0 111.967 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.5 p -108.05 144.33 35.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.888 1.275 . . . . 0.0 113.796 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -141.73 156.59 45.6 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.686 1.995 . . . . 0.0 111.52 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.18 -18.99 34.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -172.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.57 155.99 43.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.212 1.005 . . . . 0.0 113.037 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 25' ' ' ILE . 37.8 t70 -62.86 -35.72 80.9 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.5 -0.75 . . . . 0.0 112.253 173.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -66.32 -9.08 29.61 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -100.42 -44.45 5.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.624 1.17 . . . . 0.0 111.407 171.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 22' ' ' ASP . 8.4 tp -67.72 -38.6 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.19 0.904 . . . . 0.0 112.985 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -65.52 -40.25 92.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.564 -0.71 . . . . 0.0 111.193 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 m -65.26 -40.21 93.66 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.1 -48.56 81.22 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.463 0.705 . . . . 0.0 112.019 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.08 -40.88 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 0.0 110.66 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.38 -40.36 89.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.769 1.228 . . . . 0.0 112.764 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 t -90.23 -28.02 19.12 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -101.63 -28.7 12.36 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.65 40.42 0.6 Allowed Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -63.14 -30.67 75.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.005 2.47 . . . . 0.0 114.693 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.2 -2.41 37.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.265 1.026 . . . . 0.0 113.753 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -110.2 -16.89 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.064 1.746 . . . . 0.0 112.234 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.462 1.905 . . . . 0.0 113.718 176.927 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.9 t -148.89 150.15 32.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.042 1.337 . . . . 0.0 111.896 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.8 p -83.52 -9.61 58.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.188 1.395 . . . . 0.0 113.698 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.21 17.76 80.16 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.46 1.029 . . . . 0.0 115.025 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.5 p -69.07 164.38 22.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 113.406 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.4 p -136.85 161.46 35.92 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.232 1.413 . . . . 0.0 113.038 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.12 6.76 48.41 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.871 1.225 . . . . 0.0 115.793 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.6 mtm-85 -80.79 -11.45 59.6 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.856 1.328 . . . . 0.0 114.391 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.4 m -95.87 148.27 22.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.973 1.309 . . . . 0.0 111.639 172.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.48 149.33 42.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.136 1.374 . . . . 0.0 110.747 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 p -144.73 143.28 30.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 0.0 112.664 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -59.84 129.11 87.6 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.55 1.14 . . . . 0.0 112.159 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -8.56 21.62 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.57 -38.07 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.159 . . . . 0.0 112.701 -176.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.7 p -137.37 25.78 2.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 61.11 -20.36 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.996 3.318 . . . . 0.0 118.816 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -54.36 139.6 36.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.197 1.399 . . . . 0.0 113.629 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -92.94 148.58 21.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.769 1.228 . . . . 0.0 113.392 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.84 148.69 42.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.203 1.801 . . . . 0.0 111.688 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 m -88.95 -11.86 43.23 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -145.15 154.09 42.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.092 1.357 . . . . 0.0 111.741 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.09 -35.57 80.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.926 0.891 . . . . 0.0 112.693 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -67.95 -33.42 74.64 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.426 -0.796 . . . . 0.0 113.113 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.37 -45.53 69.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.386 0.674 . . . . 0.0 111.313 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.55 -36.82 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.183 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -63.33 -42.35 98.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.945 1.248 . . . . 0.0 112.21 174.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -61.42 -41.16 96.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.205 0.911 . . . . 0.0 112.198 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -62.4 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.01 0.823 . . . . 0.0 112.537 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.58 -42.67 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.655 0.782 . . . . 0.0 110.517 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -74.58 -21.65 59.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -94.22 -34.86 12.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.783 1.233 . . . . 0.0 113.975 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -106.74 -27.72 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.258 1.023 . . . . 0.0 113.656 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -134.89 48.43 2.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.489 1.516 . . . . 0.0 112.18 -172.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -61.12 -35.35 86.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.234 2.623 . . . . 0.0 114.918 -168.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.03 -2.59 18.86 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.2 -4.41 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 127.443 2.297 . . . . 0.0 111.696 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.479 1.512 . . . . 0.0 112.89 175.545 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 p -145.3 175.9 9.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.374 1.469 . . . . 0.0 112.243 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.2 p -70.85 -16.99 62.74 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -17.06 5.81 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.037 1.303 . . . . 0.0 113.988 -168.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -88.86 -25.43 22.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.129 1.372 . . . . 0.0 112.666 175.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -81.64 46.56 0.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.596 1.559 . . . . 0.0 112.141 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 121.85 8.01 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.918 1.247 . . . . 0.0 112.043 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -140.4 157.58 45.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.931 1.692 . . . . 0.0 111.479 -170.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -140.45 165.58 27.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.246 1.418 . . . . 0.0 112.992 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.04 149.09 51.91 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.89 2.076 . . . . 0.0 109.765 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -133.71 138.48 45.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.604 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.17 133.18 87.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.363 1.465 . . . . 0.0 112.83 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.19 -11.52 25.11 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.257 2.638 . . . . 0.0 113.692 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.7 -40.64 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.332 1.053 . . . . 0.0 112.876 -176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -128.24 1.28 5.77 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 60.33 16.8 6.52 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.644 1.978 . . . . 0.0 115.618 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -64.45 137.26 57.78 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.902 -1.124 . . . . 0.0 110.648 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.2 m -102.2 147.48 26.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.207 1.003 . . . . 0.0 113.537 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -140.66 149.61 42.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.624 1.97 . . . . 0.0 111.552 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -87.96 -18.25 29.48 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -142.61 152.1 42.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.952 1.301 . . . . 0.0 111.802 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.91 -37.43 86.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -23.1 62.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.66 -45.42 37.18 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.616 0.767 . . . . 0.0 111.063 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -68.11 -40.48 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.711 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.74 -43.68 90.29 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.581 1.082 . . . . 0.0 111.75 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -62.89 -43.91 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.164 0.586 . . . . 0.0 111.95 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -59.76 -52.28 66.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.737 0.699 . . . . 0.0 112.41 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.37 -40.55 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.153 0.433 . . . . 0.0 110.202 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -71.09 -32.43 69.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.133 0.973 . . . . 0.0 113.398 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -88.86 -27.58 20.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.24 -25.03 11.69 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.99 71.76 79.9 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.533 1.133 . . . . 0.0 111.625 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -56.75 -24.93 57.97 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.454 3.436 . . . . 0.0 117.074 -171.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.78 -3.6 35.87 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.97 -42.25 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.53 1.532 . . . . 0.0 112.494 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.484 1.914 . . . . 0.0 113.069 -179.923 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 p -64.13 -21.04 66.39 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -65.26 -14.94 61.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.125 1.37 . . . . 0.0 113.922 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.85 60.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.7 1.143 . . . . 0.0 115.25 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.6 m 57.97 28.79 16.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.716 1.606 . . . . 0.0 115.038 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 m -77.49 64.1 2.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.908 1.683 . . . . 0.0 112.044 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.26 169.02 39.09 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.873 1.225 . . . . 0.0 112.697 -169.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 155.03 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.99 1.316 . . . . 0.0 111.94 -176.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.8 t -97.63 148.06 23.68 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.891 1.277 . . . . 0.0 111.047 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.4 147.0 50.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.121 1.768 . . . . 0.0 111.201 -174.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -121.04 133.29 55.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.369 1.068 . . . . 0.0 112.114 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.55 131.12 71.14 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.897 1.279 . . . . 0.0 112.164 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.38 -6.21 18.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.294 2.663 . . . . 0.0 113.784 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.86 -37.61 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.287 1.035 . . . . 0.0 113.244 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.04 8.96 4.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 59.7 16.37 5.44 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.906 2.482 . . . . 0.0 116.679 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -68.09 150.21 48.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.469 1.108 . . . . 0.0 112.078 172.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -103.28 142.06 34.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.699 1.2 . . . . 0.0 113.249 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -140.0 133.03 29.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.429 1.491 . . . . 0.0 111.633 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -82.84 -1.23 51.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -141.33 141.7 33.85 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.429 1.892 . . . . 0.0 110.544 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.19 -33.77 76.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.244 0.618 . . . . 0.0 112.453 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -66.84 -29.55 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.186 0.995 . . . . 0.0 113.471 173.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.5 mt -78.69 -40.34 34.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.959 0.8 . . . . 0.0 112.114 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.73 -40.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.268 0.94 . . . . 0.0 111.292 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.97 -40.0 94.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.801 1.182 . . . . 0.0 111.897 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.8 m -63.43 -42.41 98.69 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.786 0.721 . . . . 0.0 112.223 173.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -62.49 -45.85 91.13 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.486 -0.759 . . . . 0.0 112.227 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.09 -44.23 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.328 0.651 . . . . 0.0 109.934 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -68.67 -31.29 70.31 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.065 1.302 . . . . 0.0 113.958 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 p -91.39 -40.27 11.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.612 1.165 . . . . 0.0 113.847 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -102.8 -30.9 10.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.505 1.122 . . . . 0.0 112.536 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.02 49.78 5.01 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.56 -172.98 0.5 Allowed 'Trans proline' 0 N--CA 1.421 -2.759 0 N-CA-C 101.737 -3.986 . . . . 0.0 101.737 152.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.261 10.1 pt-20 48.65 -10.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 131.139 3.776 . . . . 0.0 116.004 -167.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.98 -37.2 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.413 2.285 . . . . 0.0 112.109 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.048 1.739 . . . . 0.0 112.186 -176.217 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 m -136.43 135.09 38.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.445 1.098 . . . . 0.0 111.399 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -57.96 127.8 80.03 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.446 1.098 . . . . 0.0 112.104 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.62 -6.83 19.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.952 2.435 . . . . 0.0 113.587 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -115.9 -34.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.41 1.084 . . . . 0.0 113.092 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -132.71 5.57 3.97 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 61.72 12.9 4.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.93 2.092 . . . . 0.0 116.0 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -61.66 139.12 58.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.705 -1.247 . . . . 0.0 111.258 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.6 m -81.49 148.0 29.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.354 1.062 . . . . 0.0 113.236 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -141.13 147.63 38.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.96 2.104 . . . . 0.0 111.679 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 p -92.86 -17.21 24.35 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -142.67 150.04 39.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.656 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.52 -37.62 81.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.227 1.411 . . . . 0.0 112.899 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -66.33 -30.14 70.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.21 -42.72 25.35 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.601 0.761 . . . . 0.0 111.465 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -66.59 -38.24 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 118.329 0.513 . . . . 0.0 111.548 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.83 -40.85 97.58 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.902 -1.124 . . . . 0.0 112.198 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -61.6 -40.77 96.0 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.558 0.617 . . . . 0.0 111.916 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.0 -46.41 84.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.689 0.795 . . . . 0.0 112.674 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.0 -42.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.607 -0.683 . . . . 0.0 110.487 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -68.15 -32.5 72.82 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.8 p -91.97 -35.89 13.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -107.36 -26.4 11.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.48 1.112 . . . . 0.0 113.425 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 . . . . . 0 CA--C 1.556 1.203 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 -172.73 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 110.856 -0.053 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -131.39 136.74 48.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.932 0.893 . . . . 0.0 112.11 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.0 t -61.18 131.77 92.23 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.122 0.969 . . . . 0.0 111.967 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.01 -7.54 20.04 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.405 2.736 . . . . 0.0 113.935 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.02 -37.06 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.28 1.032 . . . . 0.0 113.492 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -129.82 14.1 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 61.53 4.69 1.05 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.351 2.661 . . . . 0.0 117.285 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.27 147.45 53.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.728 1.211 . . . . 0.0 112.794 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 m -96.39 140.71 30.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.959 1.304 . . . . 0.0 112.954 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -137.66 147.62 45.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 111.605 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 m -89.51 -13.89 36.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -142.54 151.39 41.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.649 1.18 . . . . 0.0 111.954 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -14.94 63.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -81.98 -32.99 30.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.121 0.968 . . . . 0.0 112.86 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.57 -39.45 70.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.565 0.746 . . . . 0.0 111.365 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 118.094 0.406 . . . . 0.0 111.789 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -62.89 -46.29 88.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.656 0.782 . . . . 0.0 111.407 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -59.23 -42.67 91.62 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.391 0.541 . . . . 0.0 112.248 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -64.18 -46.76 82.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.106 0.866 . . . . 0.0 112.542 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.04 -42.61 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.692 -0.63 . . . . 0.0 110.655 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.84 -34.17 73.27 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 p -85.86 -35.56 20.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -109.42 -28.19 9.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -169.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -139.62 143.21 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.6 130.64 81.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.344 1.458 . . . . 0.0 112.471 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.79 -8.42 22.35 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.119 2.546 . . . . 0.0 113.557 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -113.88 -37.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.547 1.139 . . . . 0.0 112.826 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -135.22 11.63 3.55 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.2 6.71 1.39 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.192 2.597 . . . . 0.0 117.407 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -63.56 142.64 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.895 -1.128 . . . . 0.0 111.649 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 p -95.29 146.4 24.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.513 1.125 . . . . 0.0 114.006 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.87 144.4 33.82 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.923 1.689 . . . . 0.0 111.685 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.2 m -81.9 -20.24 39.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -142.82 151.68 41.39 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.962 1.305 . . . . 0.0 112.104 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.85 -34.88 76.77 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.333 1.053 . . . . 0.0 112.896 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -67.8 -31.05 70.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.98 -43.62 57.5 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.381 0.672 . . . . 0.0 111.372 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.09 -37.58 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.671 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -60.84 -43.55 98.14 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.957 1.253 . . . . 0.0 112.227 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -63.15 -37.33 86.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.227 0.921 . . . . 0.0 112.738 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.51 -46.12 87.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.21 0.913 . . . . 0.0 112.547 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.94 -41.78 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.549 -0.719 . . . . 0.0 110.725 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.32 -34.89 78.3 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 p -88.66 -34.26 17.31 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -109.61 -27.16 9.53 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 . . . . . 0 CA--C 1.557 1.222 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -171.109 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 p -142.35 141.92 32.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.681 0.792 . . . . 0.0 112.352 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -57.34 132.4 81.27 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.758 1.223 . . . . 0.0 112.72 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.85 -10.12 27.07 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.165 2.577 . . . . 0.0 113.833 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.93 -37.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.318 1.047 . . . . 0.0 113.184 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.21 4.91 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 60.23 12.1 3.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.264 2.226 . . . . 0.0 116.14 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.79 133.2 54.06 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.824 1.249 . . . . 0.0 111.119 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.8 m -85.86 145.32 27.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.214 1.006 . . . . 0.0 112.87 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.31 152.13 46.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.986 1.714 . . . . 0.0 111.763 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.1 p -97.69 -11.74 23.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.54 151.41 43.22 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.24 1.416 . . . . 0.0 111.484 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -36.45 83.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.198 0.599 . . . . 0.0 112.456 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -65.06 -28.78 69.71 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.57 -44.66 33.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.461 0.705 . . . . 0.0 111.617 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -68.27 -37.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.562 0.619 . . . . 0.0 111.737 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -60.01 -44.81 94.32 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.594 1.088 . . . . 0.0 111.512 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 m -61.07 -41.82 97.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.03 0.532 . . . . 0.0 112.053 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.28 -46.91 84.57 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.573 -0.705 . . . . 0.0 112.691 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.63 -44.48 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.592 -0.692 . . . . 0.0 110.265 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -68.25 -30.33 69.34 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.3 p -92.35 -35.2 13.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -107.99 -26.53 10.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.073 0.949 . . . . 0.0 113.116 -172.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 110.707 -0.109 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -137.73 134.29 35.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.797 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.43 130.19 80.81 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.798 1.239 . . . . 0.0 112.413 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.12 -9.98 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.158 2.572 . . . . 0.0 113.67 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -111.97 -37.07 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.379 1.072 . . . . 0.0 113.026 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -130.91 3.03 4.4 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 58.29 22.96 9.87 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.59 1.956 . . . . 0.0 115.45 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.53 135.62 51.85 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.726 169.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 m -87.05 144.83 26.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 113.235 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.88 145.98 38.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.643 1.577 . . . . 0.0 112.251 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 -18.41 37.23 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -142.26 148.62 38.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.65 1.58 . . . . 0.0 112.091 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.28 -34.27 73.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.49 1.116 . . . . 0.0 112.843 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -67.32 -29.81 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.881 0.873 . . . . 0.0 113.274 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.68 -37.29 27.65 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.319 1.048 . . . . 0.0 111.969 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.61 -38.58 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.748 -0.595 . . . . 0.0 110.955 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -60.53 -46.86 88.61 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.885 1.22 . . . . 0.0 112.387 174.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.8 p -65.22 -36.39 84.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.097 0.862 . . . . 0.0 112.385 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.8 -50.32 73.91 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.978 0.808 . . . . 0.0 112.52 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.09 -42.13 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 10.1 mmpt? -75.14 -16.13 60.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -99.25 -34.37 10.37 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.581 1.152 . . . . 0.0 113.73 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -106.15 -28.01 10.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.644 1.178 . . . . 0.0 113.465 -173.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 . . . . . 0 CA--C 1.557 1.212 0 C-N-CA 125.196 1.398 . . . . 0.0 111.623 -176.431 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p -140.09 142.55 36.09 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.11 131.39 87.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.25 1.42 . . . . 0.0 112.599 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 -10.13 23.87 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.262 2.642 . . . . 0.0 113.686 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.6 t -113.18 -36.34 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.598 1.159 . . . . 0.0 112.897 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -134.96 10.61 3.6 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 60.89 9.45 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.011 2.524 . . . . 0.0 117.18 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.65 144.8 56.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.439 1.096 . . . . 0.0 112.003 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.8 m -96.64 143.74 27.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.43 1.092 . . . . 0.0 113.633 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -140.16 154.25 46.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.348 1.859 . . . . 0.0 111.54 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.3 p -97.83 -10.2 25.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -142.01 151.78 42.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.498 1.119 . . . . 0.0 112.818 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.71 -39.13 76.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.245 1.418 . . . . 0.0 112.448 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.112 0.965 . . . . 0.0 113.541 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.83 -44.24 41.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.469 0.708 . . . . 0.0 111.415 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -67.43 -38.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.717 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.29 -42.98 99.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.809 1.186 . . . . 0.0 112.072 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.7 t -57.79 -45.18 86.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.667 0.667 . . . . 0.0 111.596 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -60.69 -49.14 78.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.712 0.805 . . . . 0.0 112.947 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.12 -42.39 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -72.7 -23.86 60.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 t -104.01 -15.82 15.49 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -116.03 -28.62 6.57 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 . . . . . 0 CA--C 1.557 1.238 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.274 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -137.86 134.15 34.75 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 0.0 112.148 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.5 t -56.84 128.96 77.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.133 1.373 . . . . 0.0 112.185 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.52 -8.52 22.71 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.107 2.538 . . . . 0.0 113.481 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.25 -37.13 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.614 1.166 . . . . 0.0 112.682 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 p -136.5 7.56 3.06 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 58.55 22.26 9.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.103 2.161 . . . . 0.0 116.073 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -72.71 142.44 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.003 -1.061 . . . . 0.0 111.129 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 p -96.24 145.03 25.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.445 1.098 . . . . 0.0 113.923 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -141.26 157.61 44.99 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.2 1.8 . . . . 0.0 111.668 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -106.2 -2.77 22.11 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -146.14 150.71 36.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.469 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.64 -35.25 79.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.729 0.812 . . . . 0.0 112.626 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -68.84 -29.45 67.78 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.11 -44.59 53.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.676 0.671 . . . . 0.0 111.398 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.87 -38.94 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.805 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -60.92 -42.71 98.66 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.016 1.28 . . . . 0.0 112.095 172.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.47 -42.34 98.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.357 0.526 . . . . 0.0 111.765 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -62.5 -48.51 79.23 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.687 -0.633 . . . . 0.0 112.628 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.4 mt -57.71 -44.49 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.431 0.692 . . . . 0.0 110.441 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.98 -32.67 71.0 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 p -89.43 -37.46 14.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.62 -24.75 14.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.438 1.095 . . . . 0.0 113.168 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 . . . . . 0 CA--C 1.557 1.226 0 C-N-CA 125.019 1.328 . . . . 0.0 112.772 -175.554 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.3 p -115.19 141.37 48.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.186 0.994 . . . . 0.0 113.06 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.36 129.49 86.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.308 . . . . 0.0 112.198 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.83 -8.96 23.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.309 2.673 . . . . 0.0 113.424 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.4 t -113.28 -38.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.601 1.16 . . . . 0.0 112.59 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 p -137.51 20.74 2.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 58.26 -6.58 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.756 3.222 . . . . 0.0 119.221 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -62.25 146.23 51.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.055 1.298 . . . . 0.0 112.531 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.4 m -108.11 146.52 32.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.529 1.132 . . . . 0.0 113.855 -171.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -137.71 145.12 42.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.829 2.051 . . . . 0.0 110.972 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -87.39 -8.27 56.76 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -143.32 152.54 41.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.008 1.323 . . . . 0.0 111.471 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.31 -33.65 75.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.818 0.847 . . . . 0.0 112.828 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.5 -29.6 69.06 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.309 -0.869 . . . . 0.0 113.181 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.21 -42.05 47.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.613 0.765 . . . . 0.0 111.389 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -68.61 -38.71 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.493 0.588 . . . . 0.0 111.846 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -63.58 -39.99 95.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.903 1.229 . . . . 0.0 112.174 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -60.65 -44.53 96.32 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.358 0.663 . . . . 0.0 111.78 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.44 -47.99 83.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 112.532 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.2 mt -60.24 -42.49 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 110.79 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.2 -20.12 60.3 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 p -99.02 -27.6 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.812 1.245 . . . . 0.0 114.014 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -111.08 -28.74 8.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.294 1.038 . . . . 0.0 113.776 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 CA--C 1.557 1.221 0 C-N-CA 125.352 1.461 . . . . 0.0 112.77 -173.715 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.048 -0.025 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.3 p -137.83 140.8 40.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.752 0.821 . . . . 0.0 112.973 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.3 t -56.87 131.96 79.25 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.06 1.344 . . . . 0.0 112.592 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.67 -9.61 25.24 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.149 2.566 . . . . 0.0 113.774 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.15 -38.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 113.009 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.2 p -132.72 10.73 4.34 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 60.56 7.17 1.28 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.295 2.638 . . . . 0.0 117.208 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -62.21 142.78 57.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.423 1.089 . . . . 0.0 111.658 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 p -96.1 146.26 24.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.634 1.173 . . . . 0.0 113.983 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.36 144.27 33.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.996 1.719 . . . . 0.0 111.774 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 m -84.38 -19.08 34.16 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -143.63 153.78 42.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.173 1.389 . . . . 0.0 111.78 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.54 -40.39 87.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.633 0.773 . . . . 0.0 112.435 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -60.56 -30.01 69.52 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.149 -0.969 . . . . 0.0 113.565 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.58 -44.89 26.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.8 -38.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.37 0.532 . . . . 0.0 111.942 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.751 1.16 . . . . 0.0 111.474 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 t -59.03 -44.93 91.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.396 0.544 . . . . 0.0 111.792 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.82 -46.03 92.15 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.383 -0.823 . . . . 0.0 112.981 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.51 -44.02 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.726 0.811 . . . . 0.0 110.588 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -72.79 -28.63 62.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -90.15 -35.72 15.23 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -108.35 -26.4 10.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.393 1.077 . . . . 0.0 113.662 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 113.797 -173.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -136.68 134.44 37.25 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 112.468 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.59 132.75 82.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.155 1.382 . . . . 0.0 112.695 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.06 -10.72 26.43 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.161 2.574 . . . . 0.0 113.569 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.16 -41.08 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.399 1.08 . . . . 0.0 112.91 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.9 p -124.9 7.12 8.03 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 58.43 10.96 1.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.423 2.289 . . . . 0.0 115.392 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -66.49 135.7 54.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.486 2.315 . . . . 0.0 111.372 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 p -97.12 145.54 25.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -142.31 153.94 44.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.501 1.92 . . . . 0.0 111.808 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -87.22 -23.3 24.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -141.52 155.49 45.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.677 1.191 . . . . 0.0 113.085 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.56 -39.75 74.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.965 1.306 . . . . 0.0 112.652 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -64.48 -30.64 71.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.21 -44.31 26.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.937 0.895 . . . . 0.0 111.2 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.27 -41.22 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.543 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -63.38 -40.27 96.8 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.078 1.308 . . . . 0.0 111.85 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -60.57 -40.48 91.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.994 0.816 . . . . 0.0 112.01 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -63.41 -51.76 64.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.558 0.617 . . . . 0.0 112.657 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.83 -40.83 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.488 0.586 . . . . 0.0 110.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.3 -33.84 76.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -92.97 -29.8 15.67 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 113.959 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -106.86 -25.57 11.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.421 1.088 . . . . 0.0 113.766 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 . . . . . 0 CA--C 1.556 1.197 0 C-N-CA 124.755 1.222 . . . . 0.0 111.307 -172.643 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -134.75 141.0 46.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.719 0.808 . . . . 0.0 112.926 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.73 129.3 81.27 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.394 1.478 . . . . 0.0 112.608 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.02 -9.07 21.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.323 2.682 . . . . 0.0 113.387 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.4 t -112.34 -37.91 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.703 1.201 . . . . 0.0 112.693 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.4 p -137.72 19.92 2.87 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -172.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.51 -5.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 129.55 3.14 . . . . 0.0 119.05 168.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -62.18 143.66 56.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.916 1.235 . . . . 0.0 112.48 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.0 p -101.07 150.36 23.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.697 1.199 . . . . 0.0 113.891 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -140.03 147.82 40.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.009 2.124 . . . . 0.0 110.685 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 p -89.81 -10.4 45.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -150.92 158.95 44.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 111.652 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.38 -33.32 75.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -67.21 -24.91 65.89 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.057 -1.027 . . . . 0.0 112.931 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.43 -42.82 34.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 111.497 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -67.8 -38.59 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.428 0.558 . . . . 0.0 111.623 171.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.49 -39.72 94.37 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.853 1.206 . . . . 0.0 111.888 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -62.82 -42.07 99.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.571 0.623 . . . . 0.0 111.991 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.62 -46.69 88.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.635 0.774 . . . . 0.0 112.419 174.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.64 -42.49 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.038 0.935 . . . . 0.0 110.675 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -30.39 68.76 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -92.94 -25.84 17.84 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -114.18 -28.46 7.29 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 . . . . . 0 CA--C 1.554 1.124 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.916 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 119.7 -0.191 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -137.18 139.23 40.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.862 0.865 . . . . 0.0 112.067 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.8 129.64 71.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.576 1.55 . . . . 0.0 112.294 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.51 -7.87 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 113.469 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -113.02 -37.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 112.756 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -135.78 11.49 3.4 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 61.66 10.07 3.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.871 2.468 . . . . 0.0 117.024 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.59 141.17 55.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.609 -1.307 . . . . 0.0 111.773 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -99.57 147.14 25.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -139.91 148.11 41.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.953 2.101 . . . . 0.0 111.329 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -88.11 -20.58 25.48 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -141.33 151.03 43.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.615 1.166 . . . . 0.0 112.699 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -61.72 -36.59 81.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.346 1.458 . . . . 0.0 113.769 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -68.2 -26.35 65.68 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.147 -0.971 . . . . 0.0 113.107 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.45 -43.24 33.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.679 0.792 . . . . 0.0 111.345 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.49 -39.57 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.115 0.416 . . . . 0.0 111.448 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -63.72 -38.27 90.49 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.983 -1.073 . . . . 0.0 112.373 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.2 m -62.59 -43.67 98.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.288 0.635 . . . . 0.0 111.692 171.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.92 -45.2 94.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 0.0 112.537 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.0 -42.11 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.404 0.681 . . . . 0.0 110.298 175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.68 -36.44 82.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 113.529 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -88.42 -33.9 17.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.44 -27.67 10.79 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 124.687 1.195 . . . . 0.0 113.976 -171.224 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -139.41 142.03 37.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -61.1 130.05 91.07 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.839 1.256 . . . . 0.0 112.31 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.17 -7.58 20.77 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.058 2.505 . . . . 0.0 113.525 177.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.88 -36.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.5 1.12 . . . . 0.0 113.055 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.85 3.5 4.46 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 62.16 12.91 5.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.907 2.083 . . . . 0.0 116.181 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.54 138.22 58.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.701 -1.249 . . . . 0.0 111.169 170.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -82.3 148.91 28.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.8 152.69 43.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.962 2.105 . . . . 0.0 111.458 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -96.49 -14.36 22.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -141.98 144.59 33.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.489 1.115 . . . . 0.0 112.32 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.42 -37.63 81.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.275 1.43 . . . . 0.0 113.156 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.44 -31.3 70.52 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.73 -43.59 46.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.39 0.676 . . . . 0.0 111.419 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.74 -38.83 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.135 0.425 . . . . 0.0 111.681 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -63.39 -41.22 98.76 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.674 1.125 . . . . 0.0 112.208 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -60.96 -43.66 98.41 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.615 . . . . 0.0 111.905 172.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -60.45 -48.47 81.61 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.836 0.855 . . . . 0.0 112.792 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.03 -41.99 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.997 0.919 . . . . 0.0 110.476 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -66.57 -36.77 83.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.909 1.284 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 t -95.01 -27.27 15.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -103.12 -28.62 11.84 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.558 1.271 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -169.882 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -124.0 131.73 53.6 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.868 0.867 . . . . 0.0 112.24 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.9 t -56.22 131.34 75.23 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 112.45 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.16 -9.38 23.28 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.298 2.665 . . . . 0.0 113.923 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.57 -36.85 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.324 1.05 . . . . 0.0 113.253 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 p -132.51 10.11 4.38 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 60.17 12.0 3.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.923 2.489 . . . . 0.0 116.918 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -64.78 147.26 53.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.457 1.103 . . . . 0.0 111.922 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.9 t -101.73 145.62 28.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 113.282 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -141.58 149.28 40.56 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.178 2.191 . . . . 0.0 111.119 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -90.81 -14.99 30.82 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.654 1.354 . . . . 0.0 114.654 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -141.59 151.58 43.28 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.603 1.161 . . . . 0.0 112.73 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.328 1.451 . . . . 0.0 112.896 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -67.61 -28.68 67.96 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.05 -42.72 25.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.634 0.774 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 tt -66.02 -38.7 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.243 0.474 . . . . 0.0 111.414 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.42 -39.01 93.02 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.669 1.122 . . . . 0.0 112.33 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -61.86 -41.2 97.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.729 0.695 . . . . 0.0 111.944 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -64.13 -46.28 84.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.519 0.727 . . . . 0.0 112.578 174.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.56 -43.24 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 110.788 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -29.66 67.88 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 p -91.9 -30.92 15.89 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -113.71 -27.73 7.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 CA--C 1.558 1.287 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -169.922 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -137.47 142.77 41.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.5 t -58.32 132.92 84.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.083 1.353 . . . . 0.0 112.684 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.9 -10.51 26.35 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.297 2.665 . . . . 0.0 113.973 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 -39.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.234 1.014 . . . . 0.0 113.039 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -129.69 9.9 5.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.94 10.7 2.26 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.071 2.548 . . . . 0.0 116.933 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -64.06 144.32 57.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.531 1.132 . . . . 0.0 111.771 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -98.27 143.85 28.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.464 1.106 . . . . 0.0 113.367 -172.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.26 145.98 39.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.157 1.783 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m -88.49 -15.15 36.04 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -140.82 148.72 41.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.797 1.239 . . . . 0.0 112.09 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.06 -37.64 83.39 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 112.684 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -67.52 -28.47 67.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.97 -43.91 33.2 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.438 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.79 -38.85 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.437 0.562 . . . . 0.0 111.573 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.39 -40.05 96.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.589 1.086 . . . . 0.0 112.19 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.9 m -61.67 -41.41 97.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.685 0.675 . . . . 0.0 111.882 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.51 -47.62 80.95 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.681 -0.637 . . . . 0.0 112.582 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.55 -43.6 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.406 0.683 . . . . 0.0 110.462 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -67.59 -31.5 71.59 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.9 p -91.47 -32.75 15.48 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 114.061 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -109.38 -27.47 9.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 CA--C 1.555 1.17 0 C-N-CA 124.435 1.094 . . . . 0.0 112.936 -172.737 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 m -127.36 135.3 50.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.723 0.809 . . . . 0.0 112.418 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.02 133.66 74.12 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.529 1.532 . . . . 0.0 112.959 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -10.5 27.62 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.16 2.574 . . . . 0.0 114.021 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.15 -34.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.114 0.966 . . . . 0.0 113.51 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -129.02 2.88 5.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 60.38 10.22 2.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.247 2.219 . . . . 0.0 116.347 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -62.48 143.91 56.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.048 -1.032 . . . . 0.0 111.574 171.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.0 p -102.9 148.75 25.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.86 149.31 41.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.912 2.085 . . . . 0.0 111.161 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 p -89.48 -14.52 35.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.59 146.29 39.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.19 1.396 . . . . 0.0 112.349 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.19 -36.59 80.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.198 1.399 . . . . 0.0 113.146 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -69.23 -28.65 66.54 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.29 -42.75 44.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.359 0.663 . . . . 0.0 111.552 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.6 -39.53 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 118.407 0.549 . . . . 0.0 111.573 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -63.53 -41.28 98.48 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.704 1.138 . . . . 0.0 112.203 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -59.12 -45.54 90.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.145 0.578 . . . . 0.0 111.46 171.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -60.98 -47.55 85.95 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.334 -0.854 . . . . 0.0 112.86 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.75 -45.19 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.971 0.908 . . . . 0.0 110.778 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.83 -25.2 52.92 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -91.17 -36.75 13.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 113.895 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -104.9 -27.63 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.182 0.993 . . . . 0.0 113.488 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 . . . . . 0 CA--C 1.552 1.05 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.23 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -137.09 146.61 45.33 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.01 129.51 86.3 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.523 1.129 . . . . 0.0 111.666 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 -7.32 19.0 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.122 2.548 . . . . 0.0 113.251 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 t -111.94 -38.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.691 1.196 . . . . 0.0 112.749 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 p -135.09 9.98 3.53 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.82 7.95 2.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.079 2.552 . . . . 0.0 117.04 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -66.19 147.31 53.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.43 1.092 . . . . 0.0 111.967 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.5 p -108.05 144.33 35.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.888 1.275 . . . . 0.0 113.796 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -141.73 156.59 45.6 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.686 1.995 . . . . 0.0 111.52 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.18 -18.99 34.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -172.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.57 155.99 43.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.212 1.005 . . . . 0.0 113.037 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 25' ' ' ILE . 37.8 t70 -62.86 -35.72 80.9 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.5 -0.75 . . . . 0.0 112.253 173.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -66.32 -9.08 29.61 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -100.42 -44.45 5.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.624 1.17 . . . . 0.0 111.407 171.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 22' ' ' ASP . 8.4 tp -67.72 -38.6 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.19 0.904 . . . . 0.0 112.985 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -65.52 -40.25 92.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.564 -0.71 . . . . 0.0 111.193 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 m -65.26 -40.21 93.66 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.1 -48.56 81.22 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.463 0.705 . . . . 0.0 112.019 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.08 -40.88 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 0.0 110.66 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.38 -40.36 89.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.769 1.228 . . . . 0.0 112.764 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 t -90.23 -28.02 19.12 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -101.63 -28.7 12.36 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 . . . . . 0 CA--C 1.558 1.286 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.651 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 p -144.73 143.28 30.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 0.0 112.664 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -59.84 129.11 87.6 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.55 1.14 . . . . 0.0 112.159 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -8.56 21.62 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.57 -38.07 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.159 . . . . 0.0 112.701 -176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.7 p -137.37 25.78 2.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 61.11 -20.36 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.996 3.318 . . . . 0.0 118.816 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -54.36 139.6 36.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.197 1.399 . . . . 0.0 113.629 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -92.94 148.58 21.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.769 1.228 . . . . 0.0 113.392 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.84 148.69 42.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.203 1.801 . . . . 0.0 111.688 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 m -88.95 -11.86 43.23 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -145.15 154.09 42.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.092 1.357 . . . . 0.0 111.741 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.09 -35.57 80.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.926 0.891 . . . . 0.0 112.693 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -67.95 -33.42 74.64 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.426 -0.796 . . . . 0.0 113.113 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.37 -45.53 69.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.386 0.674 . . . . 0.0 111.313 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.55 -36.82 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.183 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -63.33 -42.35 98.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.945 1.248 . . . . 0.0 112.21 174.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -61.42 -41.16 96.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.205 0.911 . . . . 0.0 112.198 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -62.4 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.01 0.823 . . . . 0.0 112.537 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.58 -42.67 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.655 0.782 . . . . 0.0 110.517 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -74.58 -21.65 59.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -94.22 -34.86 12.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.783 1.233 . . . . 0.0 113.975 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -106.74 -27.72 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.258 1.023 . . . . 0.0 113.656 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 125.489 1.516 . . . . 0.0 112.18 -172.232 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -133.71 138.48 45.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.604 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.17 133.18 87.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.363 1.465 . . . . 0.0 112.83 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.19 -11.52 25.11 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.257 2.638 . . . . 0.0 113.692 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.7 -40.64 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.332 1.053 . . . . 0.0 112.876 -176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -128.24 1.28 5.77 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 60.33 16.8 6.52 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.644 1.978 . . . . 0.0 115.618 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -64.45 137.26 57.78 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.902 -1.124 . . . . 0.0 110.648 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.2 m -102.2 147.48 26.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.207 1.003 . . . . 0.0 113.537 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -140.66 149.61 42.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.624 1.97 . . . . 0.0 111.552 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -87.96 -18.25 29.48 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -142.61 152.1 42.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.952 1.301 . . . . 0.0 111.802 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.91 -37.43 86.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -23.1 62.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.66 -45.42 37.18 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.616 0.767 . . . . 0.0 111.063 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -68.11 -40.48 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.711 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.74 -43.68 90.29 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.581 1.082 . . . . 0.0 111.75 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -62.89 -43.91 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.164 0.586 . . . . 0.0 111.95 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -59.76 -52.28 66.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.737 0.699 . . . . 0.0 112.41 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.37 -40.55 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.153 0.433 . . . . 0.0 110.202 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -71.09 -32.43 69.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.133 0.973 . . . . 0.0 113.398 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -88.86 -27.58 20.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.24 -25.03 11.69 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 124.533 1.133 . . . . 0.0 111.625 -172.167 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 111.201 0.075 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -121.04 133.29 55.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.369 1.068 . . . . 0.0 112.114 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.55 131.12 71.14 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.897 1.279 . . . . 0.0 112.164 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.38 -6.21 18.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.294 2.663 . . . . 0.0 113.784 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.86 -37.61 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.287 1.035 . . . . 0.0 113.244 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.04 8.96 4.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 59.7 16.37 5.44 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.906 2.482 . . . . 0.0 116.679 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -68.09 150.21 48.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.469 1.108 . . . . 0.0 112.078 172.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -103.28 142.06 34.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.699 1.2 . . . . 0.0 113.249 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -140.0 133.03 29.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.429 1.491 . . . . 0.0 111.633 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -82.84 -1.23 51.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -141.33 141.7 33.85 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.429 1.892 . . . . 0.0 110.544 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.19 -33.77 76.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.244 0.618 . . . . 0.0 112.453 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -66.84 -29.55 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.186 0.995 . . . . 0.0 113.471 173.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.5 mt -78.69 -40.34 34.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.959 0.8 . . . . 0.0 112.114 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.73 -40.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.268 0.94 . . . . 0.0 111.292 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.97 -40.0 94.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.801 1.182 . . . . 0.0 111.897 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.8 m -63.43 -42.41 98.69 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.786 0.721 . . . . 0.0 112.223 173.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -62.49 -45.85 91.13 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.486 -0.759 . . . . 0.0 112.227 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.09 -44.23 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.328 0.651 . . . . 0.0 109.934 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -68.67 -31.29 70.31 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.065 1.302 . . . . 0.0 113.958 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 p -91.39 -40.27 11.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.612 1.165 . . . . 0.0 113.847 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -102.8 -30.9 10.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.505 1.122 . . . . 0.0 112.536 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 . . . . . 0 C--O 1.242 0.695 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 -177.543 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -75.27 154.87 37.24 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.06 0.944 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -68.79 144.13 54.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.784 1.234 . . . . 0.0 113.142 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.01 -178.32 50.72 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.394 0.997 . . . . 0.0 113.898 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 m -63.14 148.26 48.48 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.503 1.121 . . . . 0.0 112.413 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 t -146.48 154.45 41.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.532 1.133 . . . . 0.0 112.71 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.42 141.51 5.93 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.392 1.949 . . . . 0.0 110.941 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -140.59 155.64 46.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.794 1.238 . . . . 0.0 113.051 -170.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 p -107.03 165.32 11.44 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.479 1.912 . . . . 0.0 110.91 169.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -133.88 157.04 46.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.808 1.243 . . . . 0.0 111.851 -169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.3 m -136.43 135.09 38.38 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.445 1.098 . . . . 0.0 111.399 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -57.96 127.8 80.03 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.446 1.098 . . . . 0.0 112.104 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.62 -6.83 19.97 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.952 2.435 . . . . 0.0 113.587 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -115.9 -34.49 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.41 1.084 . . . . 0.0 113.092 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -132.71 5.57 3.97 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 61.72 12.9 4.94 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.93 2.092 . . . . 0.0 116.0 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -61.66 139.12 58.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.705 -1.247 . . . . 0.0 111.258 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.6 m -81.49 148.0 29.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.354 1.062 . . . . 0.0 113.236 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -141.13 147.63 38.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.96 2.104 . . . . 0.0 111.679 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 p -92.86 -17.21 24.35 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -142.67 150.04 39.67 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.656 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.52 -37.62 81.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.227 1.411 . . . . 0.0 112.899 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -66.33 -30.14 70.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.21 -42.72 25.35 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.601 0.761 . . . . 0.0 111.465 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -66.59 -38.24 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 118.329 0.513 . . . . 0.0 111.548 172.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.83 -40.85 97.58 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.902 -1.124 . . . . 0.0 112.198 173.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.6 m -61.6 -40.77 96.0 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.558 0.617 . . . . 0.0 111.916 172.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.0 -46.41 84.67 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.689 0.795 . . . . 0.0 112.674 174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.0 -42.23 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.607 -0.683 . . . . 0.0 110.487 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -68.15 -32.5 72.82 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.8 p -91.97 -35.89 13.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -107.36 -26.4 11.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.48 1.112 . . . . 0.0 113.425 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -134.28 40.82 0.59 Allowed Pre-proline 0 CA--C 1.556 1.203 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 -172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.2 -36.21 70.25 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.797 2.331 . . . . 0.0 114.474 -169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.53 -2.91 27.88 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -113.56 -4.22 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.943 2.097 . . . . 0.0 112.042 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.254 1.312 0 C-N-CA 126.387 1.875 . . . . 0.0 112.62 179.193 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m -67.15 152.17 46.23 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.454 1.101 . . . . 0.0 113.152 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -70.81 -16.8 62.75 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.92 179.94 48.81 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.493 1.52 . . . . 0.0 112.828 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 86.4 p -149.25 167.69 25.34 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.174 1.389 . . . . 0.0 112.265 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -79.33 -6.29 56.41 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.91 168.34 53.52 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.011 1.291 . . . . 0.0 114.754 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -134.2 155.69 49.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.826 1.65 . . . . 0.0 112.153 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.5 p -127.3 165.43 19.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.419 1.888 . . . . 0.0 111.537 172.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -125.8 146.63 49.7 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 110.856 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -131.39 136.74 48.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.932 0.893 . . . . 0.0 112.11 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 47.0 t -61.18 131.77 92.23 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.122 0.969 . . . . 0.0 111.967 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.01 -7.54 20.04 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.405 2.736 . . . . 0.0 113.935 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.02 -37.06 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.28 1.032 . . . . 0.0 113.492 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -129.82 14.1 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 61.53 4.69 1.05 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.351 2.661 . . . . 0.0 117.285 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.27 147.45 53.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.728 1.211 . . . . 0.0 112.794 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 m -96.39 140.71 30.66 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.959 1.304 . . . . 0.0 112.954 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -137.66 147.62 45.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.305 1.842 . . . . 0.0 111.605 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 m -89.51 -13.89 36.44 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -142.54 151.39 41.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.649 1.18 . . . . 0.0 111.954 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -14.94 63.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -81.98 -32.99 30.39 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.121 0.968 . . . . 0.0 112.86 169.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.57 -39.45 70.59 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.565 0.746 . . . . 0.0 111.365 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.81 -38.76 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 118.094 0.406 . . . . 0.0 111.789 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -62.89 -46.29 88.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.656 0.782 . . . . 0.0 111.407 174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.7 m -59.23 -42.67 91.62 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.391 0.541 . . . . 0.0 112.248 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -64.18 -46.76 82.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.106 0.866 . . . . 0.0 112.542 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.04 -42.61 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.692 -0.63 . . . . 0.0 110.655 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.84 -34.17 73.27 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 p -85.86 -35.56 20.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -109.42 -28.19 9.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -137.48 38.57 0.37 Allowed Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -169.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.76 -20.04 67.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.762 2.308 . . . . 0.0 114.338 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.19 -14.61 63.11 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.14 -19.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 119.203 0.911 . . . . 0.0 113.233 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.05 1.74 . . . . 0.0 113.357 -178.338 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.2 p -77.06 162.61 27.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.704 1.202 . . . . 0.0 113.069 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m -73.18 -16.35 61.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.39 175.91 40.77 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.037 1.303 . . . . 0.0 113.538 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 m -86.13 23.72 1.47 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.405 1.482 . . . . 0.0 114.225 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.9 p -72.34 156.87 38.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.207 1.403 . . . . 0.0 113.66 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.96 -177.56 48.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.012 1.291 . . . . 0.0 113.184 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -86.71 -6.05 58.95 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -66.86 157.79 32.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.971 1.308 . . . . 0.0 113.188 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -107.55 154.86 20.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.334 1.854 . . . . 0.0 110.851 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.4 p -139.62 143.21 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 171.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.6 130.64 81.72 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.344 1.458 . . . . 0.0 112.471 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.79 -8.42 22.35 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.119 2.546 . . . . 0.0 113.557 177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -113.88 -37.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.547 1.139 . . . . 0.0 112.826 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -135.22 11.63 3.55 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.2 6.71 1.39 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.192 2.597 . . . . 0.0 117.407 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -63.56 142.64 58.32 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.895 -1.128 . . . . 0.0 111.649 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 p -95.29 146.4 24.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.513 1.125 . . . . 0.0 114.006 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -141.87 144.4 33.82 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.923 1.689 . . . . 0.0 111.685 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.2 m -81.9 -20.24 39.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -142.82 151.68 41.39 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.962 1.305 . . . . 0.0 112.104 -171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.85 -34.88 76.77 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.333 1.053 . . . . 0.0 112.896 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -67.8 -31.05 70.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.98 -43.62 57.5 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.381 0.672 . . . . 0.0 111.372 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.09 -37.58 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.671 172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -60.84 -43.55 98.14 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.957 1.253 . . . . 0.0 112.227 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.1 m -63.15 -37.33 86.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.227 0.921 . . . . 0.0 112.738 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.51 -46.12 87.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.21 0.913 . . . . 0.0 112.547 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.94 -41.78 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.549 -0.719 . . . . 0.0 110.725 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -67.32 -34.89 78.3 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.0 p -88.66 -34.26 17.31 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -109.61 -27.16 9.53 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -134.72 40.0 0.51 Allowed Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -171.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.67 -23.35 56.57 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.003 2.469 . . . . 0.0 114.769 -170.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -90.52 3.93 52.6 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.756 1.222 . . . . 0.0 113.804 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.25 -0.81 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.806 1.643 . . . . 0.0 112.817 -170.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.686 1.594 . . . . 0.0 114.536 179.134 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -76.0 167.28 22.15 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.944 1.298 . . . . 0.0 113.14 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -80.93 -10.31 59.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.084 1.354 . . . . 0.0 113.296 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.0 -140.55 48.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.554 1.074 . . . . 0.0 113.056 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.2 m -71.21 -12.14 61.31 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.2 m -84.15 -11.18 57.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.31 -174.9 46.15 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.156 0.889 . . . . 0.0 114.656 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.5 tpp85 -61.31 137.13 58.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.032 1.333 . . . . 0.0 111.516 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.6 m -127.13 152.7 46.98 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.849 1.66 . . . . 0.0 111.67 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -134.27 137.38 44.24 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.977 1.311 . . . . 0.0 109.78 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 p -142.35 141.92 32.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.681 0.792 . . . . 0.0 112.352 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -57.34 132.4 81.27 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.758 1.223 . . . . 0.0 112.72 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.85 -10.12 27.07 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.165 2.577 . . . . 0.0 113.833 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.93 -37.39 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.318 1.047 . . . . 0.0 113.184 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -129.21 4.91 5.25 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 60.23 12.1 3.16 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.264 2.226 . . . . 0.0 116.14 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.79 133.2 54.06 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.824 1.249 . . . . 0.0 111.119 171.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.8 m -85.86 145.32 27.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.214 1.006 . . . . 0.0 112.87 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -139.31 152.13 46.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.986 1.714 . . . . 0.0 111.763 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.1 p -97.69 -11.74 23.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -141.54 151.41 43.22 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.24 1.416 . . . . 0.0 111.484 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -63.87 -36.45 83.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.198 0.599 . . . . 0.0 112.456 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -65.06 -28.78 69.71 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.57 -44.66 33.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.461 0.705 . . . . 0.0 111.617 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -68.27 -37.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.562 0.619 . . . . 0.0 111.737 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -60.01 -44.81 94.32 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.594 1.088 . . . . 0.0 111.512 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 m -61.07 -41.82 97.34 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.03 0.532 . . . . 0.0 112.053 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.28 -46.91 84.57 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.573 -0.705 . . . . 0.0 112.691 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -59.63 -44.48 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.592 -0.692 . . . . 0.0 110.265 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -68.25 -30.33 69.34 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.3 p -92.35 -35.2 13.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -107.99 -26.53 10.64 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -135.74 62.38 47.53 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.073 0.949 . . . . 0.0 113.116 -172.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -66.23 -19.64 56.31 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.401 2.068 . . . . 0.0 115.798 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.07 -2.38 27.2 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.49 145.47 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.355 1.862 . . . . 0.0 111.527 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.172 1.789 . . . . 0.0 112.852 -178.453 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -148.39 161.22 42.03 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.322 1.449 . . . . 0.0 111.707 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -136.55 153.59 50.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 -173.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.41 177.62 50.31 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.758 1.17 . . . . 0.0 114.549 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -85.56 -10.35 56.06 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m 54.27 30.13 11.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.834 1.654 . . . . 0.0 114.993 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.17 171.87 44.33 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.962 1.268 . . . . 0.0 113.385 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -120.62 12.06 11.4 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.429 1.892 . . . . 0.0 113.588 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 m -66.92 154.51 40.86 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.946 1.298 . . . . 0.0 113.612 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -102.55 155.55 18.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.788 2.035 . . . . 0.0 110.707 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.4 t -137.73 134.29 35.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.258 1.023 . . . . 0.0 111.797 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.7 t -57.43 130.19 80.81 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.798 1.239 . . . . 0.0 112.413 -176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.12 -9.98 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.158 2.572 . . . . 0.0 113.67 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 t -111.97 -37.07 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.379 1.072 . . . . 0.0 113.026 -176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -130.91 3.03 4.4 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 58.29 22.96 9.87 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.59 1.956 . . . . 0.0 115.45 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -68.53 135.62 51.85 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.726 169.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.5 m -87.05 144.83 26.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.319 1.048 . . . . 0.0 113.235 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.88 145.98 38.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.643 1.577 . . . . 0.0 112.251 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 -18.41 37.23 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -142.26 148.62 38.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.65 1.58 . . . . 0.0 112.091 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.28 -34.27 73.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.49 1.116 . . . . 0.0 112.843 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -67.32 -29.81 69.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.881 0.873 . . . . 0.0 113.274 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.68 -37.29 27.65 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.319 1.048 . . . . 0.0 111.969 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.61 -38.58 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.748 -0.595 . . . . 0.0 110.955 169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -60.53 -46.86 88.61 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.885 1.22 . . . . 0.0 112.387 174.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.8 p -65.22 -36.39 84.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.097 0.862 . . . . 0.0 112.385 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -60.8 -50.32 73.91 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.978 0.808 . . . . 0.0 112.52 171.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.09 -42.13 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 121.609 -0.682 . . . . 0.0 110.257 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 10.1 mmpt? -75.14 -16.13 60.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -99.25 -34.37 10.37 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.581 1.152 . . . . 0.0 113.73 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -106.15 -28.01 10.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.644 1.178 . . . . 0.0 113.465 -173.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -135.96 56.81 15.76 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.196 1.398 . . . . 0.0 111.623 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -58.33 -32.45 96.09 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.758 2.305 . . . . 0.0 116.748 -167.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.16 -4.8 38.02 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -172.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 p -126.75 141.58 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.358 1.863 . . . . 0.0 110.387 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.906 1.682 . . . . 0.0 112.012 -176.291 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -135.74 153.64 51.5 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.151 1.38 . . . . 0.0 112.079 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.9 m -71.6 153.2 42.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.482 1.113 . . . . 0.0 113.019 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.49 177.51 46.64 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.632 1.11 . . . . 0.0 114.727 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 t -82.84 -22.77 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.304 1.042 . . . . 0.0 113.808 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -132.31 155.68 47.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.464 1.505 . . . . 0.0 112.795 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.43 178.57 43.7 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.425 1.488 . . . . 0.0 112.688 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -135.7 157.03 47.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.166 1.386 . . . . 0.0 112.58 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.2 p -135.01 157.5 46.78 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.871 1.668 . . . . 0.0 111.456 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -131.62 148.5 52.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 -176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 79.3 p -140.09 142.55 36.09 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.11 131.39 87.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.25 1.42 . . . . 0.0 112.599 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 -10.13 23.87 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.262 2.642 . . . . 0.0 113.686 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.6 t -113.18 -36.34 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.598 1.159 . . . . 0.0 112.897 -175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.1 p -134.96 10.61 3.6 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 60.89 9.45 2.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 128.011 2.524 . . . . 0.0 117.18 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.65 144.8 56.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.439 1.096 . . . . 0.0 112.003 175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.8 m -96.64 143.74 27.32 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.43 1.092 . . . . 0.0 113.633 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -140.16 154.25 46.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.348 1.859 . . . . 0.0 111.54 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.3 p -97.83 -10.2 25.14 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -142.01 151.78 42.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.498 1.119 . . . . 0.0 112.818 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.71 -39.13 76.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.245 1.418 . . . . 0.0 112.448 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -65.84 -32.68 74.34 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.112 0.965 . . . . 0.0 113.541 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.83 -44.24 41.95 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.469 0.708 . . . . 0.0 111.415 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.3 tt -67.43 -38.4 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 119.021 -0.514 . . . . 0.0 111.717 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -63.29 -42.98 99.13 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.809 1.186 . . . . 0.0 112.072 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.7 t -57.79 -45.18 86.39 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.667 0.667 . . . . 0.0 111.596 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -60.69 -49.14 78.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.712 0.805 . . . . 0.0 112.947 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.8 mt -61.12 -42.39 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.039 0.936 . . . . 0.0 110.914 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -72.7 -23.86 60.93 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 t -104.01 -15.82 15.49 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -116.03 -28.62 6.57 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -132.33 26.16 0.12 Allowed Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.45 -22.75 51.56 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.689 2.259 . . . . 0.0 114.689 -169.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.58 10.09 31.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.711 1.604 . . . . 0.0 113.222 174.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.49 -28.0 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.393 1.477 . . . . 0.0 112.902 -169.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 C--O 1.256 1.41 0 C-N-CA 125.455 1.502 . . . . 0.0 114.652 176.468 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 t -147.97 158.45 44.06 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.029 1.331 . . . . 0.0 111.684 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -70.27 148.21 48.81 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.91 1.284 . . . . 0.0 113.313 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.89 162.5 28.42 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.971 1.272 . . . . 0.0 113.097 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t -153.78 153.53 32.35 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.881 1.272 . . . . 0.0 111.773 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.0 t 61.38 -58.0 0.1 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.506 2.722 . . . . 0.0 116.068 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.57 162.6 53.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.97 1.272 . . . . 0.0 114.008 177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -144.56 145.75 31.98 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.026 1.73 . . . . 0.0 110.844 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -91.77 137.07 32.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.128 0.971 . . . . 0.0 111.673 175.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -127.53 149.45 50.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.367 1.867 . . . . 0.0 109.777 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -137.86 134.15 34.75 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.929 0.892 . . . . 0.0 112.148 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 40.5 t -56.84 128.96 77.33 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.133 1.373 . . . . 0.0 112.185 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -72.52 -8.52 22.71 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.107 2.538 . . . . 0.0 113.481 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.25 -37.13 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.614 1.166 . . . . 0.0 112.682 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 p -136.5 7.56 3.06 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 58.55 22.26 9.53 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.103 2.161 . . . . 0.0 116.073 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -72.71 142.44 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.003 -1.061 . . . . 0.0 111.129 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 p -96.24 145.03 25.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.445 1.098 . . . . 0.0 113.923 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -141.26 157.61 44.99 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.2 1.8 . . . . 0.0 111.668 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 m -106.2 -2.77 22.11 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -146.14 150.71 36.4 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.469 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -62.64 -35.25 79.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.729 0.812 . . . . 0.0 112.626 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -68.84 -29.45 67.78 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.5 mt -74.11 -44.59 53.29 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.676 0.671 . . . . 0.0 111.398 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -67.87 -38.94 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.805 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -60.92 -42.71 98.66 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.016 1.28 . . . . 0.0 112.095 172.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.4 m -61.47 -42.34 98.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.357 0.526 . . . . 0.0 111.765 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -62.5 -48.51 79.23 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.687 -0.633 . . . . 0.0 112.628 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.4 mt -57.71 -44.49 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.431 0.692 . . . . 0.0 110.441 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.98 -32.67 71.0 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.0 p -89.43 -37.46 14.79 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.62 -24.75 14.07 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.438 1.095 . . . . 0.0 113.168 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -130.88 48.5 3.78 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 125.019 1.328 . . . . 0.0 112.772 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -62.44 -29.69 79.32 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.493 2.795 . . . . 0.0 115.075 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.8 0.34 31.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.289 1.036 . . . . 0.0 113.153 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -121.9 -3.37 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 127.462 2.305 . . . . 0.0 111.827 -176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.489 1.916 . . . . 0.0 113.072 -179.469 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.6 m -72.07 149.01 45.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.332 1.053 . . . . 0.0 113.019 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -137.61 147.41 44.98 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.404 1.481 . . . . 0.0 111.74 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.44 -5.94 33.38 Favored Glycine 0 CA--C 1.541 1.711 0 C-N-CA 125.058 1.313 . . . . 0.0 116.376 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -141.34 150.23 42.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.931 1.692 . . . . 0.0 111.737 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.1 m -137.81 154.66 49.52 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.584 1.554 . . . . 0.0 111.807 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.62 -178.41 48.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.48 1.038 . . . . 0.0 113.336 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -142.11 146.46 35.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.647 1.579 . . . . 0.0 111.656 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -124.75 157.55 35.44 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.756 1.623 . . . . 0.0 110.845 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -128.29 134.87 49.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.705 1.602 . . . . 0.0 110.126 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.3 p -115.19 141.37 48.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.186 0.994 . . . . 0.0 113.06 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -59.36 129.49 86.78 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.971 1.308 . . . . 0.0 112.198 -174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.83 -8.96 23.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.309 2.673 . . . . 0.0 113.424 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.4 t -113.28 -38.57 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.601 1.16 . . . . 0.0 112.59 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 p -137.51 20.74 2.92 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 58.26 -6.58 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 129.756 3.222 . . . . 0.0 119.221 168.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 mtmm -62.25 146.23 51.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.055 1.298 . . . . 0.0 112.531 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.4 m -108.11 146.52 32.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.529 1.132 . . . . 0.0 113.855 -171.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -137.71 145.12 42.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.829 2.051 . . . . 0.0 110.972 -173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -87.39 -8.27 56.76 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -143.32 152.54 41.76 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.008 1.323 . . . . 0.0 111.471 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -63.31 -33.65 75.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.818 0.847 . . . . 0.0 112.828 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.5 -29.6 69.06 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.309 -0.869 . . . . 0.0 113.181 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.21 -42.05 47.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.613 0.765 . . . . 0.0 111.389 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -68.61 -38.71 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.493 0.588 . . . . 0.0 111.846 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -63.58 -39.99 95.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.903 1.229 . . . . 0.0 112.174 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.4 t -60.65 -44.53 96.32 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.358 0.663 . . . . 0.0 111.78 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -60.44 -47.99 83.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.622 0.769 . . . . 0.0 112.532 175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.2 mt -60.24 -42.49 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.007 0.923 . . . . 0.0 110.79 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -74.2 -20.12 60.3 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 p -99.02 -27.6 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.812 1.245 . . . . 0.0 114.014 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -111.08 -28.74 8.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.294 1.038 . . . . 0.0 113.776 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -133.59 42.59 0.86 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 125.352 1.461 . . . . 0.0 112.77 -173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -60.25 -19.92 59.79 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.7 2.933 . . . . 0.0 115.46 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.15 -17.74 42.71 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 p -93.0 -9.57 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.463 1.105 . . . . 0.0 113.59 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.466 1.506 . . . . 0.0 112.539 -178.051 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 m -67.91 151.32 47.32 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.575 1.15 . . . . 0.0 113.174 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 p -77.29 162.16 27.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.924 1.29 . . . . 0.0 113.146 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.73 178.72 48.43 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.941 1.258 . . . . 0.0 113.203 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.4 t -149.96 144.27 25.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.823 1.249 . . . . 0.0 111.864 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -68.51 -23.2 64.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.402 1.081 . . . . 0.0 112.879 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.4 -9.78 86.11 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.001 1.286 . . . . 0.0 114.311 169.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.6 mmt-85 60.48 163.94 0.06 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.526 2.731 . . . . 0.0 115.525 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -127.6 160.79 30.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.413 1.885 . . . . 0.0 110.865 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.04 152.4 26.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.45 1.5 . . . . 0.0 110.975 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.3 p -137.83 140.8 40.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.752 0.821 . . . . 0.0 112.973 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.3 t -56.87 131.96 79.25 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.06 1.344 . . . . 0.0 112.592 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.67 -9.61 25.24 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.149 2.566 . . . . 0.0 113.774 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.15 -38.25 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 113.009 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.2 p -132.72 10.73 4.34 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 60.56 7.17 1.28 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.295 2.638 . . . . 0.0 117.208 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -62.21 142.78 57.49 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.423 1.089 . . . . 0.0 111.658 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.2 p -96.1 146.26 24.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.634 1.173 . . . . 0.0 113.983 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.36 144.27 33.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.996 1.719 . . . . 0.0 111.774 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 m -84.38 -19.08 34.16 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -143.63 153.78 42.86 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.173 1.389 . . . . 0.0 111.78 -173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.54 -40.39 87.07 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.633 0.773 . . . . 0.0 112.435 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -60.56 -30.01 69.52 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.149 -0.969 . . . . 0.0 113.565 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.58 -44.89 26.95 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 111.356 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.8 -38.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.37 0.532 . . . . 0.0 111.942 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.751 1.16 . . . . 0.0 111.474 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.9 t -59.03 -44.93 91.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.396 0.544 . . . . 0.0 111.792 171.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.82 -46.03 92.15 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.383 -0.823 . . . . 0.0 112.981 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.51 -44.02 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.726 0.811 . . . . 0.0 110.588 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -72.79 -28.63 62.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -90.15 -35.72 15.23 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -108.35 -26.4 10.53 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.393 1.077 . . . . 0.0 113.662 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -134.08 44.73 1.3 Allowed Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.507 1.123 . . . . 0.0 113.797 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.66 -23.97 41.94 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.803 1.668 . . . . 0.0 114.514 -174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -66.15 -12.16 54.04 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -117.61 -7.49 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.739 2.016 . . . . 0.0 112.821 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 C--O 1.255 1.366 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -176.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m 57.71 -71.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 127.896 2.479 . . . . 0.0 116.014 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.9 m -80.31 -12.71 59.57 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.153 1.381 . . . . 0.0 113.635 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.13 165.67 39.09 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.573 1.559 . . . . 0.0 112.514 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.3 p -78.57 -7.6 57.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -173.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 m -61.15 135.17 57.67 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.936 1.294 . . . . 0.0 112.879 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.13 -6.33 78.94 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.64 1.114 . . . . 0.0 115.345 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -138.5 118.93 13.76 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.138 1.775 . . . . 0.0 110.621 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -144.24 150.83 38.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.503 1.521 . . . . 0.0 112.093 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -132.05 148.02 52.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.319 1.848 . . . . 0.0 109.483 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.2 m -136.68 134.44 37.25 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.808 0.843 . . . . 0.0 112.468 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.59 132.75 82.23 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.155 1.382 . . . . 0.0 112.695 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.06 -10.72 26.43 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.161 2.574 . . . . 0.0 113.569 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 t -110.16 -41.08 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.399 1.08 . . . . 0.0 112.91 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.9 p -124.9 7.12 8.03 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 58.43 10.96 1.49 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.423 2.289 . . . . 0.0 115.392 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -66.49 135.7 54.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.486 2.315 . . . . 0.0 111.372 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 p -97.12 145.54 25.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -142.31 153.94 44.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.501 1.92 . . . . 0.0 111.808 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -87.22 -23.3 24.8 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -141.52 155.49 45.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.677 1.191 . . . . 0.0 113.085 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.56 -39.75 74.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.965 1.306 . . . . 0.0 112.652 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -64.48 -30.64 71.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.21 -44.31 26.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.937 0.895 . . . . 0.0 111.2 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.27 -41.22 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.543 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -63.38 -40.27 96.8 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.078 1.308 . . . . 0.0 111.85 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -60.57 -40.48 91.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.994 0.816 . . . . 0.0 112.01 172.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -63.41 -51.76 64.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.558 0.617 . . . . 0.0 112.657 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.83 -40.83 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.488 0.586 . . . . 0.0 110.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -64.3 -33.84 76.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.7 p -92.97 -29.8 15.67 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.613 1.165 . . . . 0.0 113.959 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -106.86 -25.57 11.61 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.421 1.088 . . . . 0.0 113.766 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -133.88 68.15 74.82 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.755 1.222 . . . . 0.0 111.307 -172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -56.68 -28.41 75.32 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.954 3.102 . . . . 0.0 117.103 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.84 -3.58 42.25 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.1 t -112.28 -23.98 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.827 1.651 . . . . 0.0 112.465 -170.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.5 m . . . . . 0 C--O 1.251 1.161 0 C-N-CA 126.331 1.852 . . . . 0.0 111.777 169.697 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m -72.19 -22.43 61.28 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.3 p -150.53 153.48 35.88 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.359 1.464 . . . . 0.0 112.39 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.59 158.01 48.3 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.253 0.93 . . . . 0.0 113.454 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.3 m 52.35 36.51 20.03 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.495 1.518 . . . . 0.0 114.442 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.9 t -144.6 173.84 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.493 1.517 . . . . 0.0 112.248 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.81 179.75 43.16 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.506 1.527 . . . . 0.0 114.948 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -105.55 5.28 31.26 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.555 1.942 . . . . 0.0 113.584 -170.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.8 m -81.42 146.78 30.1 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.211 -0.931 . . . . 0.0 112.644 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -135.3 154.05 51.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.186 1.794 . . . . 0.0 110.418 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.8 m -134.75 141.0 46.35 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.719 0.808 . . . . 0.0 112.926 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -57.73 129.3 81.27 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.394 1.478 . . . . 0.0 112.608 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.02 -9.07 21.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.323 2.682 . . . . 0.0 113.387 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.4 t -112.34 -37.91 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.703 1.201 . . . . 0.0 112.693 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.4 p -137.72 19.92 2.87 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -172.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 58.51 -5.39 0.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 129.55 3.14 . . . . 0.0 119.05 168.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -62.18 143.66 56.47 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.916 1.235 . . . . 0.0 112.48 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.0 p -101.07 150.36 23.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.697 1.199 . . . . 0.0 113.891 -174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -140.03 147.82 40.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.009 2.124 . . . . 0.0 110.685 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 p -89.81 -10.4 45.59 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -150.92 158.95 44.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 111.652 174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.38 -33.32 75.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -171.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -67.21 -24.91 65.89 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.057 -1.027 . . . . 0.0 112.931 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -77.43 -42.82 34.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 111.497 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -67.8 -38.59 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.428 0.558 . . . . 0.0 111.623 171.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.49 -39.72 94.37 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.853 1.206 . . . . 0.0 111.888 174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.7 m -62.82 -42.07 99.57 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.571 0.623 . . . . 0.0 111.991 172.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.62 -46.69 88.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.635 0.774 . . . . 0.0 112.419 174.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.9 mt -60.64 -42.49 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.038 0.935 . . . . 0.0 110.675 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -30.39 68.76 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -92.94 -25.84 17.84 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -114.18 -28.46 7.29 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -135.52 36.53 0.31 Allowed Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.08 -21.75 72.57 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.641 2.228 . . . . 0.0 114.352 -171.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.71 -14.25 62.3 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -13.85 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.232 1.013 . . . . 0.0 113.31 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.58 1.552 . . . . 0.0 113.088 -179.648 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.603 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -64.74 -26.52 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -93.26 -8.71 41.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.953 1.301 . . . . 0.0 114.373 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.93 162.42 15.94 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.183 0.897 . . . . 0.0 114.365 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.0 p -150.09 160.04 43.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.696 1.598 . . . . 0.0 112.286 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.8 p -94.58 -31.89 13.68 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.089 1.356 . . . . 0.0 113.726 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.8 160.65 47.09 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.852 1.215 . . . . 0.0 113.34 174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -136.59 149.61 48.13 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.035 1.334 . . . . 0.0 111.473 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.3 p -127.8 168.97 14.4 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.424 1.89 . . . . 0.0 111.764 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -130.6 150.18 51.92 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.494 1.518 . . . . 0.0 110.695 -172.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m -137.18 139.23 40.96 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.862 0.865 . . . . 0.0 112.067 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 44.1 t -55.8 129.64 71.58 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.576 1.55 . . . . 0.0 112.294 -175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.51 -7.87 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 113.469 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -113.02 -37.38 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.5 1.12 . . . . 0.0 112.756 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -135.78 11.49 3.4 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 61.66 10.07 3.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.871 2.468 . . . . 0.0 117.024 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.59 141.17 55.52 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.609 -1.307 . . . . 0.0 111.773 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -99.57 147.14 25.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -139.91 148.11 41.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.953 2.101 . . . . 0.0 111.329 -176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.6 p -88.11 -20.58 25.48 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -141.33 151.03 43.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.615 1.166 . . . . 0.0 112.699 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -61.72 -36.59 81.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.346 1.458 . . . . 0.0 113.769 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -68.2 -26.35 65.68 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.147 -0.971 . . . . 0.0 113.107 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -77.45 -43.24 33.07 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.679 0.792 . . . . 0.0 111.345 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.49 -39.57 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 118.115 0.416 . . . . 0.0 111.448 171.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -63.72 -38.27 90.49 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.983 -1.073 . . . . 0.0 112.373 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.2 m -62.59 -43.67 98.24 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.288 0.635 . . . . 0.0 111.692 171.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -61.92 -45.2 94.77 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.392 0.677 . . . . 0.0 112.537 175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.0 -42.11 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.404 0.681 . . . . 0.0 110.298 175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.68 -36.44 82.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 113.529 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -88.42 -33.9 17.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.44 -27.67 10.79 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.69 42.99 0.91 Allowed Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.687 1.195 . . . . 0.0 113.976 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 -27.24 61.24 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.131 2.554 . . . . 0.0 114.615 -170.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.22 3.6 34.51 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.64 1.176 . . . . 0.0 113.85 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.06 18.19 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.265 1.826 . . . . 0.0 111.959 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 C--O 1.256 1.44 0 C-N-CA 126.087 1.755 . . . . 0.0 114.542 178.06 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.2 p -146.67 163.4 36.01 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.47 1.508 . . . . 0.0 112.564 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -134.76 154.63 51.51 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.449 1.499 . . . . 0.0 112.087 -176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.28 171.25 44.39 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.792 1.187 . . . . 0.0 113.328 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 t -153.52 -42.11 0.09 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.414 1.085 . . . . 0.0 113.007 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.4 m -55.36 130.66 43.36 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.754 1.222 . . . . 0.0 112.997 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.88 -10.02 27.99 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.053 1.311 . . . . 0.0 115.718 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 58.28 173.86 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.637 2.375 . . . . 0.0 114.925 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -139.16 161.24 37.89 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.99 1.716 . . . . 0.0 111.79 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -135.31 154.44 51.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.102 1.761 . . . . 0.0 110.265 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -139.41 142.03 37.5 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -61.1 130.05 91.07 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.839 1.256 . . . . 0.0 112.31 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.17 -7.58 20.77 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.058 2.505 . . . . 0.0 113.525 177.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.88 -36.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.5 1.12 . . . . 0.0 113.055 -174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.9 p -130.85 3.5 4.46 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 62.16 12.91 5.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.907 2.083 . . . . 0.0 116.181 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.54 138.22 58.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.701 -1.249 . . . . 0.0 111.169 170.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.7 m -82.3 148.91 28.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.577 1.151 . . . . 0.0 113.523 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.8 152.69 43.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.962 2.105 . . . . 0.0 111.458 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -96.49 -14.36 22.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -141.98 144.59 33.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.489 1.115 . . . . 0.0 112.32 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.42 -37.63 81.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.275 1.43 . . . . 0.0 113.156 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.44 -31.3 70.52 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.73 -43.59 46.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.39 0.676 . . . . 0.0 111.419 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.74 -38.83 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 118.135 0.425 . . . . 0.0 111.681 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -63.39 -41.22 98.76 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.674 1.125 . . . . 0.0 112.208 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -60.96 -43.66 98.41 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.236 0.615 . . . . 0.0 111.905 172.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -60.45 -48.47 81.61 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.836 0.855 . . . . 0.0 112.792 175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.03 -41.99 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.997 0.919 . . . . 0.0 110.476 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -66.57 -36.77 83.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.909 1.284 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 t -95.01 -27.27 15.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -103.12 -28.62 11.84 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -130.58 32.89 0.23 Allowed Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -169.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.86 -28.93 50.52 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.301 2.001 . . . . 0.0 114.389 -172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.9 -4.08 41.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.245 1.018 . . . . 0.0 113.642 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.61 -21.27 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.053 1.741 . . . . 0.0 112.025 -172.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.301 1.84 . . . . 0.0 113.575 177.008 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.8 p -89.37 -7.07 55.99 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -67.22 151.64 47.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.178 1.391 . . . . 0.0 113.729 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.07 171.16 42.34 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.978 1.275 . . . . 0.0 115.116 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -132.78 6.51 4.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 114.113 -174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.5 p -82.32 20.64 1.03 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.516 1.926 . . . . 0.0 115.06 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.14 -18.76 67.38 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.693 1.139 . . . . 0.0 115.389 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -127.96 134.04 49.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.374 1.87 . . . . 0.0 110.673 172.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.8 m -141.43 160.76 39.47 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.006 1.723 . . . . 0.0 111.529 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -114.98 136.99 52.52 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 109.723 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -124.0 131.73 53.6 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.868 0.867 . . . . 0.0 112.24 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.9 t -56.22 131.34 75.23 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.975 1.31 . . . . 0.0 112.45 -176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.16 -9.38 23.28 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.298 2.665 . . . . 0.0 113.923 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.57 -36.85 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.324 1.05 . . . . 0.0 113.253 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 p -132.51 10.11 4.38 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 60.17 12.0 3.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.923 2.489 . . . . 0.0 116.918 169.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -64.78 147.26 53.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.457 1.103 . . . . 0.0 111.922 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.9 t -101.73 145.62 28.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 113.282 -174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -141.58 149.28 40.56 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.178 2.191 . . . . 0.0 111.119 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.6 p -90.81 -14.99 30.82 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.654 1.354 . . . . 0.0 114.654 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -141.59 151.58 43.28 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.603 1.161 . . . . 0.0 112.73 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.328 1.451 . . . . 0.0 112.896 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -67.61 -28.68 67.96 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.05 -42.72 25.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.634 0.774 . . . . 0.0 111.407 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.7 tt -66.02 -38.7 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.243 0.474 . . . . 0.0 111.414 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -64.42 -39.01 93.02 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.669 1.122 . . . . 0.0 112.33 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -61.86 -41.2 97.56 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.729 0.695 . . . . 0.0 111.944 172.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -64.13 -46.28 84.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.519 0.727 . . . . 0.0 112.578 174.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.56 -43.24 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.835 0.854 . . . . 0.0 110.788 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.02 -29.66 67.88 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.3 p -91.9 -30.92 15.89 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -113.71 -27.73 7.71 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -134.41 29.57 0.16 Allowed Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -169.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.09 -26.54 42.88 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.666 2.244 . . . . 0.0 114.677 -169.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.77 2.18 56.88 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.878 1.271 . . . . 0.0 113.594 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.66 -38.96 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.159 1.383 . . . . 0.0 112.633 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.529 1.532 . . . . 0.0 112.905 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.6 p -80.75 -19.87 43.96 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m 54.93 25.75 7.14 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.6 1.56 . . . . 0.0 114.029 -169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.72 -7.64 80.46 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.851 1.215 . . . . 0.0 115.781 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.0 p -144.59 157.84 44.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.601 1.561 . . . . 0.0 112.525 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.9 p -96.87 165.81 11.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.757 1.623 . . . . 0.0 112.869 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.05 -146.19 40.88 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 123.962 0.791 . . . . 0.0 113.567 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -140.22 160.83 39.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.654 1.582 . . . . 0.0 112.736 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.1 p -142.15 166.07 25.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.728 1.611 . . . . 0.0 111.917 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.66 153.27 47.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.425 1.89 . . . . 0.0 110.151 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -137.47 142.77 41.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.5 t -58.32 132.92 84.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.083 1.353 . . . . 0.0 112.684 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.9 -10.51 26.35 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.297 2.665 . . . . 0.0 113.973 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 -39.92 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.234 1.014 . . . . 0.0 113.039 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -129.69 9.9 5.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.94 10.7 2.26 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.071 2.548 . . . . 0.0 116.933 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -64.06 144.32 57.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.531 1.132 . . . . 0.0 111.771 174.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.7 m -98.27 143.85 28.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.464 1.106 . . . . 0.0 113.367 -172.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -139.26 145.98 39.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.157 1.783 . . . . 0.0 111.588 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.3 m -88.49 -15.15 36.04 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -140.82 148.72 41.02 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.797 1.239 . . . . 0.0 112.09 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.06 -37.64 83.39 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 112.684 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -67.52 -28.47 67.85 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.97 -43.91 33.2 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.438 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.79 -38.85 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.437 0.562 . . . . 0.0 111.573 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.39 -40.05 96.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.589 1.086 . . . . 0.0 112.19 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.9 m -61.67 -41.41 97.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.685 0.675 . . . . 0.0 111.882 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.51 -47.62 80.95 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.681 -0.637 . . . . 0.0 112.582 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.55 -43.6 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.406 0.683 . . . . 0.0 110.462 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -67.59 -31.5 71.59 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.9 p -91.47 -32.75 15.48 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 114.061 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -109.38 -27.47 9.47 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -135.62 60.59 37.93 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.435 1.094 . . . . 0.0 112.936 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -58.51 -29.72 89.57 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.193 2.595 . . . . 0.0 116.425 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.39 -9.42 53.44 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.46 -22.3 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.964 1.706 . . . . 0.0 112.081 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.042 1.737 . . . . 0.0 113.73 179.776 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 t -149.33 157.08 43.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.145 1.378 . . . . 0.0 111.808 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -137.5 145.1 42.6 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.846 1.658 . . . . 0.0 111.586 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.53 27.77 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 123.806 0.717 . . . . 0.0 113.153 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.1 p -91.34 -21.28 21.1 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.93 1.292 . . . . 0.0 113.982 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -74.34 155.46 38.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.141 1.376 . . . . 0.0 112.831 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.82 -9.63 66.26 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 124.368 0.985 . . . . 0.0 115.247 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -135.93 144.67 45.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.765 2.026 . . . . 0.0 111.157 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.0 t -149.45 154.78 39.37 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.629 1.572 . . . . 0.0 110.874 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.92 137.82 49.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.432 1.493 . . . . 0.0 110.19 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.0 m -127.36 135.3 50.31 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.723 0.809 . . . . 0.0 112.418 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 43.0 t -56.02 133.66 74.12 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.529 1.532 . . . . 0.0 112.959 -174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.04 -10.5 27.62 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.16 2.574 . . . . 0.0 114.021 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.15 -34.47 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.114 0.966 . . . . 0.0 113.51 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -129.02 2.88 5.27 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 60.38 10.22 2.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.247 2.219 . . . . 0.0 116.347 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -62.48 143.91 56.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.048 -1.032 . . . . 0.0 111.574 171.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 64.0 p -102.9 148.75 25.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -169.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -140.86 149.31 41.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.912 2.085 . . . . 0.0 111.161 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 p -89.48 -14.52 35.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -139.59 146.29 39.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.19 1.396 . . . . 0.0 112.349 -174.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.19 -36.59 80.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.198 1.399 . . . . 0.0 113.146 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -69.23 -28.65 66.54 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.29 -42.75 44.36 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.359 0.663 . . . . 0.0 111.552 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.6 -39.53 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 118.407 0.549 . . . . 0.0 111.573 172.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -63.53 -41.28 98.48 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.704 1.138 . . . . 0.0 112.203 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -59.12 -45.54 90.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.145 0.578 . . . . 0.0 111.46 171.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -60.98 -47.55 85.95 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.334 -0.854 . . . . 0.0 112.86 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.75 -45.19 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.971 0.908 . . . . 0.0 110.778 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.83 -25.2 52.92 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -91.17 -36.75 13.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 113.895 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -104.9 -27.63 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.182 0.993 . . . . 0.0 113.488 -173.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -135.64 39.44 0.45 Allowed Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -172.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.18 -19.32 56.47 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.829 2.353 . . . . 0.0 115.045 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.62 -17.95 61.27 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -16.75 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.601 1.16 . . . . 0.0 113.549 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.541 1.536 . . . . 0.0 111.886 -176.227 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.63 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -149.86 151.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.054 1.342 . . . . 0.0 112.116 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 p -83.06 -8.37 59.55 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.171 1.388 . . . . 0.0 113.466 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.18 -2.68 54.37 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.242 1.401 . . . . 0.0 115.893 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 m -64.48 -17.36 63.78 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.005 1.403 . . . . 0.0 114.631 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.6 m -74.07 -19.61 60.55 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.57 160.73 15.54 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.443 1.021 . . . . 0.0 113.745 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -67.78 151.07 47.81 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.655 0.782 . . . . 0.0 112.868 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.8 p -135.45 156.82 48.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.721 1.608 . . . . 0.0 111.317 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -127.65 145.22 50.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.211 1.804 . . . . 0.0 109.366 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.7 p -137.09 146.61 45.33 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.01 129.51 86.3 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.523 1.129 . . . . 0.0 111.666 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 -7.32 19.0 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.122 2.548 . . . . 0.0 113.251 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 t -111.94 -38.51 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.691 1.196 . . . . 0.0 112.749 -173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.4 p -135.09 9.98 3.53 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 61.82 7.95 2.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.079 2.552 . . . . 0.0 117.04 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -66.19 147.31 53.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.43 1.092 . . . . 0.0 111.967 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 62.5 p -108.05 144.33 35.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.888 1.275 . . . . 0.0 113.796 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -141.73 156.59 45.6 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.686 1.995 . . . . 0.0 111.52 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -84.18 -18.99 34.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -172.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -145.57 155.99 43.41 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.212 1.005 . . . . 0.0 113.037 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 25' ' ' ILE . 37.8 t70 -62.86 -35.72 80.9 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.5 -0.75 . . . . 0.0 112.253 173.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -66.32 -9.08 29.61 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 173.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -100.42 -44.45 5.89 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.624 1.17 . . . . 0.0 111.407 171.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 22' ' ' ASP . 8.4 tp -67.72 -38.6 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 119.19 0.904 . . . . 0.0 112.985 -177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -65.52 -40.25 92.76 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.564 -0.71 . . . . 0.0 111.193 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.3 m -65.26 -40.21 93.66 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -60.1 -48.56 81.22 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.463 0.705 . . . . 0.0 112.019 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -63.08 -40.88 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.696 0.798 . . . . 0.0 110.66 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -66.38 -40.36 89.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.769 1.228 . . . . 0.0 112.764 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 t -90.23 -28.02 19.12 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -101.63 -28.7 12.36 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -131.65 40.42 0.6 Allowed Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -169.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -63.14 -30.67 75.31 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.005 2.47 . . . . 0.0 114.693 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.2 -2.41 37.55 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.265 1.026 . . . . 0.0 113.753 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.2 t -110.2 -16.89 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.064 1.746 . . . . 0.0 112.234 -171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.462 1.905 . . . . 0.0 113.718 176.927 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.658 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.9 t -148.89 150.15 32.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.042 1.337 . . . . 0.0 111.896 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.8 p -83.52 -9.61 58.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.188 1.395 . . . . 0.0 113.698 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.21 17.76 80.16 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.46 1.029 . . . . 0.0 115.025 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.5 p -69.07 164.38 22.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.816 1.246 . . . . 0.0 113.406 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.4 p -136.85 161.46 35.92 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.232 1.413 . . . . 0.0 113.038 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.12 6.76 48.41 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.871 1.225 . . . . 0.0 115.793 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 94.6 mtm-85 -80.79 -11.45 59.6 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.856 1.328 . . . . 0.0 114.391 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.4 m -95.87 148.27 22.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.973 1.309 . . . . 0.0 111.639 172.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.48 149.33 42.56 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.136 1.374 . . . . 0.0 110.747 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.0 p -144.73 143.28 30.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 0.0 112.664 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -59.84 129.11 87.6 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.55 1.14 . . . . 0.0 112.159 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.72 -8.56 21.62 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.57 -38.07 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.596 1.159 . . . . 0.0 112.701 -176.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.7 p -137.37 25.78 2.91 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.018 1.858 . . . . 0.0 116.018 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 61.11 -20.36 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.996 3.318 . . . . 0.0 118.816 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -54.36 139.6 36.27 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.197 1.399 . . . . 0.0 113.629 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.0 m -92.94 148.58 21.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.769 1.228 . . . . 0.0 113.392 -174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -139.84 148.69 42.49 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.203 1.801 . . . . 0.0 111.688 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 m -88.95 -11.86 43.23 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -145.15 154.09 42.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.092 1.357 . . . . 0.0 111.741 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.09 -35.57 80.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.926 0.891 . . . . 0.0 112.693 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -67.95 -33.42 74.64 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.426 -0.796 . . . . 0.0 113.113 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.37 -45.53 69.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.386 0.674 . . . . 0.0 111.313 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 tt -69.55 -36.82 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.183 175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -63.33 -42.35 98.95 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.945 1.248 . . . . 0.0 112.21 174.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 m -61.42 -41.16 96.72 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.205 0.911 . . . . 0.0 112.198 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -62.4 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.01 0.823 . . . . 0.0 112.537 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.58 -42.67 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.655 0.782 . . . . 0.0 110.517 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -74.58 -21.65 59.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -94.22 -34.86 12.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.783 1.233 . . . . 0.0 113.975 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -106.74 -27.72 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.258 1.023 . . . . 0.0 113.656 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -134.89 48.43 2.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 125.489 1.516 . . . . 0.0 112.18 -172.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -61.12 -35.35 86.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.234 2.623 . . . . 0.0 114.918 -168.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.03 -2.59 18.86 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.2 -4.41 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 127.443 2.297 . . . . 0.0 111.696 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.479 1.512 . . . . 0.0 112.89 175.545 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 p -145.3 175.9 9.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.374 1.469 . . . . 0.0 112.243 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.2 p -70.85 -16.99 62.74 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -17.06 5.81 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.037 1.303 . . . . 0.0 113.988 -168.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -88.86 -25.43 22.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.129 1.372 . . . . 0.0 112.666 175.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -81.64 46.56 0.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.596 1.559 . . . . 0.0 112.141 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 121.85 8.01 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.918 1.247 . . . . 0.0 112.043 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -140.4 157.58 45.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.931 1.692 . . . . 0.0 111.479 -170.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.2 p -140.45 165.58 27.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.246 1.418 . . . . 0.0 112.992 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -130.04 149.09 51.91 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.89 2.076 . . . . 0.0 109.765 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 m -133.71 138.48 45.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.863 0.756 . . . . 0.0 112.604 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.8 t -59.17 133.18 87.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.363 1.465 . . . . 0.0 112.83 -175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.19 -11.52 25.11 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.257 2.638 . . . . 0.0 113.692 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.5 t -107.7 -40.64 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.332 1.053 . . . . 0.0 112.876 -176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -128.24 1.28 5.77 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 60.33 16.8 6.52 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.644 1.978 . . . . 0.0 115.618 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -64.45 137.26 57.78 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.902 -1.124 . . . . 0.0 110.648 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.2 m -102.2 147.48 26.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.207 1.003 . . . . 0.0 113.537 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -140.66 149.61 42.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.624 1.97 . . . . 0.0 111.552 -173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 m -87.96 -18.25 29.48 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -175.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -142.61 152.1 42.17 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.952 1.301 . . . . 0.0 111.802 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -62.91 -37.43 86.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -23.1 62.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.66 -45.42 37.18 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.616 0.767 . . . . 0.0 111.063 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 tt -68.11 -40.48 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.711 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.74 -43.68 90.29 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.581 1.082 . . . . 0.0 111.75 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.1 m -62.89 -43.91 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.164 0.586 . . . . 0.0 111.95 174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -59.76 -52.28 66.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.737 0.699 . . . . 0.0 112.41 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 90.6 mt -60.37 -40.55 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.153 0.433 . . . . 0.0 110.202 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -71.09 -32.43 69.06 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.133 0.973 . . . . 0.0 113.398 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -88.86 -27.58 20.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -107.24 -25.03 11.69 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -131.99 71.76 79.9 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.533 1.133 . . . . 0.0 111.625 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -56.75 -24.93 57.97 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 124.454 3.436 . . . . 0.0 117.074 -171.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.78 -3.6 35.87 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.97 -42.25 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.53 1.532 . . . . 0.0 112.494 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.484 1.914 . . . . 0.0 113.069 -179.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 p -64.13 -21.04 66.39 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -65.26 -14.94 61.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.125 1.37 . . . . 0.0 113.922 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.17 -7.85 60.71 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 124.7 1.143 . . . . 0.0 115.25 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.6 m 57.97 28.79 16.71 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.716 1.606 . . . . 0.0 115.038 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.7 m -77.49 64.1 2.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.908 1.683 . . . . 0.0 112.044 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.26 169.02 39.09 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.873 1.225 . . . . 0.0 112.697 -169.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 155.03 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.99 1.316 . . . . 0.0 111.94 -176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.8 t -97.63 148.06 23.68 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.891 1.277 . . . . 0.0 111.047 170.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.4 147.0 50.62 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.121 1.768 . . . . 0.0 111.201 -174.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.3 m -121.04 133.29 55.24 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.369 1.068 . . . . 0.0 112.114 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.55 131.12 71.14 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.897 1.279 . . . . 0.0 112.164 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.38 -6.21 18.44 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.294 2.663 . . . . 0.0 113.784 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.86 -37.61 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.287 1.035 . . . . 0.0 113.244 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.04 8.96 4.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 59.7 16.37 5.44 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.906 2.482 . . . . 0.0 116.679 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -68.09 150.21 48.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.469 1.108 . . . . 0.0 112.078 172.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -103.28 142.06 34.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.699 1.2 . . . . 0.0 113.249 -171.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -140.0 133.03 29.48 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.429 1.491 . . . . 0.0 111.633 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -82.84 -1.23 51.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -141.33 141.7 33.85 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.429 1.892 . . . . 0.0 110.544 -175.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.19 -33.77 76.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.244 0.618 . . . . 0.0 112.453 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -66.84 -29.55 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.186 0.995 . . . . 0.0 113.471 173.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.5 mt -78.69 -40.34 34.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.959 0.8 . . . . 0.0 112.114 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.4 tt -66.73 -40.17 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.268 0.94 . . . . 0.0 111.292 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.97 -40.0 94.09 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.801 1.182 . . . . 0.0 111.897 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.8 m -63.43 -42.41 98.69 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.786 0.721 . . . . 0.0 112.223 173.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -62.49 -45.85 91.13 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.486 -0.759 . . . . 0.0 112.227 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.09 -44.23 94.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.328 0.651 . . . . 0.0 109.934 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -68.67 -31.29 70.31 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.065 1.302 . . . . 0.0 113.958 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.5 p -91.39 -40.27 11.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.612 1.165 . . . . 0.0 113.847 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -102.8 -30.9 10.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.505 1.122 . . . . 0.0 112.536 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -132.02 49.78 5.01 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.56 -172.98 0.5 Allowed 'Trans proline' 0 N--CA 1.421 -2.759 0 N-CA-C 101.737 -3.986 . . . . 0.0 101.737 152.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.261 10.1 pt-20 48.65 -10.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 131.139 3.776 . . . . 0.0 116.004 -167.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.98 -37.2 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.413 2.285 . . . . 0.0 112.109 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.048 1.739 . . . . 0.0 112.186 -176.217 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_